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Abstract 
Xenobiotic Organic Compounds (XOCs) are present in wastewater and wastewater-impacted 
environmental systems. Pharmaceuticals and personal care products are a broad and varied category 
of chemicals that are included among these compounds. Although, these compounds have been 
detected at low levels in surface water, concerns that these compounds may have an impact on human 
health and aquatic life, have led to increased interest in how XOCs are removed during wastewater 
treatment. Recognizing specific mechanisms in recent literature and simulating those mechanisms 
responsible for the removal of XOCs is the main objective of this study. Conventional models, such 
as the popular activated sludge models (ASM1, ASM2, etc), do not sufficiently address the removal 
processes; therefore, a fate model is created to provide a means of predicting and simulating removal 
mechanisms along with experimental analyses.  
GPS-X is a multi-purpose modeling tool for the simulation of municipal and industrial wastewater 
treatment plants. This software package includes conventional models as built-in libraries, which can 
be used as bases on which new models can be created. In this thesis, the removal mechanisms of 
XOCs are recognized and investigated; a new library for GPS-X is also created to include XOCs. 
As a first step the uncalibrated fate model, which includes all mechanisms of interest with their 
process rates and state variables, is developed using in GPS-X software. A modified ASM1 (Mantis 
model) is used as a basis for developing the fate model. Since only a group of mechanisms is 
responsible for the removal of each compound the mechanisms are categorized in three different case 
studies as the next step.  Thus, one submodel is associated with each case study. The model developer 
toolbar in GPS-X software is used to develop the model for these case studies. The first case study 
involves the removal of antibiotics, such as Sulfamethoxazole. The removal mechanisms used in this 
case are biodegradation, sorption, and parent compound formation, with co-metabolism and 
competitive inhibition effects being inserted into the structure of the model. Secondly, the removal of 
nonylphenol ethoxylates (NPEOs) occurs through abiotic oxidative cleavage, hydrolysis, and 
biodegradation. The third case study includes removal mechanisms of biodegradation and sorption for 
neutral and ionized compounds. 
In the calibration process, model parameters are tuned such that the model can best simulate the 
experimental data using optimization methods. A common error criterion is Sum of Squared Errors 
  iv 
(SSE) between the simulated results and the measured data. By minimizing SSE, optimal values of 
parameters of interest can be estimated. In each case study different data sets were used for the 
validation process. 
To validate the calibrated model, simulated results are compared against experimental data in each 
case study. The experimental data set used in the validation process is different from that used for 
calibrating the model, which means the validation process data set was obtained from the different 
literature. By looking at the validation results, it is concluded that the proposed model successfully 
simulates removal of XOCs.  
Since the operating parameters of wastewater treatment plants, such as Solids Retention Time (SRT) 
and Hydraulic Retention Time (HRT) are crucial for the fate of XOC’s, a sensitivity analysis is 
carried out to investigate the effect of those parameters. Moreover, the pH effect is studied because it 
relates to the ionized XOCs. Sensitivity analysis results show that the fate model is more sensitive to 
model parameters i.e. biodegradation rate constant (kb) than the operational parameters, i.e. SRT and 
HRT. Furthermore, the responses showed sensitivity to pH, whereby acidic conditions provide a 
better environment for removing neutral forms and alkaline conditions were suitable for removing 
ionized forms, according to the ionized compound fate model.  
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CHAPTER 1 
INTRODUCTION 
1.1 Background 
Municipal wastewater contains a complex mixture of Xenobiotic Organic Compounds (XOCs) 
originating from personal care products, pharmaceuticals, excreted hormones, household and 
industrial chemicals, and so on. Press-Kristensen et al., 2007 [31] have estimated that wastewater 
could contain many types of XOCs. 
Wastewater treatment plants (WWTPs) remove XOCs from the water mainly by sorption, biological 
and/or chemical degradation, volatilization, and/or stripping. Conventional wastewater treatment is 
not directly designed for removing XOCs but reduces concentration of several key XOCs [156, 157, 
158]. However, particular XOCs are frequently reported in WWTP effluents in potentially toxic 
concentrations [160] that are known to cause toxic effects in different recipients and species. In 
addition, these chemicals may cause long-term changes in aquatic ecosystems [161]. Feminisation of 
male fish in different species is a well-known effect observed in recipients loaded with treated 
wastewater. Experiments with caged fish have confirmed that wastewater containing Endocrine 
Disrupting Compounds (EDC) have the capability to cause feminization. EDCs originate from several 
sources, such as natural and pharmaceutical hormones and industrial chemicals. Furthermore, XOCs 
in freshwater have been observed and may constitute a risk on human health and aquatic life [67]. 
Improved wastewater treatment may be an efficient way to reduce XOCs pollution. Several studies 
have identified the biodegradation of XOCs as a vital elimination process in WWTPs [156, 159]. 
However, our ability to utilize and control the parameters and processes governing the biodegradation 
of XOCs in activated sludge systems remains a challenge. Therefore, models developed and 
calibrated from the experiments with carefully selected model pollutants should be constructed to 
support scientists to reveal and realize optimal treatment levels. 
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1.2 Objective 
The objective of this thesis is to develop and critically evaluate an enhanced fate model for XOCs in 
wastewater treatment plants. Major mechanisms that are responsible for the removal of XOCs in 
wastewater treatment were identified and integrated with an ASM1 model to create an uncalibrated 
fate model. Activated sludge models (ASM) can differentiate between viable and non-viable biomass, 
so it was expected that ASM-based integrated fate models should be able to provide more accurate 
predictions of XOC fate over a range of operating conditions. Hence the development of an integrated 
fate and ASM model was employed in this research to have an improved estimate of the viable 
biomass. 
The fate modeling will address the following categories of fate mechanisms: 
1- Physical chemical processes 
‐ Abiotic cleavage process 
‐ Abiotic hydrolysis    
‐ Stripping and volatilization 
‐ Sorption-desorption of neutral and  ionized compound process 
2- Biodegradation 
‐ Biotic hydrolysis 
‐ Aerobic and anoxic biotransformation 
‐ Aerobic and anoxic parent compound formation 
‐ Co-metabolism 
‐ Competitive inhibition 
These mechanisms will initially be incorporated into the GPS-X process simulator to create the 
uncalibrated fate model of this thesis. Since only a group of mechanisms is responsible for the 
removal of each compound the mechanisms are categorized in three different case studies as the next 
step.  Each case study will be calibrated and validated individually using corresponding data from the 
literature. 
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The combined enhanced model will be critically evaluated by conducting a sensitivity analysis that 
will evaluate the impact of operational and modeling parameters, such as Solid Retention Time 
(SRT), biodegradation and partitioning coefficients, and pH on contaminant fate. 
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CHAPTER 2 
LITERATURE BACKGROUND 
2.1 Objectives of literature review 
Most households regularly use products containing trace organic compounds (TOrCs), including 
suspected endocrine disrupting compounds (EDCs), pharmaceutically active compounds (PhACs), 
personal care products (PCPs), and household chemicals (HHCs) that ultimately end up in municipal 
wastewater treatment systems. These anthropogenic TOrCs are of concern due to the increasing 
number of reports of reproductive disorders in aquatic wildlife residing below wastewater outfalls.  
The objective of the literature review for this thesis is to initially identify the major mechanisms that 
are responsible for the removal of Xenobiotic Organic Compounds (XOCs) in wastewater treatment 
to support the creation of a model that can describe the fate of these compounds in wastewater 
treatment systems. The other aim of this review is to gather experimental data sets on the removal of 
XOCs that can be used to calibrate and validate the various models developed. The literature review 
includes major findings and research gaps related to modeling.  
2.2 Removal mechanisms 
The objective of this work is to develop a model that can be used to better understand and optimize 
the removal of Xenobiotic Organic Compounds (XOCs) in combination with removal of traditional 
pollutants in wastewater treatment plants. Therefore, accurate predictions of the removal of these 
compounds, requires appropriate recognition of removal mechanisms. XOC removal processes are 
categorized in two major groups: 1) physical-chemical processes such as sorption and volatilization, 
and 2) biological degradation. For a number of XOCs, biodegradation is recognized as the dominant 
removal process, whereas for some others, sorption is the most effective process. For antibiotics, that 
form a large group of XOCs, biodegradation and sorption are the major processes for removal, while 
volatilization and hydrolysis are negligible. For most micropollutants, volatilization is not significant 
since these compounds tend to partition into liquid phase more than into the gas phase [10, 60, 40, 75, 
83]. 
Under these two main categories, the following sub-mechanisms have been identified and will be 
subsequently described: 
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1- Physical chemical processes 
‐ Abiotic cleavage process 
‐ Sorption-desorption of neutral and ionized compound process 
2- Biodegradation 
‐ Biotic hydrolysis 
‐ Aerobic and anoxic biotransformation 
‐ Aerobic and anoxic parent compound transformation 
‐ Co-metabolism 
‐ Competitive inhibition 
2.2.1Physical chemical processes 
Physical chemical processes can occur at any scale, and can be considered as the changes in the 
conditions of chemical compounds that are not mediated by bacteria [19, 72, 73, 74]. 
2.2.1.1Abiotic cleavage process 
In this process a complex molecule is cleaved into molecules that may be more available for 
biodegradation. The rate of this process is typically described by the following equation: 
.AC ACr k a=  (2.1)
Where ACk , is the first-order abiotic cleavage coefficient (d-1) and a  is the complex molecule 
concentration (g/m3) [19, 73, 74].  
A class of compounds that are transformed by this mechanism are the Nonylphenol Ethoxylates 
(NPEOs) [19].  In aerobic systems, the major pathway of biodegradation for NPEO has been shown 
to be the stepwise oxidation and cleavage of the polyoxyethylene chain either by hydrolysis or an 
oxidative hydrolytic mechanism before biodegradation of this compound. In aerobic conditions, the 
oxidative cleavage process converts the NPEOs to nonylphenoxy acetic acid (NPE1C), and to 
nonylphenoxyethoxy acetic acid (NPE2C) [78, 79, 80, 81]. The structures of the NPEOs and their 
metabolites are shown in Figure 2.1. 
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Figure 2.1 Nonylphenol polyethoxylates and their metabolites in aerobic condition. 
2.2.1.2 Sorption-desorption of neutral and ionized compound process 
Sorption is one of the major mechanisms of XOC removal within activated sludge processes. The 
sorption process can be considered as the net result of two reactions, sorption from the liquid to the 
solid phase and desorption from the solid to the liquid phases. In a number of studies [25, 30, 40], the 
model employed for sorption of XOCs is described in Figure 2.2: 
 
Figure 2.2 Sorption model for batch experiments Taken from [40] 
Assuming sorption from the liquid phase to the particulate matter and desorption from the particulate 
matter are independent, a dynamic model of sorption can be stated as per equations 2.2-2.3: 
(parameters are also defined in nomenclature.) 
sor SS des
dS K X S K X
dt
= − ⋅ ⋅ + ⋅  (2.2)
S
Soluble Compounds
SS
Suspended Solids
X+SS
Sorbed Compounds+
Ksor XSS S
Kdes X
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sor SS des
dX K X S K X
dt
= ⋅ ⋅ − ⋅  (2.3)
Ksor: rate constant for sorptionc, 
1 1LgSS d− −  
XSS: suspended solids concentration in raw wastewater or production of suspended solids in 
primary and/or secondary treatment per L of wastewater, gss/ m3 
KDes: rate constant for desorption, 1/d 
S: soluble concentration of trace compound, 
1mgL−  
 
Sorption equilibrium occurs when the rates of sorption and desorption are equal. An equilibrium 
sorption coefficient, Kd can be employed to describe the equilibrium partitioning characteristics of a 
compound. Under equilibrium conditions, the concentration sorbed to sludge is often assumed to be 
linearly proportional to the concentration in solution [39, 75]. 
part sor
d
SS des
X KXK
S X S K
= = =⋅  
(2.4)
C X S= +  (2.5)
(1 )SS dC S X K= ⋅ + ⋅  (2.6)
The total compound concentration in a sample, C, can be defined as per equation 2.5 and under 
equilibrium conditions this expression can be written as per equation 2.6.  These equations are 
typically employed for neutral organic compounds. 
The pH of the wastewater can play a crucial role in the sorption of weak acids. The Sorption of acidic 
pharmaceuticals has been reported to increase with decreasing pH [41]. In acidic conditions (i.e pH 
<< pKa), the Kd of an ionizing compound has a linear relation with log (Kow); in other words, the 
sorption tendency of pharmaceuticals can be estimated by their corresponding log (Kow) because the 
acidic compounds in acidic conditions are electrically neutral solutes. Figure 2.3a shows the 
relationship between log Kow and log kp for selected compounds.  This figure shows a strong 
correlation for E2, EE2, BPA, E1, BZP, PPZ and CBZ, which do not have a hydrophilic carboxyl 
functional group. Unlike these electrically neutral substances, a linear relationship was not found for 
acidic pharmaceutical compounds like CA, GFZ, IBP, FEP, KEP, NPX, DCF and IDM. This is 
because these acidic pharmaceuticals are ionized at neutral pH conditions and hence have little 
tendency to adsorb in the sludge. Figure 2.3.b shows that the kp values of the target compounds were 
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correlated linearly with log Kow in the acidic pH condition. Comparing Figure 2.3.b with Figure 2.3.a, 
the kp of CA, GFZ, IBP, FEP, KEP, NPX, DCF and IDM increased in the acidic condition while the 
effect of pH on kp was small for E2, EE2, BPA, E1, BZP, PPZ and CBZ, which do not have a 
hydrophilic carboxyl functional group. These results demonstrate that the acidic pharmaceuticals are 
electrically neutral solutes in the acidic condition and the increased tendency of adsorption can be 
predicted by log Kow. So according to Figure 2.3, for removal of acidic pharmaceuticals, acidic 
condition provides a better environment [41].  
For weak organic acids with only one acidic group the compound may be partially dissociated 
depending upon the pH.  The partitioning of the neutral and ionized forms of the compounds to the 
solids phase will differ and hence the overall partitioning can be described as: 
[ ] [ ]
[ ] [ ]
oc oc
ow
w w
HA AD
HA A
−
−
+= +  
(2.7)
Where oc, represent the concentration in solid phase and w represents the concentration in water 
phase. For neutral compounds the value of Dow equals Kd. 
[ ] [ ]
[ ]a w
H AK
HA
+ −×=  (2.8)
( )
1log log log
1 10 aow ow pk pH
D K −= + +  
(2.9)
Equilibrium dissociation of the acid can be described by equation 2.8, and hence for acidic 
compounds equation 2.9 can be used to derive an expression for log Dow [45, 46]. 
The removal by sorption in municipal sewage treatment plants (STP) without biological degradation, 
for compounds with -10.3 LgSSKd ≤  has been reported to be minimal [20, 39, 41]. As the Kd of most 
pharmaceuticals lies in -10.3 LgSSKd ≤ , sorption is typically not considered to be a dominant removal 
mechanism for them. Values of Kd for musk fragrances are however greater than those of 
pharmaceuticals and thus sorption mechanism can be a dominant process for the removal of these 
types of compounds (Table 2.1). 
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(a)
 
(b)
Figure 2.3 Correlation between Kow and kp in the cases of (a) pH at 6.7 and (b) pH at 5.6 [41] 
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Table 2.1 Solid liquid partitioning coefficient Kd for pharmaceuticals and polycyclic musk fragrances in contact with 
primary and secondary sludge [10, 23, 27, 29, 40, 44, 58, 87, 90]. 
Group Compound 
Kd 
primary sludge 
 [LgSS-1] 
Kd  
secondary 
sludge 
[LgSS-1] 
pKa 
Antibiotics Azithromycin  0.38±0.09 8.7-9.5 
 Clathromycin  0.26±0.01 8.9-9.0 
 Cipofloxacin 2.6±1.6  26±7.3 6.0-8.8 
 Anhydroerythromycin  0.165 8.9 
 Norfloxacin 2.5±1.5  37±13 6.3-8.4 
 Sulfamethoxazole  0.26±0.17  1.8-5.6 
Drugs Carbamazephine ≤0.02 0.0012±0.0005 -- 
 Clofibric acid ≤0.03 0.005±0.0025 3.0 
 Cyclophosphamide 0.055±0.02 0.0024±0.0005 -- 
 Diazepam 0.044±0.026 0.02±0.008 3.3 
 Diclofenac 0.46±0.03 0.016±0.003 4.2 
 Fenoprofen  0.026 4.5 
 Gemfibrozil  0.075 4.8 
 Ibuprofen ≤0.02 0.007±0.002 4.5-5.2 
 Ifosfamide 0.022±0.014 0.0014±0.0004 -- 
 Indomethacin  0.028 4.5 
 Naproxen  0.013[27] 4.2[27] 
 Paracetamol  ≤0.001 9.5 
Contrast Media Iopromide ≤0.005 0.011±0.001 9.9 
Fragrances AHTN 4.9±2.1 1.8±0.5 -- 
 HHCB 5.3±1.9 2.4±1.0 -- 
Hormones 17α-Ethinylestradiol 0.28±0.005 0.35±0.04 10.5 
In most sorption models, the sludge is considered to be a two-compartment system in which XOCs 
are partitioned between liquid and sludge phases. However, in recent models [1], the sludge is 
described as a three-compartment matrix in which XOCs are present in three states: freely dissolved, 
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sorbed to particles, and sorbed to dissolved and colloidal matter (DCM), as depicted schematically in 
Figure 2.4.  
 
Figure 2.4 Representation of the three-compartment model of micropollutants in sludge [1] 
The sorption model depicted in Figure 2.2 can be extended for this condition, with the assumption of 
equilibrium conditions, and sorption of XOCs to sludge is described by two different equilibrium 
relationships (equations 2.10-2.11): 
1
DCM: Equilibrium constant of compound sorption to DCM (Lg ) DCMDCM
free
CK
C
− = (2.10)
1
part: Equilibrium constant of compound sorption to particles (Lg )
part
part
free
C
K
C
− = (2.11)
Since the measurement of Cfree is practically difficult, a new relevant quantity Caqu is defined which is 
much easier to measure. This variable is obtained by summing the freely dissolved and sorbed to 
DCM concentrations and afterwards Kglobal has been defined as per equation 2.12 (Barret et al. 2010 
[1]): 
[ ] [ ] 1
part part free part
global
aqu DCM free free DCM
C K C K
K
C K C DCM C K DCM
⋅= = =⋅ ⋅ + ⋅ +
(2.12)
Overall, the description of XOC sorption in a three-compartment matrix may lead to more accurate 
results for the fate of these compounds; however studies, such as [1], have shown that the affinity of 
XOCs for particles is stronger than colloids and thus in most cases it can be excluded from models.  
2.2.2 Biodegradation 
Biological degradation plays an important role in removal of XOCs in wastewater treatment.  Current 
models available in the literature which describe the biodegradation phenomenon, consist of either 
Micropollutant
Dissolved and 
Colloidal Matter (DCM)
Kpart
K DC
M
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simple structures such as pseudo-first order kinetic (or first order) models, or more complex models 
in which inhibition kinetics and metabolic models are also included [3, 25, 19, 30]. 
The pseudo-first order kinetic model is: 
bio SS
dC K X S
dt
= − ⋅ ⋅  (2.13)
And the first order kinetic model is: 
'
bio
dC K S
dt
= − ⋅  (2.14)
Batch experiments have indicated that in the absence of activated sludge, no removal is observed in 
the clean water systems [40]. Thus, the removal of XOCs occurs as a result of interactions between 
the XOCs and the sludge. Therefore, equation 2.13 is typically deemed to be more appropriate for 
describing biodegradation rates. In some reports it is assumed that the sorption and desorption 
processes are fast relative to the biodegradation process and equation 2.13 is re-written as equation 
2.15: 
1
bio
SS
d SS
KdS X S
dt K X
−= ⋅ ⋅+ ⋅  (2.15)
In some models such as TOXCHEM+, the suspended growth biodegradation process is described by 
the Monod model [76]: 
m
b
S
Cr X
Y K C
μ ⎛ ⎞= ⎜ ⎟+⎝ ⎠   
(2.16)
Rearranging equation 2.16, yields the following equation:  
''
1 /b bio S
Cr K X
C K
⎛ ⎞= ⎜ ⎟+⎝ ⎠  
 (2.17)
where '' mbio
S
K
Y K
μ= ⋅ .  
In cases where the compound concentration is low relative to KS, which is the case for XOCs, 
equation 2.17 is simplified to equation 2.18: 
if   s b bioC K r K C X→ = ⋅ ⋅?  (2.18)
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In many models, bioK , is expressed per unit of sludge dry matter, and hence this constant depends not 
only on the degradability characteristics of compounds but also on the sludge composition [75]. 
However, it would be expected that the following properties are will influence the biodegradation 
process: 
? biodiversity of the active biomass 
? fraction of active biomass within the total suspended solids 
? availability of the co-substrate  
Sludge retention time (SRT) is one of the crucial parameters in the biodegradation process. Increasing 
the SRT has been reported to result in an increase in the biodiversity of the activated sludge [5, 110, 
112], as in equation 2.18/. In COD removal plants with 4SRT d≤ , the removal of trace compounds 
has been observed to be reduced whereas for plants with 10 ,SRT d≥  a larger number of compounds 
are biologically transformed [9, 52, 75]. 
0( )( )[ ]
1m
Y S SSRTX
HRT kd SRT
−= + ⋅  
(2.18/)
mX : Viable biomass concentration 
Y : Yield coefficient 
0S : Influent concentration of soluble biodegradable COD 
S : Effluent concentration of soluble biodegradable COD 
kd ; Decay coefficient 
In most fate models, the active biomass is not measurable experimentally; thus, in practice it is 
assumed to be equal to the Mixed Liquor Suspended Solid (MLSS) or the Mixed Liquor Volatile 
Suspended Solid MLVSS [30, 83, 84]. Activated sludge models (ASM) [153], however can 
differentiate between viable and non-viable biomass, so it would be expected that ASM based 
integrated fate models, should be able to provide more accurate predictions of XOC fate over a range 
of operating conditions. Hence in this research the development of an integrated fate and ASM model 
will be employed to have an improved estimate of the viable biomass. 
Temperature is a significant factor affecting the rate of biodegradation [24]. In many of the models 
presented for biodegradation (Schwarzenbach et al. 2005 [32], Lindblom et al. 2009 [25]) temperature 
effects on biodegradation rate coefficients are based on the Arrhenius equation: 
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( )
, ,
T ref
ref
K T T
bio T bio TK K e
−= ⋅  (2.19)
where the temperature coefficient KT lies between 0.03-0.09 [38]. Consequently, considering a 
seasonal temperature variation of 10 ºC for municipal wastewater, the temperature effect on ,bio TK
would be a multiplier of 2.4 which could be significant when considering the fate of XOCs in 
wastewater treatment. 
The availability of electron acceptors (i.e. the redox potential in the reactor) can also affect the value 
of bioK . The values of bioK for estrone (E1), 17α-ethinylstradiol (EE2), ibuprofen, ketoprofen, 
naproxen and sulfamethoxazole, have been reported to be significantly higher if these compounds 
were degraded in the presence of oxygen rather than other electron acceptors like nitrate which have 
lower redox potential (Joss et al. 2004 [15], Zabczynski et al. 2009 [42]). In Appendix F, bioK for 
several XOCs are presented. In the following subsections various biodegradation processes in 
different conditions related to different electron acceptors will be discussed. 
2.2.2.1 Aerobic and anoxic biotransformation 
Depending upon the wastewater treatment plant configuration, biodegradation may occur in either 
aerobic or anoxic conditions. The differences between these two conditions are the oxygen 
availability and the bacteria that are responsible for biomass growth. In aerobic conditions, oxygen is 
available for biodegradation and the bacteria that are responsible for biomass growth are heterotrophs 
(Xbh). In anoxic conditions, oxygen is not available and the bacteria are facultative heterotrophs (Xbh) 
using different electron acceptor like nitrate for growing biomass [19, 30, 42, 71, 75]. 
2.2.2.2 Biotic hydrolysis 
Biotic hydrolysis is mediated by bacteria, and hence can only occur in the presence of biomass. In this 
process the slowly biodegradable portion of a compound is assumed to be converted to a readily 
biodegradable substrate. A wide range of conventional compounds and some XOCs can be employed 
as examples of this transformation. The kinetics of this phenomenon has been described by the 
following rate expressions [153]:  
,
, ,
/[ ][( ) ( )( )]
( / )
O Hs s BH O NO
h BH
X s BH O H O O H O NO NO
KdX X X S Sk X
dt K X X K S K S K S
η= − ++ + + +  (2.20)
,
, ,
/[ ][( ) ( )( )]
( / )
O Hs s BH O NO
h BH
X s BH O H O O H O NO NO
KdS X X S Sk X
dt K X X K S K S K S
η= ++ + + +  
(2.21)
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In equations 2.20 and 2.21, the slowly biodegradable organic compound, Xs is converted to the 
readily biodegradable compound Ss [19, 71, 72]. The stoichiometry between reactants and products is 
1:1 and the units typically have a COD basis. There are switching functions in the structure of process 
rate expressions such that the rate is influence by the availability of oxygen and nitrate (aerobic and 
anoxic).  
2.2.2.3 Aerobic and anoxic parent compound transformation 
The formation of parent compounds (PCF) from conjugated versions of the compounds has been 
identified relatively recently and introduced into predictive fate models. In the absence of this 
phenomenon, fate models have been observed to deviate from experimental data [30]. In these 
processes the metabolites of pharmaceuticals are transformed back to the parent compound as a result 
of enzyme-catalyzed reactions [61]. Plosz et al. (2010) [30] proposed equations 2.22-2.23 to describe 
biodegradation and formation of a selection of antibiotics. Equation 2.22 describes the biodegradation 
of the parent compounds, equations 2.23 and 2.24 provides the biotransformation of conjugate and 
parent compound respectively, which means the conjugate form is converted backe to the parent 
compound. 
LI
bio SS LI
dC K X C
dt
= − ⋅ ⋅  (2.22)
CJ
Dec SS CJ
dC K X C
dt
= − ⋅ ⋅  (2.23)
LI
Dec SS CJ
dC K X C
dt
= ⋅ ⋅
 
(2.24)
Evidence for this phenomenon has been provided by Nodler et al., 2012 [77].  The antibiotic 
sulfamethoxazole (SMX) which is extensively used in both human and veterinary medicine was 
studied. Since it cannot be completely eliminated by the typical wastewater treatment technology, it is 
frequently detected in the water cycle. Two transformation products (TPs) of SMX (4-nitro-N-(5-
methylisoxazol-3-yl)-benzenesulfonamide (4-nitro-SMX), and N-(5-methylisoxazol-3-yl)-
benzenesulfonamide (desamino-SMX)) were identified and these could be produced under 
denitrifying conditions. The chemical structure and properties of these compounds is shown in Table 
2.2 Hence, in this case the parent compound is SMX and the daughter compounds are 4-nitro-SMX 
and desamino-SMX. 
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Table 2.2 Structures, PKa and log KOW values 
In a denitrifying degradation experiment SMX was not detected after 10 days whereas increasing 
concentrations of the two TPs were observed. However, after 87 days the SMX concentration 
recovered to 53 ±16% of the initial concentration after most of the nitrate was consumed. The 
transformation of 4-nitro-SMX to SMX was confirmed in an anoxic water/sediment test in the 
absence of nitrate as electron acceptor. Figure 2.5 demonstrates this phenomenon that includes 
converting of SMX to the two different compounds and then reconverting them to SMX.  In 
wastewater systems it is possible that the conjugates (4-nitro-SMX and desamino-SMX) could enter 
the wastewater treatment plant in the raw wastewater and then be transformed to form the parent 
compound in the plant [30]. 
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(a) 
 
(b) 
Figure 2.5. Water/sediment experiment on SMX transformation under denitrifying conditions, chart (a): concentrations of 
SMX (biotic and sterile control), desamino-SMX and 4-nitro-SMX. Chart (b): concentrations of nitrate and nitrite [77]. 
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2.2.2.4 Co-metabolism and competitive inhibition 
In some cases the biotransformation of a target compound can be impacted by the presence of other 
substances.  Co-metabolism is defined as the degradation of two compounds simultaneously, in which 
the degradation of the secondary substrate depends on the presence of the primary substrate [62]. 
Competitive inhibition is a form of enzyme inhibition where the binding of the inhibitor to the active 
site on the enzyme prevents the binding of the substrate and vice versa. Therefore, competitive 
inhibitors bind reversibly to the active site of the enzyme; however, an enzyme may bind either the 
inhibitor or the substrate but never both at the same time [63, 64]. 
Both co-metabolism and competitive inhibition have been recently included in predictive fate models 
[30]. The simultaneous degradation of the co-substrate and the micropollutant is linked to the capacity 
of the enzymes to degrade many substrates [134]. For example, methanotrophic bacteria are known to 
co-oxidise PAHs, alkanes and aromatic compounds [85]. When a co-substrate is present, direct 
biodegradation and cometabolism can occur simultaneously. Alvarez-Cohen and Speitel (2001) [86] 
and Plosz et al. (2010) [30], described cometabolism of a micropollutant as a competitive inhibition 
of the direct biodegradation due to the presence of a co-substrate.The integration of cometabolism in 
models requires that both macropollutants and micropollutant fate be modelled simultaneously. This 
approach has been validated in recent models [30] and [96] and has been implemented through 
modification of equations 2.22-2.24 [62, 82, 86, 89, 96]. When the uptake of readily biodegradable 
growth substrates (Ss) occurs, through cometabolism, the uptake of Ss can affect the transformation 
of cometabolic substrates, causing competitive inhibition on micropollutant biotransformation 
processes. By inserting S
S
S Bio
S Bio S
K
K S
η
η
⋅
⋅ +  and 
1
1
S
S
S Dec
S Dec S
K
K S
η
η
⋅
⋅ +   in equations 2.22 and 2.23 respectively, 
the modified equations are presented as follows: 
1
S
LI LI
bio SS
S
S Bio
dC CK XSdt
K η
= − ⋅ ⋅
+ ⋅  
(2.25)
1
1
S
CJ CJ
Dec SS
S
S Dec
dC CK XSdt
K η
= − ⋅ ⋅
+ ⋅
(2.26)
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2.3 Review and comparison of existing fate models  
In this section a review of the fate models that have been reported in the literature and an assessment 
of their ability to describe XOC removal in activated sludge processes are presented.  The review 
identified seven different fate models. Four references were to commercial software including 
SimpleTreat (Struijs et al., 1991 [135]), WWTreat (Cowan et al., 1993 [95]), TOXCHEM+ (Melcer et 
al., 1994 [132]; Parker et al., 1994 [122]; Kemp et al., 2002 [153]), and WEST (Cloutier et al., 2008 
[130]; Plosz et al., 2010 [30]) (Table 2.3). Among the models, it was deemed important to 
differentiate between steady-state and dynamic models (Table 2.3). Both model types use the same 
mass balance equations, but steady-state models only simulate conditions that are constant with time. 
By design, dynamic models can account for temporal variations of micropollutants concentrations in 
the WWTP inlet. 
As previously discussed, the removal of micropollutants within activated sludge systems can be 
attributed to two main mechanisms: sorption to the sludge and biological conversion 
(biodegradation). Each of them can contribute to a change in micropollutant concentration in the 
dissolved and solid compartments. Sorption consists of a transfer of the micropollutant between the 
two compartments (dissolved-solid compartments), whereas biodegradation typically implies an 
elimination of the micropollutant from the dissolved compartment. 
In the following sections, the theoretical and modelling tools proposed in the literature to describe 
these two major removal mechanisms are reviewed. 
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Table 2.3 Models describing XOC fate in activated sludge processes, with indication of mechanism type and biomass estimation in each 
fate models 
Mechanisms 
Struijs et 
al. 
(1991)—
SimpleTre
at [135] 
Cowan et 
al.(1993)
—
WWTreat 
[95] 
Jacobsen 
and Arvin 
(1996) 
[105] 
Kemp et al. 
(2002)—
TOXCHE
M+ ™ 
[153] 
Urase 
and 
Kikuta 
(2005) 
[41] 
Lindblom 
et al. 
(2009) 
[25] 
Plosz et 
al. 
(2010)—
WEST 
[30] 
Aerobic growth of 
XOC × × × × × × × 
Anoxic growth of 
XOC       × 
Instantaneous Sorption × ×      
Sorption   × × × × × 
Desorption   ×    × 
Decay of XOC   ×   ×  
Parent compound 
transformation       × 
Co-Metabolism       × 
Competitive inhibition       × 
Abiotic hydrolysis        
Biotic hydrolysis        
Abiotic cleavage 
process   
     
Biomass prediction for 
XOC degradation MLSS MLVSS * MLVSS MLSS * MLSS 
ASM based model   ×   × × 
Dynamic   × × × × × 
Static × ×      
* Active specific biomass for XOC degradation 
 21 
 
2.3.1 Sorption processes in fate models 
As described in section 2.2, two compartments are usually defined for sorption: the aqueous 
compartment which is the dissolved phase, and the solid phase of the sludge or mixed liquor (that can 
be considered as a biosorbent). When an XOC is distributed between these two compartments under 
non-equilibrium conditions, sorption and desorption can occur simultaneously, as described in 
equation 2.28. 
( )XOC sorption sor XOC des XOC
dS k S MLSS k X
dt
= − × × + ×  (2.28)
sork : sorption kinetic constant (l/gss/d) 
desk : desorption kinetic constant (1/d) 
MLSS : liquor suspended solids concentration (mg/L) 
 
In the literature, empirical models with a limited number of parameters have frequently been 
employed to describe sorption.  The common models used to describe sorption isotherms are the 
Langmuir model, the Freundlich model and the linear model. At low concentrations of 
micropollutants (e.g., SXOC<1 μg/L), the linear model is typically employed [114].  
sor XOC
d
des XOC
k Xk
k S MLSS
= = ×  
(2.29)
In the steady state models that were reviewed sorption was assumed to be instantaneous, on the basis 
of it being more rapid than biodegradation and also because of the extended HRT employed in the 
activated sludge process (typically 6–24 h) [122]. Moreover, desorption was typically assumed to be 
significantly slower than sorption. According to Table 2.3, the two model were mentioned which 
were used instantaneous sorption concept for the sorption model. The first one is a spread sheet box 
fate model [135] and the second one is the fate model developed by Cowan et al. 1993 [95]. In the 
dynamic models (5 out of 7), a kinetic parameter (ksor) was integrated to simulate sorption [25, 30, 41, 
105, 153] 
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2.3.2 Biodegradation processes in fate models 
In the literature biodegradation modelling commonly includes a biokinetic parameter, the dissolved 
XOC concentration (the substrate; SXOC), and the concentration of biomass that is able to convert this 
substrate. Usually, a first order biodegradation reaction is shown as equation 2.30 and a pseudo first 
order kinetic is written as equation 2.31 [83, 91, 95, 131, 132, 118]. 
deg( ) ( )XOC bio radation bio XOC active
dS k S t X
dt
= − × ×  (2.30)
'
deg( ) ( )XOC bio radation bio XOC
dS k S t
dt
= − ×  (2.31)
biok : biodegradation kinetic constant ( 1 1LgSS d− − ) 
'
biok : biodegradation kinetic constant (d
-1) 
activeX : active biomass (mg/L), defined as a fraction of MLSS 
 
In practice, the active biomass is not measurable experimentally; thus, it is often assumed that the 
MLSS or MLVSS can represent the active biomass ([83, 84]). According to Table 2.3, the fate model 
presented by [30, 41, 135] inserted the MLSS instead of active biomass in biodegradation rate 
equations and the fat models by [95 and 153] used the MLVSS in biodegradation rate equation and 
the rest of them [25 and 105] considered specific active biomass that were responsible for the removal 
of the XOC. Using this assumption, the influence of the operating conditions and local conditions (for 
example: oxygen, carbon, nitrogen or phosphorus concentrations) on biodegradation kinetics is not 
taken into account. Moreover, first order kinetics depends on Sxoc at all XOC concentrations, while 
Monod-type kinetics vary with Sxoc concentration only at low concentrations. Equations using 
Monod-type kinetics with oxygen limitation for instance (equation 2.32), consider XOC 
biodegradation as a growth process, integrate variables like the dissolved oxygen concentration (SO) 
and the substrate limitation (Sxoc). Hence, they require additional parameters [128, 25, 30]. 
deg max,
,
( ) ( )1( ) ( ) ( )
( ) ( ) ( ) ( )
XOC O XOC
bio radation xoc active
xoc O xoc O XOC XOC
dS S t S t X
dt Y K t S t K t S t
μ= × × × ×+ +  
(2.32)
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xocY : yield coefficient 
max,xocμ : maximum growth rate (1/d) 
OS : oxygen concentration (mg/l) 
,O xocK : oxygen half saturation coefficient (mg/l) 
XOCK : XOC half saturation coefficient (mg/l) 
activeX : active biomass (mg/l), defined as a fraction of MLSS  
 
Other than using different structures and biomass estimation for biodegradation rate equations, in 
developed fate models, different approaches were applied to describe biodegradation process. The 
reviewed models addressed whether dissolved and sorbed compounds are considered to be subject to 
biodegradation. Among the 7 models, 2 different concepts have been proposed: 
‐ only dissolved XOC (SXOC) are biodegraded (Govind et al., 1991[13]; Struijs et al., 
1991[135]; Melcer et al., 1994 [132]; Monteith et al., 1995[105]; Kemp et al., 2002 [153]; 
Rittmann et al., 2003 [129]; Lindblom et al., 2009 [25]; Plosz et al., 2010 [30]); 
‐ Dissolved and sorbed micropollutants are biodegraded simultaneously and with separate rates 
(Cowan et al., 1993 [95]; Lee et al., 1998 [113]; Byrns, 2001[83]). 
The direct biodegradation of solid-phase substances is not commonly accepted however, Larson and 
Yashon (1983) and Shimp and Young (1988) observed biodegradation of a group of cationic 
surfactants when more than 99% of the compounds were in the sorbed phase. Cowan et al. (1993) 
[95] also observed that several classes of consumer product chemicals were biodegraded when they 
were nearly 100% associated with the solids. These observations suggest that direct biodegradation of 
target compounds in the sorbed phase could be a mechanism contributing to the total biodegradation 
of the compound [148]. This hypothesis seems most plausible for systems like activated sludge, in 
which the target compounds are sorbed onto biomass. Thus, adsorption to the solid phase may not 
decrease the compound's biodegradability when the sorbing surface is the biomass itself. 
Although the hypothesis of utilization of a sorbed compound remains to be experimentally verified, 
modeling analyses indicate that direct sorbed-phase biodegradation can significantly alter the fate of 
the target compound during activated-sludge treatment if the adsorbed compound is indeed 
bioavailable [148]. In general, direct biodegradation of sorbed increases the amount of biodegradation 
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and decreases the amount of target compound leaving in the effluent and/or sludge. Therefore, 
sorbed-phase degradation is incorporated to the model to account for the loss of sorbed compound 
through bacterial metabolism.  
In the WW-TREAT fate model [95], biodegradation was described using equations 2.33 and 2.34.  
The biodegradation rate contains two terms. The first term represents the biodegradation of the 
compound in the solution phase and is assumed to have a degradation rate, k1, and a reactor residence 
time equal to the hydraulic residence time (HRT). The second term represents the biodegradation of 
the chemical which is associated with the solids and is assumed to have a biodegradation rate, k2 and 
a reactor residence time equal to the sludge or solids residence time (SRT). This algorithm differs 
from other models of the fate of xenobiotic chemicals in activated sludge plants [135] by including 
biodegradation of the sorbed chemical in addition to biodegradation of the dissolved portion.  
   
/ (1 )r i bC C k= +  (2.33)
[1 ( / (1 ))] [ / (1 )]1 2k k HRT k MLSS k MLSS k SRT k MLSS k MLSSb d d d d= − + + +  (2.34)
rC : Concentration of compound in the reactor  
iC : Concentration of compound in the influent 
bk : overall biodegradation rate 
1k : biodegradation rate for the dissolved compound 
2k : biodegradation rate for the sorbed compound 
 
Further work is needed to better establish the most appropriate biodegradation kinetic relationship for 
each XOC. Prior researchers have adapted the biodegradation equations to their needs and hence the 
hypothesis, formalisms and parameters are different for each model.  
2.3.2.1 Parent compound transformation in fate models 
Considering the fate of an XOC without its parent compounds and/ or by-products of biodegradation 
is often a simplification. This assumption could hide important aspects of compounds behaviour; for 
example a by-product may be more toxic than the studied micropollutant. By-product analysis in 
wastewater will likely be a point of interest in the forthcoming years. Plosz et al. (2010) [30] 
proposed the parent compound concept to describe the production of micropollutants in the biological 
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reactor of an activated sludge system. The Plosz model describes the production of the dissolved form 
(SXOC) of a compound from several possible chemical conjugate forms for which the studied XOC is a 
metabolite (e.g., sulfamethoxazole, tetracycline and ciprofloxacin). However, in practice the 
relationship between parent compounds and metabolites is often unknown for many micropollutants, 
as biodegradation pathways have not been established. The possibility of the presence of XOC 
transformations during biological treatment is often detected when removal efficiencies are found to 
be negative [133].  
2.3.2.2 Cometabolism in fate models 
In some cases micropollutants are not a source of carbon or energy for the biomass and hence a co-
substrate (i.e. readily biodegradable COD or ammonium) is required to serves as a growth substrate. 
The simultaneous degradation of the co-substrate and the XOC is linked to the capacity of the 
enzymes to degrade many substrates [134]. For example, methanotrophic bacteria are known to co-
oxidise PAHs, alkanes and aromatic compounds [85]. When a co-substrate is present, direct 
biodegradation and cometabolism occur simultaneously. Alvarez-Cohen and Speitel (2001) [86] and 
Plosz et al. (2010) [30] described cometabolism of a XOC as a competitive inhibition of the direct 
biodegradation due to the presence of a co-substrate.  The integration of cometabolism in models 
requires concurrent modeling of the co-substrate and XOC fate. This approach to describing 
biodegradation reactions has been validated in recent models [30] and [96]. 
2.3.2.3 ASM-based fate models 
Activated sludge models such as ASM1 (by International Water Association (IWA)) were developed 
for design and operation of biological wastewater treatment plants and removal of conventional 
contaminants; however, these models were not designed to predict the fate and transport of XOCs. 
Recent models introduced for removal of XOCs have been based on the ASM models and 
modifications have been made to optimize and better describe the removal of XOCs [19, 25, 30, and 
105]. Those models were presented in Table 2.3 One of the major modifications in these fate models 
was that the biomass estimation is integrated in the structure of biodegradation process. The biomass 
estimation comes from the ASM part of the whole model.  
In ASM-based fate model developed by Jacobsen and Arvin 1996 [105] and Lindblom e al. 2009 
[25], the modeller consider specific biomass growth rate that were responsible for the biodegradation 
of XOC. The Peterson matrix of [105] is presented in Table 2.4. The structure of this fate model was 
based on the ASM1 model except for the sorption model that is kinetic based and is similar to that 
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presented section 2.4.1.1. For the biodegradation of the specific SOC, the Monod model was 
employed and for the biomass growth and, specific active biomass that was responsible for the 
biodegradation of SOC (X1) was included. The biomass growth on conventional compounds was 
based on ASM1 model calculation. The nomenclature for the Jacobsen et al. 1996 [105] was 
presented in Appendix L. Lindblom et al. 2009 [25], describes the aerobic growth of specific 
organisms on XOC and decay of specific organisms, similar to those in ASM1 model with  two 
processes, sorption and desorption of XOC have been added on top of ASM1. Stoichiometric matrix 
representation of the fate model developed in this reference is shown in Table 2.5 In biodegradation 
and decay process rate, the specific biomass XB,XOC was expressed. 
In another model introduced by Plosz et al. 2010 [30], model matrix is analogous to that in ASM1 
except sorption and desorption mechanisms are added to the base model and also some modifications 
on the biodegradation mechanism are done. The corresponding modified model matrix is presented in 
Table 2.6. In the structure of this model, some correction was done in biodegradation process rate that 
are included parent compound transformation, co-metabolism and competitive inhibition. These 
mechanisms were widely discussed in sections 2.2.2.3 and 2.2.2.4 
Table 2.4 Stoichiometry and process kinetics for growth on a primary substrate and degradation of a non-volatile Specific 
Organic Compound (SOC) in a completely mixed reactor [105] 
Process ↓   
Compound → 
XA XI XS X1 XSI SI S SO2/kLa Process rate 
Growth, XA 
1      -1/YXA 1-1/YXA ,
,
A
A
m X A
S X
SX
k S
μ × × +  
Hydrolysis, XS  
  -1    1  
/
s
hyd
s A x
Xk
X X k
× +  
Decay, XA -1 fi 
1- 
fi 
     AX Ab X×  
Growth, X1 
   1   -1/YXI 1-1/YXI ,
, ,
1m XI
S XI S
SX
k S
μ × × +  
Biodegradation, SI  
     -1   , ,
, ,
bio m SI
S XI S
SIk XI
k SI
× × +  
Decay, X1  fi 
1- 
fi 
-1     1 1Xb X×  
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Sorption, SI     1 -1   ( )sor A I Sk SI X X X XI× × + + +  
Desorption, SI     -1 1   des SIk X×  
Aeration        1 2, 2,( )L O sat O setk a S S× −  
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Table 2.5 Stoichiometric matrix of Lindbolm et al. 2009 [25] model 
 
Table 2.6 Stoichiometric matrix of Plosz et al. 2010 [30] model 
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2.4 Development of an ASM-based contaminant fate model 
The previous section presented a review of existing fate models and the removal mechanisms 
employed in each of them. Most of the existing models describe the fate of XOC without including 
more complex mechanisms such as parent compound transformation, co-metabolism, etc. Only a few 
models have considered biodegradation in aerobic and anoxic conditions [15, 30, 37, 136]. 
Characterising biodegradation in anoxic conditions will improve accuracy of models in treatment 
plants that employ denitrification. In addition, isolating the role of heterotrophic biomass from that of 
autotrophic biomass (nitrifiers) in aerobic modeling would also be beneficial. The sorption 
mechanism can be complex and still remains not sufficiently documented. For example it is not clear 
whether it beneficial to have 3 compartment to reflect the impact of colloids on contaminant fate [1]. 
In addition sorption is a physicochemical process and consequently, weak acid partitioning may be 
dependent on pH conditions.  
Considering these discrepancies, it is proposed to develop a fate model that will include complex 
mechanisms such as parent compound transformation, co-metabolism, etc as a general model capable 
of describing the fate of XOCs. An important aspect in fate modeling is the estimation of biomass that 
is responsible for the biodegradation of XOCs. In most fate models, the volatile fraction of total 
biomass has been employed in the biokinetic rate equations.  In the model developed in the current 
study heterotrophic biomass will be separated to describe their role in the fate of XOCs more 
precisely. The fate model will be integrated with an ASM-based model that is able to describe the 
removal of conventional compounds and XOCs simultaneously.  
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CHAPTER 3 
MODELING IN GPS-X 
3.1 Introduction 
Based on the literature review that was conducted for this research, specific removal mechanisms that 
should be recognized and included in models to obtain accurate predictions of the fate of XOCs were 
identified. The mechanisms were identified in the literature review as a starting point for model 
development and application. Operating parameters such as SRT, HRT and pH have major effect on 
fate of these compounds; therefore, a sensitivity analysis was carried out as part of this research. 
GPS-X is a multi-purpose modeling tool that can be employed for the simulation of municipal and 
industrial wastewater treatment plants. This software package provides conventional models as built-
in libraries that can be used as a basis on which new models can be created. A description of the new 
fate model that is integrated with the ASM model into the GPS-X will be provided. Hence, the new 
model is an ASM-based model for better prediction of viable biomass that is believed to be 
responsible for removing trace compounds. This ASM-based model is able to be employed for 
predicting removal of conventional and trace compounds simultaneously.  Selected case studies have 
been developed and modeled to evaluate specific aspects of the model. These case studies are detailed 
and discussed in this chapter. 
3.2 Fate model description 
In this section, the development of the fate model, including removal mechanisms and the selection of 
representative compounds is explained. The fate model is depicted using a Peterson matrix that 
includes the rates of the removal processes (mechanisms) in the rows and compound species (the 
model variables), such as particulate and soluble species in the columns. This section also includes a 
description of the GPS-X software that was used as the modeling platform in this research. The 
source of parameter values, including GPS-X, literature review, and calibration process optimal 
outputs are described. Since the new fate model is integrated with the conventional activated sludge 
models (ASM) in GPS-X, the description of GPS-X state variable libraries, that consist of 
conventional and industrial state variables (fate model variables), ASM1 and Mantis Model are 
explained in the following sections. 
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3.2.1 GPS-X state variable libraries 
A library in GPS-X is a list of wastewater process models using a set of basic wastewater components 
or state variables. The term state variable refers to the basic variables that are continuously integrated 
over time. The composite variables are those variables that are calculated from (or composed of) the 
state variables. The relationships between the state and composite variables are calculated at every 
connection point of the plant layout. Details of the different types of libraries in the GPS-X software 
can be found in Appendix L. 
In this thesis, the Industrial Pollutant Variables Library (CNIPLIB) was used. This library includes 
forty-six state variables: sixteen are predefined and thirty are user defined (15 soluble, 15 particulate). 
In this research, these state variables are used for fate model variables. For example, for Bisphenol-A 
in the solid phase, is described by Xzd while the soluble species is described by Szj.  
3.2.3 Activated sludge biological models  
3.2.3.1 ASM1 
The International Association on Water Pollution Research and Control (IAWPRC) task group 
realized that due to the long solids retention times and low growth rates of bacteria, the actual effluent 
substrate concentrations between different activated sludge treatment plants did not vary greatly. 
What significantly differed was the levels of MLSS and electron acceptor (oxygen or nitrate). Thus 
the focus of the Activated Sludge Model No.1 (ASM1) is the prediction of the solids generation and 
electron acceptor consumption. In this research, this model was employed to predict the viable 
biomass in the activated sludge process (heterotroph biomass). More details about the ASM1 model 
within the GPS-X software and ASM1 Petersen matrix can be found in Appendix B.  This approach 
differs from that employed in recent models where either the MLSS or MLVSS were employed to 
reflect biomass production in the structure of the fate model [30, 41, 75]. It should be noted that, 
instead of using Xss to describe the biomass concentration (as is traditionally employed in fate 
modeling) xbh was employed to take advantage of the integration of the fate model with the ASM 
based model. 
3.2.3.2 Mantis 
The Mantis model is identical to IAWPRC Activated Sludge No.1 (ASM1), except for the following 
modifications: 
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1- Two additional growth processes are introduced, one for autotrophic organisms and one 
for the heterotrophic organisms 
2- The kinetic parameters are temperature dependant 
3- Aerobic denitrification is introduced 
The additional growth processes account for the observed growth of organisms during conditions of 
low ammonia and high nitrate. Under these conditions, the organisms can uptake nitrate as a nutrient 
source. The Petersen Matrix for the Mantis model can be found in Appendix C.  In this research, the 
Mantis model was employed as the basis model for conventional pollutant modeling and the fate 
model was built upon it. 
3.2.4 XOC removal mechanisms 
As mentioned in section 2.1, XOC removal mechanisms have been categorized into two major groups 
with sub-mechanisms that are mentioned below:  
1- Physical chemical processes 
‐ Abiotic cleavage process 
‐ Sorption-desorption of neutral and  ionized compound process 
2- Biodegradation 
‐ Biotic hydrolysis 
‐ Aerobic and anoxic biotransformation 
‐ Aerobic and anoxic parent compound formation 
‐ Co-metabolism 
‐ Competitive inhibition 
A detailed description of these mechanisms was provided in section 2.2. These mechanisms, with 
corresponding process rates, were added to the base Mantis model to create an uncalibrated model.  
Subsequently the kinetic and stoichiometric coefficients were extracted from the literature (see 
Appendix A).  For the process rates of the conventional compounds, the default matrix of Mantis 
model within the GPS-X software was used.  
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3.3 Integration of fate model in GPS-X 
In this section, the integration of the fate model into GPS-X is explained. The integrated fate model 
employs an ASM-based (Mantis) model for prediction of viable biomass that is subsequently 
responsible for removal and transformation of trace compounds. Hence, the model is able to be 
employed for predicting the removal of conventional and trace compounds simultaneously. The 
“model developer”, which is a software tool developed by Hydromantis was used to generate the 
ASM based fate model and is subsequently described. 
3.3.1 Model developer (MD) 
To create the new model in GPS-X, the model developer that included the Mantis model matrix as the 
basis and the CNIPLIB library was used. The CNIPLIB was selected as it has the capacity to employ 
a number of pre-defined states for industrial customized components that in this research consisted of 
the target XOC’s (See Appendix L). The model developer contains several spread sheets with the first 
spread sheet containing the fate model matrix. The second sheet includes the composite variables 
vector for GPS-X. The third sheet contains the fate model parameters and coefficients, such as state 
variables, composite variables, and the stoichiometric and kinetic parameters, for both the 
conventional and the trace compounds. The last sheet contains the list of the GPS-X library state 
variables.  The model developer converts the matrix components to a language that can be read by the 
GPS-X software.   
Since specific groups of mechanisms were identified to be responsible for the removal of selected 
compounds, three different case studies were created for three different groups of compounds. Hence, 
three different submodels were created within the fate model.  Each submodel was generated in the 
GPS-X software separately. To achieve this goal, compounds that were not included in a specific 
submodel, were omitted by inserting zero values in the corresponding rows and columns. For 
example for Case Study 1 that was created for removal of SMX process rates and compounds that 
were not related to SMX fate were zeroed (See Appendix D for more details). The three different 
submodels were calibrated separately using relevant literature data for both the conventional and trace 
compounds, and the optimal parameters were obtained and inserted in the corresponding sheet of the 
model developer (third sheet). After this step, each submodel was generated in the GPS-X software 
by using the model developer tool, and the simulation results were reported. Figure 3.1 depicts the 
work flow for the modeling process. 
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Figure 3.1. Schematic modeling process flow chart of this thesis 
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3.3.2 Model calibration and validation 
3.3.2.1 Calibration 
Models that are employed to simulate XOC fate in WWTP systems include a number of kinetic and 
stoichiometric parameters. Without accurate values for these parameters, the equations in the model 
merely describe a general shape or pattern of the real behaviour of the system. In the calibration 
process, using optimization methods, model parameters can be ‘tuned’ such that the model can best 
follow the experimental data. A common error metric is Sum of Squared Errors (SSE) between the 
simulated results and measured data, optimal values of parameters of interest were found.  Equation 
3.1 shows the objective function for the calibration: 
1
=
n
i
i
SSE SSE
=
∑  with exp 2exp=( )
sim
i i
i
i
y ySSE
y
−
 (3.1)
where simiy  and 
exp
iy  are the simulated and measured values of the response variable y (usually 
effluent substrate concentration), respectively.  Index i refers to the ith data point where the total 
number of data points is n in the experimental process. 
Although using optimized parameter values, the model can best describe the system behaviour, in 
some cases, these parameter values are infeasible [25]. Hence in the optimization problem, lower and 
upper bounds were added to the model parameters to avoid infeasible values for parameters.  
Therefore, the calibration process formulation was written as:  
min  ( , )
j j j
SSE t P
LB P UB≤ ≤  
(3.2)
where SSE is a function of time and vector of parameters P, LB and UB are the lower bounds and 
upper bounds on the parameter, and index j refers to the jth parameter. 
In this research, minimum and maximum values that were obtained from the literature were adopted 
as LB and UB. In Appendix G, a list of references from which the ranges of parameter values were 
obtained are presented. The details of the procedure and convergence study on the optimal design 
parameters are subsequently described.  For each calibration, parameters were obtained by solving the 
optimization problem using the Genetic Algorithm (GA) in MATLAB. To assure the optimality of 
the parameter values, GA was run for three times, and then the parameters corresponding to the least 
objective function were put into the Pattern Search function as a Direct Search (DS) routine until the 
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change in the objective function and constraint violation values were less than 1E-6.  At this point the 
resulting values were accepted to provide the global optimum.  
The uncertainties involved in the calibration process are computed by means of a numerical method 
explained in Draper and Smith, 1981 [154]; Smith et al., 1998 [155]. In a general case, the objective 
function J can be multi-objective, and defined as: 
1
n
i
i
J J
=
= ∑ with exp exp2 21 1 2 21 2exp exp
1 2
= ( ) ( ) ...
sim sim
i i i i
i
i i
y y y yJ
y y
μ μ− −+ +  (3.3)
where 1 2,  ,...μ μ are the weights of different terms in the objective function and 1 2,  ,...i iy y  are ith 
values of the multiple responses. Assuming a linear behaviour for the response, this approach 
approximates the mean square error for each parameter from the sensitivity of the objective function 
to each parameter and a variance defined as follows: 
2 Jˆ
n p
σ = −  
(3.4)
where Jˆ  is the objective function value at the optimal point, n is the number of observations, and p is 
the number of calibration parameters. 
Additionally, the sensitivity can be approximated in discrete form as follows: 
ˆ ˆ( ) ( )i j j i ji
j j
J P P J PJ
P P
+ Δ −∂
∂ Δ?  
(3.5)
where ˆjP is the optimal estimate of parameter P, index i refers to the i
th data point, index j refers to the 
jth parameter, ˆj jP P+ Δ is the perturbed parameter, ˆ( )i j jJ P P+ Δ  is the objective function at the 
perturbed parameter value, and ˆ( )i jJ P is the objective function value at the optimal parameter 
estimate. Note that iJ is equal to the iSSE in case the objective function is single objective, as defined 
in equation 3.1. Then the sensitivity matrix can be formed as follows: 
11 12 1
21 22 2
1 2
p
p
MN
p p pp
S S S
S S S
S
S
S S S
⎡ ⎤⎢ ⎥⎢ ⎥= ⎢ ⎥⎢ ⎥⎢ ⎥⎣ ⎦
?
?
? ? ?
?
 (3.6)
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The sensitivity matrix is a symmetric square matrix (pxp) that includes the sensitivity of the objective 
function with respect to all calibration parameters. Each component is defined as: 
{ }
1
       with  , 1, 2,...,
n
i i
MN
i M N
J JS M N p
P P=
∂ ∂= ∈∂ ∂∑  (3.7)
Then the 95% confidence interval for each parameter is acquired as: 
2 1ˆ 1.96   with  j jjP V V Sσ −± =  (3.8)
where equation 3.8 calculates the interval for the jth estimated parameter with 95% confidence.  
The described calibration process was employed to initially calibrate the fate model for the trace 
compounds; however, calibration of the conventional parameters was also deemed to be important. 
The viable biomass production that is predicted by the conventional part of the model also required 
calibration Therefore, the wastewater characteristics, such as the ratio of inert particulate COD to 
biodegradable COD and influent VSS were established from the literature data. However in some 
cases this data was not available and hence the default values for municipal wastewater characteristics 
were chosen within the typical range. In addition steady state mixed liquor suspended solid 
production in the bioreactor (MLSS) and operational parameters including SRT and HRT, were 
determined from the literature data. The plant layout for the plant under study was built for the 
calibration process along with operational parameters. The MLSS production in steady state condition 
in the calibrated model was tuned with the MLSS production of that plant in steady state condition by 
trial and error within the GPS-X software. The results of the calibration process for each case study 
are explained in chapter 4. 
 3.3.2.2 Validation 
Once the model was calibrated, it was able to describe the experimental data used in the calibration 
process; however its ability to predict results under other conditions was not verified. Therefore the 
model was validated using different data sets. The validation process assures more reliability of the 
model under desired conditions. In this thesis, for each case study, different data sets were used for 
the validation. In the validation procedure, the plant operating condition was matched to the case used 
for the validation, but parameters that obtained from the calibration process were not changed. As will 
be subsequently discussed in some cases, the calibrated model could not describe that additional data 
set well. Potential causes of the poor validation will be discussed in chapter 4. 
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3.4 Case study descriptions 
Since only selected mechanisms are responsible for the removal of a specific compound, three 
different case studies (three sub models) were developed in this study.  Each case study addressed a 
specific group of compounds. The case studies are described in Table 3.1.  
Table 3.1 Case studies for fate modeling of XOCs 
 Compound Mechanism 
Case study 
1 Sulfamethoxazole (SMX) 
1. Aerobic and anoxic biodegradation 
2. Parent compound formation 
3. Co-metabolism and competitive inhibition 
4. Aerobic and anoxic sorption 
Case study 
2 Nonylphenol ethoxylates (NPEOs) 
1. Abiotic oxidative cleavage 
2. Biotic hydrolysis 
3. Aerobic biodegradation 
Case study 
3 Ibuprofen and Bisphenol-A 
1. Aerobic biodegradation of ionized and neutral 
compounds 
2. Sorption of ionized and neutral compounds 
3.4.1 Selection of target compounds  
In this study, the selection of compounds was motivated by the following criteria: (1) the presence of 
the compounds in Canadian municipal wastewater effluent at relatively high concentrations; (2) high 
usage of the selected pharmaceuticals by the Canadian population; (3) and most importantly, they are 
impacted by specific removal mechanisms which were recognized recently in the literature. The 
considered XOCs were: ibuprofen, sulfamethoxazole, Nonylphenol ethoxylates, and Bisphenol-A. 
Table 3.2 displays a list of the selected compounds and some of their general properties, including 
therapeutic classes, molecular weights, octanol-water and sludge-water partitioning coefficients, and 
pKa (acid dissociation constant). Further details on the chemical and physical properties of the 
compounds are provided in the following sections. 
Table 3.2 Target compound chemical properties 
Compound Therapeutic Class Molar Mass (g/mol) Log Kow Kd (l/gss) Pka 
Sulfamethoxazole (Case study 1) Antibiotic 253.279 (C10H11N3O3S) 0.89 0.26±0.17 [40] 5.7 
Nonylphenol (NPEO) (Case study 2) Nonionic detergent metabolite 220.35 (C15H24O) 4.48 15 
[152] 10.7 
Bisphenol-A (Case study 3)  228.29 (CH3)2C(C6H4OH)2 3.05 0.071-1[25] 9.78 
Ibuprofen (Case study 3) Anti-inflammatory 206.28 (C13H18O2) 3.5 
0.007±0.002 
[40, 45] 4.74 
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3.4.1.1 Sulfamethoxazole (SMX) 
Sulfamethoxazole (SMX) is an antibiotic that is used for the treatment of infectious diseases in 
humans. A wide range of removal efficiencies, even negative in some cases have been reported for 
this compound in WWTP and this has been attributed to the potential presence of conjugated 
metabolites of SMX [151]. Biodegradation and sorption are the two main processes for removal of 
this compound, although some specific mechanisms, such as co-metabolism and parent compound 
transformation, and competitive inhibition, have been reported to affect the removal of this substance 
[30, 37]. The value of the solid/liquid partition coefficient (Kd) for SMX in the literature has been 
reported to be in the range of 0.26±0.17 LgSS-1 [40].  The Henry’s law constant for SMX has has 
been reported to be 6.42E-13; and hence SMX is considered as non-volatile in WWTPs.  
3.4.1.2 NPEOs  
Nonylphenol and its ethoxylates (NPEOs) are widely used surfactants found in soaps, detergents, and 
similar cleaning products. More than half of the NP found in the environment is as a result of 
individual consumer use of products containing NPEOs. Concern about the endocrine disrupting 
properties of NPEOs led Environment Canada to introduce national regulations and restrictions on the 
manufacture and importation of NPEOs. Consequently, annual NPEO production has reduced from 
3.35 million kg in 2003 to 1.03 million kg in 2006.  
Removal efficiencies of NPEOs in wastewater treatment plants have been reported to be between 60 
and 97%, depending on the type of treatment [51, 52, 66, 68, and 69]. Nonetheless, concentrations of 
NPEOs in the microgram per litre range have been observed in various surface waters [65, 67, and 
69]. Biodegradation has been reported to be the dominant process for removal of these compounds 
[19]. 
3.4.1.3 Bisphenol-A 
Bisphenol-A (BPA) is referred to as a neutral compound with a pKa of 9.78. The solid/liquid partition 
coefficient (Kd) for BPA has been reported in the literature to range from 0.07 L gSS-1 [59] to 1 L 
gSS-1; [25] The Henry’s law constant for BPA is 1.7 E-9 [59] and hence BPA is considered as non-
volatile in WWTPs. BPA has been deemed to be readily biodegradable under aerobic conditions and 
biodegradation under anoxic and anaerobic conditions is unlikely [60].  
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3.4.1.4 Ibuprofen  
Ibuprofen is a non-prescription antiphlogistic drug that is used for relieving symptoms of arthritis, 
primary dysmenorrhea, fever, and pain. Excretion rates for non-metabolized ibuprofen have been 
estimated to be 7 and 23% via urine and feces, respectively [48]. The removal of ibuprofen in 
wastewater treatment has been reported to exceed 90% in numerous studies [49-54]. Given sufficient 
hydraulic residence time (i.e. at least 6 hours), virtually complete removal can be achieved [22]. In 
wastewater treatment, removal may occur via biodegradation and sorption [55, 50].  Acidic 
pharmaceuticals, such as ibuprofen, have been reported to have low sorption capacity in natural 
systems [88].  
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3.4.2 Case study 1 
This case study was created to address the biodegradation and sorption of SMX along with 
biodegradation (conversion) of its metabolite to the parent compound (SMX). In developing Case 
Study 1, all process rates and compound species that were not related to the SMX and its metabolite 
removal were omitted from the fate model matrix by inserting zeros in the relevant rows and columns. 
The submodel for this case was a Mantis based model that addressed the removal of SMX and its 
metabolite along with the conventional compounds (see Appendix D for the relevant matrix). The 
removal mechanisms responsible for the removal of SMX and its metabolite were presented in Table 
3.1, and the Matrix for the SMX and its metabolite was presented in Table 3.3. 
Two major mechanisms are responsible for removal of SMX: biodegradation and sorption. For fate 
modeling of this compound, the impact of aerobic and anoxic conditions was considered for both 
biodegradation and sorption mechanisms.  The biodegradation of its metabolite (daughter compound, 
Szg) was also considered in this model. The metabolite that was present in the raw wastewater during 
the biodegradation process was converted to the parent compound (SMX). The expressions for the 
process rates of aerobic/anoxic biodegradation, and aerobic/anoxic parent and daughter compounds 
transformation contain modifying terms 1
1
( ) ( )
( ) ( )
s bio s DEC
s bio s s DEC s
K Kand
K S K S
η η
η η
⋅ ⋅
⋅ + ⋅ +  respectively that reduce 
the rates in the presence of readily biodegradable COD. The uptake of readily biodegradable COD 
(Ss) has been reported to cause competitive inhibition of micropollutant biotransformation processes 
[30].  
Plosz et al. (2010) [30] observed an increase in the concentration of SMX, through wastewater 
treatment with negative or low removal efficiencies observed for this compound.  Hence it was 
concluded that other mechanisms should be taken into account during the removal of this compound 
[30, 151]. In activated sludge, the presence of metabolites of pharmaceuticals that can be transformed 
back to the parent compound as a result of enzyme-catalyzed reactions has been reported [30]. It is 
possible for certain pharmaceuticals that the conjugated form may be present in the raw wastewater at 
concentrations greater than of the parent. Hence a mechanism referred to as parent compound 
transformation was added. Equations 3.10 and 3.12 describe the process rates for the aforementioned 
phenomenon.  
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Table 3.3 process matrix of SMX and its metabolite 
SMX and its metabolite 
components 
Process rate Process rate description 
Szf Szg Xza 
-1   1
( )
( ) ( )
s bio o
BioOx
s bio s o o
K Sk Szf xbh
K S K S
η
η
⋅⋅ ⋅ ⋅ ⋅⋅ + +
( ) ( ) ( )
Aerobic biotransformation of Szf (3.9) 
1 -1  11
1
( )
( ) ( )
s DEC o
DecOx
s DEC s o o
K Sk Szg xbh
K S K S
η
η
⋅⋅ ⋅ ⋅ ⋅⋅ + +  
Aerobic parent compound 
transformation (3.10) 
-1   1
( )
( ) ( )
s bio o
BioAX
s bio s o o
K Sk Szf xbh
K S K S
η
η
⋅⋅ ⋅ ⋅ ⋅⋅ + +  Anoxic biotransformation of Szf (3.11) 
1 -1  11
1
( )
( ) ( )
s DEC o
DecAx
s DEC s o o
K Sk Szg xbh
K S K S
η
η
⋅⋅ ⋅ ⋅ ⋅⋅ + +  
Anoxic parent compound 
transformation (3.12) 
1  -1 
( )
o
Des
o o
SK Xza
K S
⋅ ⋅ +  Aerobic desorption of Szf (3.13) 
-1  1 1 . ( )
o
Des DOx ss
o o
SK K Szf X
K S
⋅ ⋅ ⋅+ Aerobic sorption of Szf (3.14) 
1  -1 
( )
o
Des
o o
KK Xza
K S
⋅ ⋅ +  Anoxic desorption of Szf (3.15) 
-1  1 1 . ( )
o
Des DAx ss
o o
KK K Szf X
K S
⋅ ⋅ ⋅+  Anoxic sorption of Szf (3.16) 
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The model in this case study was calibrated using the data provided in Plosz et al. 2010 [30]. The 
plant configuration for this study is shown in Figure 3.2. Since aerobic and anoxic biodegradation 
were included as removal mechanisms for SMX and its metabolite removal, aerobic and anoxic 
compartments were employed in the activated sludge process plant. For the sensitivity analysis of this 
case against SRT and HRT, only aerobic parent compound transformation, aerobic biodegradation, 
and aerobic sorption-desorption were considered (see Appendix D1 for the process matrix of this 
model) to simplify the data interpretation. 
 
Figure 3.2 Plant configuration for the removal of SMX 
The WWTP physical and operational parameters are shown in Table 3.4. These parameters were 
extracted from the work by Plosz et al. 2010 [30]. Calibration was conducted using the WWTP 
physical and operational parameters, presented in Table 3.4, and the experimental data provided for 
both conventional parameters and SMX and its metabolite. 
  
 44 
 
Table 3.4 WWTP Physical and Operational Parameters 
Influent flow rate 21390 m3/d 
RAS flow rate 21400 m3/d 
Wastage flow rate 302.1 m3/d 
SRT 16 d 
HRT 5.33 hr 
Aeration tank  volume 9500 m3 
Anoxic tank  volume 9750 m3 
Aeration volume  19250 m3 
HRT* 10.8 hr 
Secondary Flat bottom Clarifier 
dimensions Surface: 458 m
2   Water Depth: 6 m 
DO concentration in Aeration Tank 3 mg/l 
Temperature 20°C 
* Anoxic zone omitted  
3.4.5 Case study 2 
This case study assessed the fate of nonylphenol ethoxylates (NPEOs) in an activated sludge process. 
A mechanism that has been reported to contribute to the removal of NPEO’s is an abiotic oxidative 
cleavage process [19]. In this process, the NPEO’s are converted to slowly biodegradable NPEOs, 
readily biodegradable NPEOs and non biodegradable NPEOs. In addition, through a hydrolysis 
process the slowly biodegradable portion of this compound is converted to the readily biodegradable 
form, and then this portion is biodegraded during the growth processes. This submodel was designed 
to predict the fate of NPEO’s along with conventional compounds that was based on the Mantis 
model the relevant matrix is shown in appendix E.  The process rates are described in Table 3.5. 
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Table 3.5 process matrix of NPEO 
NPEO Components 
Process rate Process rate Description 
Sza Szb Szc Szd 
-(1-fINPEO) α 1- α fINPEO OCLK Sza⋅  Abiotic cleavage (3.17) 
 1 -1  
( / )[ ]
( / )hNPEO xNPEO
Szc xbhk xbh
K Szc xbh
⋅ ⋅+  
Hydrolysis of 
NPEO (3.18) 
 -1   
( ) ( )
s o
bioNPEO
s s oh o
K SK Szb xbh
K S K S
⋅ ⋅ ⋅ ⋅+ +  Growth on SSNPEO (3.19) 
The structure of the expression for the hydrolysis rate of NEPO’s is similar to that of entrapped 
organics in Mantis model. The biodegradation structure of the SSNPEO is similar to that employed for 
the biodegradation of SMX and included a modifying term for readily biodegradable substrate 
[(Ks)/(Ks+Ss)] as the uptake of Ss can reduce the biodegradation of SSNPEO [19].  In this case study 
the model was calibrated using the experimental data provided in Karahan et al. 2010 [19]. The plant 
configuration for this study is shown in Figure 3.3. The WWTP physical and operational parameters 
are shown in Table 3.6. These parameters were also extracted from [19]. 
 
Figure 3.3 Plant configuration for the removal of NPEOs 
Table 3.6 WWTP physical and operational parameters 
Influent flow rate 1000 m3/d 
RAS flow rate 1000 m3/d 
Wastage flow rate 71.49 m3/d 
SRT 15 d 
HRT 24 hr 
Aeration tank  volume 2000 m3 
Secondary flat bottom clarifier dimensions Surface: 200 m2   Water Depth: 4 m 
DO concentration in aeration tank 2 mg/l 
Temperature 20°C
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The calibration process was conducted using the WWTP physical and operational parameters 
presented in Table 3.6, and experimental data provided for both conventional and NPEOs responses. 
Details on calibration and validation process are explained in sections 4.2.2.1 and 4.2.2.2, 
respectively. Appendix J presents the optimal values for stoichiometric and kinetic parameters of 
NPEO and conventional parameters. 
3.4.6 Case study 3 
Case Study 3 was developed to address the neutral and ionized compounds, Ibuprofen and Bisphenol-
A. In this study, the biodegradation and sorption of this compound was considered. Since pH is an 
important parameter in the removal of ionized compounds, the biodegradation and sorption processes 
were modified to include a pH effect. Equation 3.20 describes the equilibrium reaction that was taken 
into account while equation 3.21 addresses the equation relating the extent of dissociation of an acid. 
kaHA H A+ −⎯⎯→ +←⎯⎯  (3.20)
[ ] [ ]
[ ]
H Aka
HA
+ −+=  (3.21)
Figure 3.4 presents an overall schematic of the general model for ionized compound fate and includes 
the dissociation of the acid: 
kaHA H A+ −⎯⎯→ +←⎯⎯
 
Figure 3.4: Schematic of general model for ionized compound fate model 
In this model biodegradation and sorption of both the neutral, (HA) and ionized forms (A-) were 
considered. Combining equations 3.20, 3.21, 2.2, 2.3, 2.4, and 2.18, the process rates for these 
compounds were developed and the matrix was shown in Table 3.7. 
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Table 3.7 Process matrix of Ibuprofen 
Ibuprofen Components 
Process rate Process rate Description 
Szh Szi Xzb Xzc 
-1    
1 ( )
( ) .
(10 1)bio pH pka
Szh SziK xbh∧ −
+⋅ +  
Biodegradation of neutral 
form of compound 
(3.22) 
 -1   
2 ( )
( ) .
(10 1)bio pka pH
Szh SziK xbh∧ −
+⋅ +
Biodegradation of ionized 
form of compound 
(3.23) 
-1  1  1 1des D ssK K Szh X⋅ ⋅ ⋅  Sorption of neutral form of 
compound 
(3.24) 
1  -1  1desK Xzb⋅  Desorption of neutral form of 
compound 
(3.25) 
 -1  1 2 2des D ssK K Szi X⋅ ⋅ ⋅  Sorption of ionized form of 
compound 
(3.26) 
 1  -1 2desK Xzc⋅  Desorption of ionized form of 
compound 
(3.27) 
 
For modeling of neutral compounds, dissociation was not considered and hence the process rates were 
written according to equations 2.2, 2.3 and 2.18. Table 3.8 presents the matrix for Bisphenol-A. 
Table 3.8 process matrix of Bisphenol-A 
Bisphenol-A 
Components Process rate Process rate Description 
Szj Xzd 
-1  3 ( )
o
bio
oh o
SK Szj xbh
K S
⋅ ⋅+  Biodegradation of neutral compound (3.28) 
-1 1 3 3des d ssK K Szj X⋅ ⋅ ⋅  Sorption of neutral compound (3.29) 
1 -1 3desK Xzd⋅  Desorption of neutral compound (3.30) 
This case study was calibrated using the experimental data provided in Zhao et al. 2007 [137] for the 
neutral compound and Collado et al. 2012 [146] for the ionized compound. The plant configuration 
for this study is shown in Figure 3.5. It should be noted that the plant configurations for the neutral 
and ionized compounds were similar with different wastewater characteristics, design and operational 
parameters. 
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Figure 3.5 Plant configuration for the removal of Ibuprofen 
The WWTP physical and operational parameters employed in the calibration for Ibuprofen and 
Bisphenol-A are shown in Tables 3.9 and 3.10. These parameters were extracted from [137, 146] 
respectively. The calibration was conducted using the WWTP physical and operational parameters, 
presented in Tables 3.9 and 3.10, and experimental data provided for conventional, Ibuprofen, and 
Bisphenol-A responses. Further details on calibration and validation processes are explained in 
sections 4.2.3.1 and 4.2.3.2, respectively and the results of calibration are provided in Appendix K, 
which presents the optimal values for the stoichiometric and kinetic parameters of Ibuprofen, 
Bisphenol-A, and conventional parameters. 
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Table 3.9 WWTP Physical and Operational Parameters for Case Study 3-Ibuprofen 
Influent flow rate 3000 m3/d 
RAS flow rate 1000 m3/d 
Wastage flow rate 34.55 m3/d 
SRT 15 d 
HRT 12 hr 
Aeration tank  volume 2000 m3 
Secondary flat bottom clarifier dimensions Surface: 200 m2   Water Depth: 4 m 
DO concentration in aeration tank 2 mg/l  
Kinetics CNIPLIB library in GPS-X V.6.02 
Temperature 20°C 
 
Table 3.10 WWTP Physical and Operational Parameters for Case Study 3-Bisphenol-A 
Influent flow rate 2800 m3/d 
RAS flow rate 2000 m3/d 
Wastage flow rate 21 m3/d 
SRT 25 d 
HRT 10 hr 
Aeration tank  volume 2000 m3 
Secondary flat bottom clarifier dimensions Surface: 250 m2   Water Depth: 3.5 m 
DO concentration in aeration tank 2 mg/l  
Kinetics CNIPLIB library in GPS-X V.6.02 
Temperature 20°C 
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CHAPTER 4 
SIMULATION RESULTS AND DISCUSSION 
4.1 Introduction 
In the previous chapter, the development of the fate model and its integration with the GPS-X 
software was explained. Three case studies that included different mechanisms for the removal of 
specific groups of compounds were introduced. At the end of the chapter, the plant configurations and 
parameters in each cases study were explained. This chapter describes the model calibration in each 
case study, the implementation of the model in GPS-X in each case study through use of the model 
developer tool and the model validation with different data sets. A sensitivity analysis is presented at 
the end to investigate the effect of SRT, HRT and pH on the removal efficiencies. 
4.2 Model calibration and validation 
In this section, the model calibration in the three case studies is described and the optimal values for 
the model parameters are reported. The calibration step was carried out for both conventional and fate 
model parameters. At the end, the validation process of each case study is explained in detail. 
4.2.1 Case study 1 
This case study was created to investigate the removal of Sulfamethoxazole (SMX). Parent compound 
transformation, competitive inhibition and co-metabolism mechanisms were included in the structure 
of this submodel. In this case study, calibration, simulation, validation and sensitivity analysis were 
performed for SMX only. 
4.2.1.1 Calibration and simulation 
The calibration of the model was performed for both conventional and fate model parameters. Since 
the estimation of biomass production is one of the key parameters for addressing the fate of trace 
compound, matching of the biomass production in the steady state condition with the data set was 
employed for calibration. The experimental data presented in [30] was used for the calibration of this 
model. The data set for the SMX was presented from continuous effluent flow of both the anoxic and 
aerobic reactor (Figure 4.1) in soluble form. Since the full data set was not available, the conventional 
parameters including total COD, inert inorganic suspended solids, particulate inert organic material, 
total suspended solids in the waste water influent, plant configuration, and plant operational 
parameters, (SRT=16 days and HRT=5.33 hr) were set to those described by Plosz et al. 2010 [30]. 
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For other ASM1 parameters that were not reported in the related literature, the default values for 
municipal wastewater treatment plants were employed. By adjusting the inert organic suspended 
solids, influent VSS and the ratio of inert particulate COD to biodegradable COD in the wastewater 
influent by trial and error within the GPS-X software, and running simulations on the submodel of 
this case study, the biomass concentration in the bioreactor at steady state was matched with the 
corresponding experimental data presented in the literature. The relative error for this calibration was 
0.5%.  As mentioned in section 2.3.2 active biomass is not measurable experimentally; thus, it is often 
assumed in fate models that the MLSS or MLVSS can represent the active biomass. However, in the 
new fate model that was developed in this research, the active heterotrophic biomass was used as the 
active fraction of the MLSS and was predicted by the conventional part of the model within GPS-X. 
Hence, the parameter values (kb, kd, etc) predicted in this research can be expected to be different 
from that reported in the literature. The values of the conventional parameters are presented in 
Appendix I.  
After conventional parameter calibration, according to the plant layout and submodel matrix, which 
are presented in appendix D, a corresponding set of differential equations were transferred to 
MATLAB where the fate model was calibrated with experimental data reported for the trace 
compound (SMX).  To this goal, for each parameter of interest in the structure of the model matrix 
(see Appendix D), the mean (µ) and standard deviation (σ) of the literature reported ranges were 
calculated. The mean and standard deviation were calculated over those reported in each reference, 
i.e., in most references, the reported values were in the form of uncertainty ranges (µ±σ). Then lower 
and upper bounds for the calibration parameters were set to µ-σ and µ+σ, respectively, see Table 4.1. 
For the anoxic bioreactor, as the work by [30] provided the only reported parameter values, the lower 
and upper bounds were set to 0.1 and 10 times the reported values [30]. For this case, the following 
objective function was considered: 
2 2
, , , ,
1 1
, ,
- -
 0.25 0.25
max( ) max( )
-
          0.25
max(
sim ref sim refn n
i aerobic i aerobic i aerobic i aerobic
ref ref
i iaerobic aerobic
sim ref
i anoxic i anoxic
ref
anoxic
Szf Szf Szg Szg
SSE
Szf Szg
Szf Szf
Szf
= =
⎛ ⎞ ⎛ ⎞= + +⎜ ⎟ ⎜ ⎟⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠∑ ∑
2 2
, ,
1 1
-
0.25
) max( )
sim refn n
i anoxic i anoxic
ref
i i anoxic
Szg Szg
Szg= =
⎛ ⎞ ⎛ ⎞+⎜ ⎟ ⎜ ⎟⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠∑ ∑
(4.1)
where index i refers to the ith data point, simaerobicSzf is the simulated value for Szf (effluent concentration 
of SMX), simanoxicSzf , is the simulated value for Szf (effluent of anoxic reactor),  
ref
aerobicSzf and 
ref
anoxicSzf
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represent the experimental data for Szf  in effluent of aeration and anoxic reactor, respectively from 
Plosz et al. 2010 [30], simaerobicSzg is the simulated Szg (the compound concentration biotransformed via 
the Szf in aerobic reactor effluent), simanoxicSzg  is the simulated Szg in effluent of anoxic reactor, and 
ref
iSzg denotes the model results by [30]. Note that no experimental data was reported for Szg [30]. It 
should be added that the objective function is written in a non-dimensionalized form to provide 
relatively similar effects of the two terms on the SSE; otherwise, the four terms could have such 
different values the optimizer would mostly reduce only the larger terms.  For more information 
regarding the calibration process and the involved optimization, see section 3.3.2.1. 
A summary of the calibration results is presented in the following table: 
Table 4.1 Calibration results for case study 1 
Parameter Lower Bound Upper Bound Optimal Value ± Standard Error 
K1BioOx (m3/gbiomass/d) 6.937E-4 1.904E-3 1.529E-3±3.7E-4 
K1BioAx (m3/gbiomass/d) 6.937E-4 1.904E-3 1.529E-3±3.7E-4 
K1DecOx (m3/gbiomass/d) 6.8E-4 6.8E-2 3.312E-2±6.3E-3 
K1DecAx (m3/gbiomass/d) 7.85E-4 7.85E-2 3.823E-2±5.8E-3 
K1Dox (m3/gbiomass) 5.110E-5 3.893E-4 2.914E-4±3.4E-5 
K1DAx (m3/gbiomass) 5.5E-5 5.5E-3 5.500E-4±4.1E-5 
ηbio 1 3 2.886±0.46 
η1Dec 1 3 1.920±0.31 
To examine the quality of model calibration for case 1, a comparison of the simulated Szf and Szg 
values against the corresponding target values as well as the R2 values are presented in Figure 4.1. It 
should be pointed out that for Szg, the R2 is calculated using the same points existing in Szf. To do so, 
the Szg values were extracted at the points that Szf was provided experimentally; these values are 
shown in solid circles. Therefore, there were the same number and distribution of data points in all 4 
figures, and the R2 values were calculated consistently.   
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(a) (b) 
(c) (d) 
Figure 4.1 Simulated against the target concentrations in the calibration of case 1 model. 
 
Figures 4.1 shows the quality of fit for the calibration process of case study one. Figures 4.1 (a and c) 
show the curves for SMX in the aerobic and anoxic conditions, respectively; whereas Figures 4.1 (b 
and d) show the curves for the metabolite under aerobic and anoxic conditions, respectively. As 
shown in Figures 4.1 (a and c), the model (solid line) followed the experimental data (solid circles) 
relatively well; the R2 values were 0.69 for the aerobic condition and 0.65 for anoxic condition, 
respectively, which can be related to the sparsity of the experimental data. Additionally, the first data 
point (at time=0) had a significantly higher value compared to the second data point (at nearly 0.02 
d), which is in contrast with the trend of the data set. The first data point could be considered as an 
outlier, but as Plosz et al. 2010 [30] had included that data point, it was considered in this thesis too, 
which resulted in the lower R2 value.  
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Figure 4.1(b and d) show how the calibrated model could follow the target values of Szg. As 
mentioned, the target values only for this compound were the output data from Plosz’s model, since 
no experimental data was reported in the reference. The trends in the respones were similar in shape 
and the R2 values were deemed to be reasonable. 
Simulation outputs according to the calibrated results of Table 4.1 are reported in Table 4.2 for the 
soluble concentration of SMX in the effluent stream and the solid phase concentration of SMX in the 
wastage stream. Soluble COD in the effluent stream, heterotroph biomass production in aeration 
bioreactor, total suspended solid (TSS) production in bioreactor and total TSS production in wastage 
flow are also presented in Table 4.2. The solids retention time for this simulation was 16 days and the 
hydraulic retention time was 5.33 hours. The details of the plant configuration were presented in 
section 3.4.4, Table 3.7. These results were obtained by running simulation in steady state condition 
within the GPS-X software. From Table 4.2 it can be seen that the simulated effluent concentration 
for SMX is higher than that in the influent (0.00021 g/m3). The biotransformation of this compound 
includes two phenomena: biodegradation and the other one transforming the metabolite (Szg) to the 
parent compound. Hence the concentration of this compound would be reduced due to the 
biodegradation process, but  would increase as a result of the conversion of the metabolite to the 
parent compound. The higher effluent concentration of SMX in comparison with the influent 
concentration, results in a removal efficiency that is negative, which is in agreement with results of 
Plosz et al. 2010 [30] and also [9, 151]. The simulation results showed the sorption of SMX as well; 
the particulate concentration of SMX in solid phase was estimated to be 0.000744 g/m3. The 
simulation results also showed the biodegradation of metabolite (Szg), for which the removal 
efficiency was 98%. This metabolite was converted to SMX during the biotransformation process. In 
Table 4.2, the viable biomass prediction was addressed as well, since the fate model is ASM-based. 
 
   
Table 4.2 Simulation results of case study 1,  Considering aerobic and anoxic parent compound transformations 
Szfi 
(g/m3) 
Szf 
(g/m3) 
Szgi 
(g/m3) 
Szg 
(g/m3) 
Xza in WAS 
(g/m3) 
fCOD 
(gCOD/m3) 
xbh 
(gCOD/m3) 
TSS in 
AR 
(g/m3) 
0.00021 0.0003314 0.000467 1.086E-5 0.000744 37.74 965.2 3116 
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4.2.1.2 Case study 1 validation 
Following calibration, the fate model was validated with a different data than that used for 
calibration; therefore, in the validation phase, the experimental results of Suarez et al. 2010 [37] were 
used. To this goal, the wastewater characteristics and the plant operation conditions in the fate model 
were set to those presented in [37]. Those parameters are shown in Table 4.3. The fate model was run 
with these parameters at steady state condition. The removal efficiency of the SMX was predicted as -
51%, which was somewhat different from that of reported by [37]. 
Table 4.3 Characteristics and the plant operating conditions used for 
validation of SMX removal in wastewater treatment 
Parameter Suarez et al. 2010 [37] 
Influent concentration of SMX (g/m3) 0.02 
Removal efficiency (%) 22±5 
SRT (days) <20 
HRT (hours) 24 
Mixed liquor suspended solid (MLSS) in 
steady state condition (g/m3) 
1600 
Total COD in influent (gCOD/m3) 500 
Temperature (°C) 20 
The removal efficiency was reported based on the parent compound that led to negative removal 
efficiency. The metabolite compound, which was called daughter compound, during 
biotransformation process was converted to the SMX. The main reason of the difference in removal 
efficiencies between Suarez et al. 2010 [37] and the calibrated model could be because of the 
different ratio of the SMX and its metabolite, since in Suarez et al. 2010 [37] the concentration of 
metabolite was not reported. This ratio in the calibrated model was inserted from the wastewater 
characteristics provided by [30]. Temperature changes do not have influence on the removal of SMX 
[37].  Removal efficiencies reported in the literature varied in a wide range. For example, 
eliminations of 33±64, 0–84% and (-138)–60% can be found in [151, 150] and [9] respectively. The 
reason for this wide range removal efficiency is due to the fact that real wastewaters, which have a 
more complex matrix, were used in these works. Negative elimination has also been found in the 
literature because of presence of conjugated metabolites in the complex wastewater [30, 37, 151]. 
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4.2.2 Case study 2 
Case study 2 evaluated abiotic cleavage, hydrolysis and biodegradation mechanisms that are 
responsible for the removal of nonylphenol ethoxylates (NPEO’s). The details of each mechanism 
were discussed in chapter 2. 
4.2.2.1 Case study 2 calibration 
The submodel for case study 2 was calibrated for both conventional and fate model parameters before 
running simulations. In the conventional parameter calibration effort, wastewater characteristics, the 
biomass production at steady state conditions, SRT, and HRT in the system were adjusted to the plant 
data that were used for the calibration. The batch experimental data presented by Karahan et al. 2010 
[19] was used for the calibration of this model. For the other ASM1 parameters that were not reported 
in the related literature, the default value for municipal wastewater treatment plant was inserted into 
the GPS-X software. The SRT of 15 d and HRT of 24 hr were tuned with those of [19]. By adjusting 
the inert organic suspended solids, influent VSS and the ratio of inert particulate COD to 
biodegradable COD in wastewater influent by trial and error within the GPS-X software and running 
simulation on the submodel of this case study, the biomass concentration in the bioreactor at steady 
state was matched with the corresponding experimental data presented in that literature. This relative 
error for this calibration was 1.6% where the relative error (RE) for the calibration was calculated as 
100*(experimental value -estimated value for TSS (gXssL-1)/ experimental value for TSS. In recent 
fate models, in the structure of trace compound biodegradation process, the active biomass is not 
measurable experimentally; thus, it is often assumed that the MLSS or MLVSS can represent the 
active biomass. However, in the new fate model, which was developed in this research, the active 
heterotrophic biomass was used as an active fraction of MLSS and was predicted by the conventional 
part of the model within the GPS-X. The aforementioned conventional parameters are presented in 
Appendix J.  
After conventional parameter calibration, according to the plant layout and submodel matrix, which 
are presented in appendix E, the corresponding set of differential equations were transferred to 
MATLAB where the fate model was calibrated with experimental data reported for the trace 
compound (NPEO). The calibration for case study 2 is detailed here according to data presented for 
total COD and NPEO concentration in bulk liquid. The mean µ and standard deviation σ of the 
literature ([19, 70, 139,140, 141,142, 143]) for the parameters of interest were calculated. It should be 
noted that the values in most references of the literature were reported as uncertainty intervals (µ±σ), 
and there was no deterministic range for each parameter reported in the literature. Hence, a total mean 
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and standard deviation over those reported means and standard deviations was calculated. Then lower 
and upper bounds of each parameter for the calibration were set to µ-σ and µ+σ, respectively, see 
Table 4.4. For this case, the following objective function was considered: 
2 2exp exp
exp exp
1 1
- -0.5 0.5
max( ) max( )
sim simn n
i i i i
i i
Sza Sza COD CODSSE
Sza COD= =
⎛ ⎞ ⎛ ⎞= +⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠∑ ∑  
(4.3)
where i is the data point index, Sza is the effluent concentration of NPEO in bulk liquid, the 
superscripts “sim” and “exp” represent simulation (model) and experimental data (from Karahan et al. 
2010 [19]), respectively. Note that the objective function is written in a non-dimensionalized form to 
provide relatively similar effects of the two terms on the SSE; otherwise, the two terms could have 
such different values that the optimizer would reduce only the larger term. A summary of the 
calibration results is presented in the following table: 
Table 4.4 Calibration results for case study 2 
Parameter Lower Bound Upper Bound Optimal Value ± Standard Error 
KOCL (1/d) 0 - 250±13 
KhNPEO (1/d) 0 - 1.45±0.09 
KbioNPEO (m3/gbiomass/d) 0.122 0.312 0.237±0.072 
To investigate the quality of this calibration, a comparison of simulated and corresponding target 
values as well as the R2 values are presented in Figure 4.2: 
  
(a) (b) 
Figure 4.2 Simulated against the target concentrations in the calibration of case 2 model. 
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As shown in Figure 4.2(a), model (solid line) has followed the experimental data (solid circles) quite 
well; the R2 value was 0.96, which indicates that the model was calibrated accurately. Figure 4.1(b) 
shows how the calibrated model could follow the target values of NPEO. The trends look quite the 
same and the R2 value was 0.95. The high quality of the fit in the calibration was attributed to the 
accurate estimation of viable biomass production in the activated sludge process in the case 2 model. 
During the abiotic cleavage process, NPEO’s in the bulk liquid (Sza) are converted to readily 
biodegradable substrate (Szb), slowly biodegradable substrate (Szc), and non biodegradable substrate. 
During the hydrolysis process, slowly biodegradable substrate converts to readily biodegradable 
substrate, and then readily biodegradable substrate is biodegraded. Hence, these were the processes 
that were modeled in this case study. The simulated effluent concentration of Sza, Szb, Szc and Szd 
are presented in Table 4.5. The details of plant configuration parameters were presented in section 
3.4.5, Table 3.8. These results were obtained by running a simulation at steady state condition within 
the GPS-X software. The removal efficiency based on NPEO in the bulk liquid (Sza) was 99.7%, 
which was in good agreement with data provided by [19]. The estimation of total suspended solid 
concentration in the aeration basin was in a typical range and equal to the concentration in batch 
experiment by [19] in steady state condition.  In Table 4.5, the viable biomass prediction was 
addressed as well, since the fate model is ASM-based. 
 
  
Table 4.5 Simulation results of case study 2 
Szai 
(g/m3) 
Sza 
(g/m3) 
Szb 
(g/m3) 
Szc 
(g/m3) 
Szd 
(g/m3) 
SCOD 
(gCOD/m3) 
xbh 
(gCOD/m3) 
TSS in AR 
(g/m3) 
TSS in WAS 
(g/m3) 
114 0.300 0.570 0.997 35.910 26.530 760.70 1762 3286 
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4.2.2.2 Case study 2 validation 
As mentioned previously, the fate model parameters for NPEOs were calibrated using data by 
Karahan et al. 2010 [19]. Following calibration, the fate model simulation results were validated with 
data reported by Zhang et al. 2007 [70]. To this goal, the wastewater characteristics and the plant 
operation conditions of the fate model were set to those presented in [70]. The value of total COD 
influent was considered as 232 gCOD/m3 and the key parameters are shown in Table 4.6. The fate 
model was run with these parameters at steady state condition. The removal efficiency of the NPEO 
was predicted as 98%. Since the SRT was not reported by [70], that value was set to be 15 days. COD 
removal efficiency was estimated as 84%. 
Table 4.6 Characteristics and the plant operation condition for prediction 
of NPEO removal in Wastewater Treatment 
Parameter Zhang et al. 2007 [70] 
Removal efficiency (%) >92 
HRT (hours) 15.8 
Mixed liquor suspended solid (MLSS) in 
steady state condition (g/m3) 
1500 
Total COD in influent (gCOD/m3) 232 ± 15 
COD Removal efficiency (%) 82.3% 
According to Table 4.6, the estimated value was in good agreement with the results reported by [70], 
even though the removal efficiency predicted by [70] was 92%, the calibrated fate model higher 
estimation removal efficiency could be because of higher SRT than that of [70]. 
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4.2.3 Case study 3 
This case study was created to investigate the removal of a group of compounds that are present in the 
water phase in neutral and ionized forms. Biodegradation in the aeration reactor and sorption were the 
major processes included in the structure of this submodel. In this case study, calibration, simulation 
and  validation processes and sensitivity analysis against SRT, HRT were done for Bisphenol-A, 
which is a neutral compound, and Ibuprofen, which is an ionized compound. For the ionized 
compound, the pH was also considered as a sensitivity analysis parameter. 
4.2.3.1 Case study 3 calibration and simulation 
Similar to the previous case studies, the calibration of the model was performed for both conventional 
and fate parameters. The experiment results presented by Zhao et al. 2007 [137] was used for the 
calibration of the neutral compound (Bisphenol-A) parameters, and the experimental results of 
Collado et al. 2012 [146] were used for calibration of the ionized compound (Ibuprofen) parameters. 
The biomass production in the aeration baisn in steady state condition (MLSS in steady state) was 
kept the same as those in the mentioned references, respectively for each case. In order to achieve 
this, the wastewater characteristics in terms of inert inorganic suspended solids, particulate inert 
organic material and total suspended solid in the waste water influent and also operational parameters, 
such as SRT and HRT, were tuned with corresponding reported values. Since only total COD values 
were available for the influent, the default values for the wastewater characteristics and ASM1 model 
parameters within the typical range were used for the calibration. By adjusting the inert organic 
suspended solids, influent VSS and the ratio of inert particulate COD to biodegradable COD in 
wastewater influent by trial and error within the GPS-X software and running simulation on the 
submodel of this case study, the biomass concentration in the bioreactor at steady state was matched 
with the corresponding experimental data presented in that literature. This relative error for this 
calibration for the neutral and ionized compounds were 2.3 and 1.8% respectively where R.E. 
=100*(estimated value - experimental value for TSS (gXssL-1)/ experimental value for TSS. As 
mentioned in section 2.3.2, in recent fate models, in the structure of trace compound biodegradation 
process, the active biomass is not measurable experimentally; thus, it is often assumed that the MLSS 
or MLVSS can represent the active biomass. However, in the new fate model that was developed in 
this research, the active heterotrophic biomass was used as the active fraction of MLSS and was 
predicted by the conventional part of the model within the GPS-X. Hence, it was expected that the 
parameter values (kb, kd, etc) predicted in this research would be different from that of reported in the 
literature.  The aforementioned conventional parameters were presented in Appendix K.  
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After conventional parameter calibration, according to the plant layout and submodel matrix, which 
was presented in appendix F, the corresponding set of differential equations were transferred to 
MATLAB where the fate model was calibrated with experimental data reported for the trace 
compounds Bisphenol-A and Ibuprofen. To this goal, for each parameter of interest (see Appendix F), 
the mean µ and standard deviation σ of the literature reported range were calculated. It should be 
pointed out that the values in most references of the literature were reported as uncertainty intervals 
(µ±σ), and there was no deterministic value and therefore range for each parameter reported in the 
literature. Hence, a total mean and standard deviation over the reported means and standard 
deviations was calculated. Then lower and upper bounds for the calibration were set to µ-σ and µ+σ, 
respectively, see Table 4.7 and 4.8. For this case, the following objective functions were considered: 
2exp
exp
1
-
max( )
simn
i i
i
Szj SzjSSE
Szj=
⎛ ⎞= ⎜ ⎟⎝ ⎠∑  
(4.6)
2exp
exp
1
-
max( )
simn
i i
i
Szh SzhSSE
Szh=
⎛ ⎞= ⎜ ⎟⎝ ⎠∑  
(4.7)
where index i refers to the ith observation point, simSzj is the simulated value for Szj (effluent 
concentration of Bisphenol-A), expSzj  represents the experimental data for Szj from Zhao et al. 2007 
[137], simSzh is the simulated Szh (effluent concentration of Ibuprofen), and expSzh denotes the model 
results by Collado et al. 2012 [146]. For more information regarding the calibration process and the 
involved optimization, see section 3.3.2.1. 
A summary of the calibration results is presented in the following table: 
Table 4.7 Calibration results for case study 3-ionized compound 
Parameter Lower Bound Upper Bound Optimal Value ± Standard Error 
KD1 (m3/gbiomass) 1.59E-5 7.53E-4 3.23E-4±6.02E-5 
Kbio1 (m3/gbiomass/d) 0.0681 0.2877 0.1943±0.10 
KD2 (m3/gbiomass) 1.32E-6 6.26E-5 1.96E-5±5.72E-6 
Table 4.8 Calibration results for case study 3-Neutral compound 
Parameter Lower Bound Upper Bound Optimal Value ± Standard Error 
Kd3 (m3/gbiomass) 5.747E-5 7.186E-4 4.935E-4±5.3E-5 
Kbio3 (m3/gbiomass/d) 0.0047 0.0697 0.0502±7.9E-3 
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To examine the quality of model calibration for this case, a comparison of the simulated Szj and Szh 
values against the corresponding target values as well as the R2 values are presented in Figures 4.3: 
 
(a) (b) 
Figure 4.3 Results of Case 3 calibration. (a) Bisphenol-A, (b) Ibuprofen 
As shown in Figure 4.3(a), model (solid line) followed the experimental data (solid circles) fairly 
well; the R2 value is 0.93.  Figure 4.3(b) shows how the calibrated model could follow the target 
compound elimination values. The trends look similar and the R2 value was very good (0.99). 
After model calibration, the soluble and solid phase concentrations of Bisphenol-A and Ibuprofen 
were simulated in the effluent and wastage flow, at steady state for the plant reported in section 3.4.6. 
The soluble COD in the effluent stream, heterotroph biomass production in the aeration bioreactor 
and total suspended solid (TSS) production in the bioreactor and the wastage stream were also 
simulated. These results are shown in Table 4.9 and 4.10. The solids retention time for this simulation 
was 15 days and hydraulic retention time was 12 hours. More details of the plant configuration are 
presented in section 3.4.6, Table 3.6. The removal efficiencies predicted by the fate model for the 
neutral and ionized compounds were 95.5% and 99.5% with were in good agreement with the works 
by [137] for the Bisphenol-A and [146] for the Ibuprofen.  
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        Table 4.9 Simulation results of case study 3 (Neutral compound)   
 Szji 
(g/m3) 
Szj 
(g/m3) 
Xzd in 
WAS 
(g/m3) 
SCOD 
(gCOD/m3) 
xbh 
(gCOD/m3) 
TSS in AR 
(g/m3) 
TSS 
(g/m3)  
 0.02 9 E(-4) 0.003 23.01 1137 3449 13300  
 Table 4.10 continued: Simulation results of case study 3 (Ionized compound)  
Szhi 
(g/m3) 
Szii 
(g/m3) 
Szh 
(g/m3) 
Szi 
(g/m3) 
Xzb in 
WAS 
(g/m3) 
Xzc in 
WAS 
(g/m3) 
SCOD 
(gCOD/m3) 
xbh 
(gCOD/m3) 
TSS in 
AR 
(g/m3) 
TSS 
(g/m3) 
0.024 4.37 1.2E(-4) 0.022 8.58E(-6) 1.3E(-4) 21 1137 3453 13320 
4.2.3.2 Case study 3 validation 
The  data reported by Athanasios et al. 2010 [138] for bisphenol-A in a batch experiment was 
employed for validation in this case. The wastewater characteristics and operational plant parameters 
that were use for validation are shown in Table 4.11 and 4.12. The removal efficiency predicted by 
the fate model was 97.5%, which was in the range reported by [138]. 
Table 4.11 Characteristics and the plant operation condition for prediction 
of Bisphenol-A removal in Wastewater Treatment 
Parameter Athanasios et al. 2010 
[138] 
Influent concentration of Bisphenol-A 
(g/m3) 
0.0019 
Removal efficiency (%) 93.8±5.9 
SRT (d) 20 
HRT (hr) 10 
Mixed liquor suspended solid (MLSS) in 
steady state condition (g/m3) 
3000 
Total COD in influent (gCOD/m3) 358 ± 46 
Temperature (°C) 22.0 ± 1.0 
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Table 4.12 Characteristics and the plant operation condition for prediction of Ibuprofen removal in Wastewater Treatment 
Parameter Smook et al. 2008 [145] 
Influent concentration of Ibuprofen (g/m3) 0.009 
Removal efficiency (%) >95 
SRT (d) 9.5 
HRT (hr) 14.2 
Mixed liquor suspended solid (MLSS) in steady state 
condition (g/m3) 
2330 
Temperature (°C) 12-21 
Table 4.11 presents experimental conditions that were reported by Smook et al. 2008 [145] and which 
were used for validation of the Ibuprofen model.  Using these values as input, the predicted removal 
efficiency for Ibuprofen was 96.3% and this was in good agreement with that of [145]. 
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4.3 Sensitivity analysis of the fate model 
In wastewater treatment, certain design and operational parameters that affect the fate of micro-
constituents can be controlled, while other parameters may be determined by the facility design 
and/or geographic area. The crucial controllable operational parameter for relatively non-volatile 
compounds such as XOCs is the solid retention time (SRT), which has been identified in the literature 
as an important factor. Hydraulic retention time (HRT), which is fixed by the process unit design 
volume and influent flow rate, is an example of relatively non-controllable parameters. pH is another 
factor that mainly influences the removal of ionized compounds. The importance of the three 
aforementioned factors in removal of XOCs was investigated via a sensitivity analysis in the GPS-X 
software. 
Other parameters in the proposed model, such as biodegradation and sorption rate coefficients (kb, 
kd) have been reported in the literature to span a range of values. Although in chapter 3, values for 
these parameters were computed through a calibration process, to study the robustness of the 
simulation results, a sensitivity analysis was performed in this section. To this goal, different 
parameter values were collected from the literature, the mean and standard deviation of these were 
calculated, and separate simulations using µ+σ (upper bound), and µ-σ (lower bound) and the 
calibrated parameter value for these parameters were run. The results of the various cases were 
plotted for analysis purposes.  For case study 1 the anoxic compartment was excluded to simplify the 
sensitivity analysis interpretation. The modified matrix of this model is presented in Appendix D1. 
4.3.1 Effect of solid retention time  
SRT has been identified earlier in the literature as an operational parameter that can be used to 
minimize the effluent concentrations of XOCs [5, 9, 37, 112]. The effect of solid retention time on 
XOC fate over a range of approximately 5 to 20 days at 20°C was investigated in each case study. 
The fate model was the ASM based model, so it addresses the fate of conventional compounds and 
xenobiotic organic compounds simultaneously. To explain the effect of SRT on the fate of xenobiotic 
organic compounds, the effect of SRT on heterotrophic biomass concentration and total suspended 
solid concentration in the aeration basin were plotted for each case study. 
4.3.1.1 Case study 1  
Figure 4.4 presents some of the predicted conventional responses versus SRT for the sensitivity study. 
The HRT in this sensitivity analysis was set to 10.8hr. The concentrations of active heterotrophic 
biomass (xbh) (Figure 4.4a) and total suspended solids (TSS) in the aeration basin (Figures 4.4b) 
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increased with increasing SRT. Since xbh and TSS in the aeration basin are important parameters in 
the biodegradation and sorption of SMX, the effect of SRT on the fate of this compound could be 
explained by the variation of xbh and TSS concentration with respect to SRT. 
(a) (b) 
Figure 4.4 (a) Active heterotrophic biomass (xbh), (b) Total suspended solid (TSS) in aeration, HRT=10.8hr 
The influent concentration of the soluble (Szf) and particulate (Xza) forms of SMX were set at 210 
ng/l and 0 ng/l respectively, and the influent concentration of the daughter compound (Szg) was set at 
467 ng/l. Figure 4.5 presents the influence of SRT on the concentration of the soluble form of SMX 
(Szf) over a range of values of kd and kb. Figure 4.6 presents the corresponding solid phase 
concentration of SMX (Xza) in the waste stream while Figure 4.7 shows the effluent concentration 
and rate of biodegradation of Szg. From Figure 4.5 it can be see that there was a significant reduction 
in the effluent concentration of Szf (about 34% increase in removal efficiency of Szf between SRT=5 
and SRT= 20 days) and Szg (about 15% increase in removal efficiency between SRT=5 and SRT= 20 
days). During the biotransformation process, there was an interaction between metabolite compounds 
(Szg) and the parent compound (Szf). As a result of the biotransformation of Szg, these compounds 
were converted to the parent compounds and also the parent compound was biodegraded itself. The 
net result of these biotransformation processes was the production of the parent compound. As can be 
seen in Figure 4.5 at SRT= 16 days and kb and kd equal to the optimal values, with influent 
concentration of 210 ng/l, the effluent concentration of Szf was approximately 358 ng/l, so the 
removal efficiency of Szf was negative (See Table 4.9).  The increase in concentration of active 
biomass (xbh) due to increase of SRT (Figure 4.4a) resulted in increases in the biodegradation rate of 
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Szf (Figure 4.8) and Szg (Figure 4.7b) (about 27% increase in biodegradation of Szf and 3% increase 
in biodegradation of Szg).  
Figure 4.9 presents the sorption rate for SMX and represents the net effect of the sorption and 
desorption rates. The positive value shows that the rate of sorption was greater than the rate of 
desorption.  The net sorption rate of SMX increased nearly 32% (Figure 4.9) over the range of SRTs 
examined.  With the increase of MLSS concentration, the amount of sorbed SMX to the sludge 
increases. This is because an increase of suspended solids in the system increases the number of 
reactive sites available to sorb SMX from solution. Following that the amount of SMX sorbed to the 
sludge was increased. Therefore, the increase of solid sludge in the solution enhanced the total 
sorption of SMX (Xza) (growth about 88%) by sludge and benefited the removal of SMX from water 
phase (Figures 4.6a and b) [137]. However the wastage rate of SMX decreased with increasing SRT, 
because for regulating SRT wastage flow rate was increased and this term was dominant in wastage 
flow of SMX (See Table 4.11)  
(a) (b) 
Figure 4.5 (a) Soluble SMX conc. in the effluent (Szf) with respect to kd in constant kb (b) Soluble SMX in effluent (Szf) 
with respect to kb in constant kd, Influent concentration of Szf= 210 ng/l, HRT=10.8hr 
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(a) (b) 
Figure 4.6 (a) Particulate SMX conc. in wastage flow (Xza) with respect to kd in constant kb (b) Particulate SMX conc. in 
wastage flow (Xza) with respect to kb in constant kd,  Influent concentration of Xza=0, HRT=10.8hr 
 
(a) (b) 
Figure 4.7 (a) Szg conc. (b) and biodegradation rate for Szg, Influent concentration of Szg= 467 ng/l, HRT=10.8hr 
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(a) (b) 
Figure 4.8 (a) Biodegradation rate for SMX with respect to kd in constant kb and (b) Biodegradation rate for SMX with 
respect to kb in constant kd , HRT=10.8hr 
 
(a) (b) 
Figure 4.9 (a) Net sorption rate for SMX with respect to kd in constant kb  and (b) Net sorption rate for SMX with respect to 
kb in constant kd versus SRT, HRT=10.8hr 
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To investigate the effect of biodegradation and solid liquid partitioning rate parameters on the 
removal of SMX, two different sets of plots (Figures 4.5-4.9) have been presented. The first set 
(Figures 4.5a-4.9a) shows the responses with three different solid liquid partitioning coefficient 
values (kd= µ+σ, calibrated value and µ-σ) at a fixed biodegradation rate coefficient (set to the 
calibrated value, kb=1.529E-3). The second set demonstrates the effects of varying the biodegradation 
rate coefficient (kb= µ+σ, calibrated value and µ-σ) at a fixed solid solid liquid partitioning 
coefficient (set to the calibrated value, kd=2.914E-4). The purpose of presenting theses two sets of 
plots was to see the influence of these parameters on removal of XOCs.  
Table 4.13 shows the percent of SMX removed, biotransformed and wasted at constant kb, SRT= 16 
days, and HRT=10.8 hr. Increasing the value of kd resulted in a decrease of SMX in the soluble phase 
and an increase in the the concentration of particulate SMX (Xza). Therefore, there was more removal 
in the liquid and solid phases (Figure 4.5a and Figure 4.6a). Furthermore, at constant kb, the higher kd 
has a higher net sorption rate, (Figure 4.9a) but a lower biodegradation rate, although, as can be seen 
in Figure 4.8, there was not a significant reduction of the biodegradation rate with higher kd values 
(Figure 4.8a). The concentration of particulate SMX (Xza) contributed to the wasted mass. Since Xza 
increases in the wastage flow by the sorption process the wastage percentage was positive, but the 
removal and biotransformed percentage due to increasing soluble SMX in effluent were negative. 
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Table 4.13 Quantified effects of kd on percentage of removed, biotransformed and wasted SMX 
Rate Parameter %removed* %biotransformed* %wasted 
K
b=
 
1.
52
9E
-3
 Kd1=3.893E-4 -68.95 -78.35 9.40 
Kd2=2.914E-4 -70.19 -77.71 7.52 
Kd3=5.110E-5 -71.47 -77.06 5.59 
* It should be noted that negative %removed and %biotransformed was because of biotransformation of metabolite to the SMX  
Table 4.14 presents the percentage of SMX removed, biotransformed and wasted at constant kd with 
SRT= 16 days, HRT=10.8 hr. With kd constant, at the higher values of kb, the biodegradation rate 
increases (Figure 4.8b) and effluent concentration becomes lower (Figure 4.5b). Therefore, there is 
more removal in liquid phase; however, in this case, the sorption rate decreases (Figure 4.9b) and the 
particulate concentration in solid phase is lower (Figure 4.6b).  
Table 4.14 Quantified effects of kb on percentage of removed, biotransformed and wasted SMX 
Rate Parameter %removed %biotransformed %wasted 
K
d=
 
2.
91
4E
-4
 Kb1=1.904E-3 -41 -47.21 6.21 
Kb2=1.529E-3 -70.19 -77.71 7.52 
Kb3=6.937E-4 -114.76 -124.23 9.47 
* It should be noted that negative %removed and %biotransformed was because of biotransformation of metabolite to the SMX  
Generally, at higher SRTs, there was higher removal and biotransformation of SMX and a lower 
wasted percentage of SMX (Table 4.14). The wastage of SMX decreased with increasing SRT, 
because the wastage flow rate regulated for SRT control and this term was dominant in wastage of 
SMX (See Table 4.15). The negative removal efficiency and biotransformation were due to the 
conversion of the conjugate form to the parent compound (SMX) that compensated for the 
biodegradation of SMX. At higher SRT, more of SMX was biodegraded and at lower SRT, the 
conversion of the conjugated compound to parent compound dominated (Table 4.15).  
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Table 4.15 Variation of removed, biotransformed and wasted percentage of SMX at constant kb and 
kd, kb=1.529E-3, kd=2.914E-4, versus SRT, HRT=10.8hr 
SRT (d) %removed %biotransformed %wasted 
5 -99.86 -121.86 22.00 
9 -82.86 -94.89 12.03 
13 -74.24 -83.03 8.79 
16 -70.19 -77.71 7.52 
20 -66.38 -72.86 6.48 
* It should be noted that negative %removed and %biotransformed was because of biotransformation of metabolite to the SMX  
Important results that can be obtained from sensitivity analysis in this section are as follows:  
? Increases in SRT can enhance removal of SMX and its metabolite (daughter compound), 
since at higher SRT, there is higher removal efficiency and lower wasted of SMX and also 
lower effluent concentration of metabolite. 
? Due to conversion of metabolite to the parent compound, net biotransformation of parent 
compound causes producing of this compound. Therefore, the removal efficiency and also 
biotransformation rate of SMX were negative.   
? At SRT higher than 16 days, the removal efficiency does not change significantly, so 
SRT=16 days can be reported as the optimal SRT for this case. 
? In the region of low SRT, the descending rate of effluent concentration of SMX is higher than 
that of higher region. 
? Results of Table 4.13 and 4.14 show the removal efficiency is more sensitive to 
biodegradation rate than sorption rate. 
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4.3.1.2 Case study 2 
Case study 2 addressed the sensitivity of NPEO responses to SRT.  The effect of SRT on fCOD in 
effluent, and viable biomass, xbh in aeration basin, and TSS in aeration basin are presented here. 
Similar to the other case studies, the model employed in this case study is ASM-based.  Hence, it 
takes advantage of xbh prediction in ASM-based model to address biodegradation and hydrolysis 
processes. The concentration of soluble COD (fCOD) in Figure 4.10a decreased by increasing SRT. 
The concentrations of active heterotrophic biomass (xbh) in Figures 4.10b and total suspended solid 
(TSS) in aeration in Figures 4.10c increased with increasing SRT. 
(a) (b) 
 
(c) 
Figure 4.10. (a) Filtered COD (soluble COD), (b) Active heterotrophic biomass (xbh), (c) Total suspended solid (TSS) in aeration 
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This case study addressed the degradation of NPEO that involves multiple transformations including 
initial conversion of NPEO (Sza) to a readily biodegradable substrate (Szb), a slowly biodegradable 
substrate (Szc) and a non biodegradable substrate (Szd) as a result of abiotic cleavage process. In 
addition, the slowly biodegradable substrate (Szc) was converted to readily biodegradable substrate 
(Szb) through a hydrolysis process. Since the cometabolism effect was involved in the biodegradation 
process of NPEO, the integration of cometabolism in models requires that both macropollutants (Ss) 
and micropollutant (NPEO) fate be modelled simultaneously.  
Figure 4.11 depicts the effect of SRT on the effluent concentrations of Sza, Szb and Szc. The influent 
concentration of NPEO in the bulk liquid was 114 mg/l. HRT was set at 24 hours in this study. The 
concentration of NPEO in the bulk liquid (Sza) did not change with increasing SRT, because the 
abiotic cleavage process rate was not a function of biomass production in the reactor. The 
concentration of Szb decreased with increasing SRT (Figure 4.11a), because of the increasing viable 
biomass concentration that increased the biodegradation rate of NPEO (Figure 4.11d). The 
concentration of Szc decreased with SRT, as the hydrolysis process rate is also a function of viable 
biomass. By increasing the SRT, more Szc is converted to Szb, and this leads to reduction in 
concentration of Szc over the range of SRT between 5 and 20 days. 
Figure 4.11 also presents the final effluent concentrations and rate of biodegradation of NPEO that 
were predicted over a range of biodegradation rate coefficients that have been reported in the 
literature (kb). The upper and lower kb values are the µ±σ, which µ is the mean of experimental date 
range on biodegradation rate parameter and σ is the standard deviation of experimental data. The 
intermediate curve (solid line) shows results with the previously calibrated value of kb.  From this 
figure, it can be seen that, with increasing kb value, the reduction in Szb, which was the biodegradable 
portion of NPEO, was about 60.83%. However, the reduction in Szb over the range of SRT=5-20 
days, with constant kb varied by 37.5%. This result shows that the fate of NPEO was more sensitive 
to the biodegradation rate constant than SRT. Due to different biodegradation rates that were reported 
in the literature, the different removal efficiency can be expected in practice due to the sensitivity of 
the model to the biodegradation rate constant.  
Generally, at higher SRT, there was higher removal and more biodegradation; therefore, higher SRT 
provides a good operational condition for removal of NPEO. For SRT values higher than 15 days, the 
removal efficiency did not change significantly, i.e. SRT=15 days can be reported as optimum SRT 
for this case. At low SRT, the change in effluent concentration of NPEO with SRT was higher than 
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that at high SRT. As per different kb, at lower SRT, the difference between biodegradation rates is 
more significant than that at higher SRT. These results also can be seen in Figures 4.11b. 
(a) (b) 
(c) (d) 
Figure 4.11. (a) CNPEO (Sza) (NPEO in the bulk liquid CNPEO), (b) SS,NPEO (Szb) (readily biodegradable substrate portion 
of NPEO), (c) SH,NPEO (Szc) (slowly biodegradable portion of NPEO) and (d) Biodegradation of NPEO with respect to 
different kb 
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4.3.1.3 Case study 3 
In this section, the effect of SRT on the fate of the ionized compound Ibuprofen was investigated over 
a range of SRTs between 5 and 20 days. Biodegradation and sorption were the main mechanisms for 
the removal of this compound. Since pH is a crucial parameter for biodegradation of this compound, 
the effect of this parameter was investigated in section 4.3.3. 
Similar to case studies 1 and 2, the responses of the conventional compounds, xbh and TSS versus 
SRT are also provided in this section, since the fate model addresses the fate of conventional and 
trace compounds simultaneously. Since xbh and TSS in aeration basin are important parameters in the 
biodegradation and sorption of Ibuprofen, the effect of SRT on the fate of this compound could be 
examined by looking at the xbh and TSS concentrations versus SRT. The concentrations of active 
heterotrophic biomass (xbh) in Figures 4.12a and total suspended solid (TSS) in aeration in Figures 
4.12b were predicted to increase with increasing SRT. 
(a) (b) 
Figure 4.12 (a) Active heterotrophic biomass (xbh), (b) Total suspended solid (TSS) in aeration, HRT=12hr 
Figure 4.13 shows the effect of SRT on the effluent concentrations of soluble ibuprofen in both the 
neutral and ionized forms.  Figure 4.14 presents the corresponding solid phase concentrations. The 
influent concentrations of the neutral and ionized forms of Ibuprofen in the influent were Szh=24000 
ng/l and Szi= 4.3673E6 ng/l. Since the availability of viable biomass increased with increasing SRT 
(Figure 4.12a), the concentration of total suspended solid (TSS) in aeration increased (4.12b), and as a 
result, the biodegradation rate of Ibuprofen also increased (Figure 4.15), which lead to a reduction in 
the concentration of the soluble compound in the effluent (Figure 4.13). The concentration of the 
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soluble compound in this case was the summation of the neutral and ionized forms of Ibuprofen. The 
concentration of the particulate compound (summation of neutral and ionized form of Ibuprofen) 
increased because of the increase of available solids (TSS in aeration) at higher SRT and higher 
sorption rate (Figure 4.14). Similar to case study 1, Figures 4.16 presents the net sorption rate for 
Ibuprofen in the neutral and ionized form, since the definition of sorption rate was in terms of 
sorption and desorption rates. 
The concentrations of soluble and particulate Ibuprofen, and its biodegradation and sorption rates 
compound were predicted for three different biodegradation and sorption rate coefficients. The values 
consisted of the smallest value in the literature, the calibrated value, and the largest value in the 
literature. The purpose of presenting theses two different series of plots (series 1: kb constant are 
equal to the calibrated value, series 2: kd constant and set to the calibrated value) was to see the 
influence of the parameters on the removal of Ibuprofen.  
At constant kb, increasing the kd value caused the effluent concentration of the ionized compound in 
the soluble phase (Szh and Szi) to decrease, and the concentrations of the particulate species (Xzb and 
Xzc) to increase; therefore, there is a higher removal in the liquid and solid phases (Figure 4.13a and 
c, Figures 4.14a and c). Also at constant kb, the higher kd has a higher sorption rate (Figure 4.16a and 
c) but a lower biodegradation rate, because at a higher kd, the soluble phase concentration is lower 
that leads to reduction in biodegradation rate (Figure 4.15a and c). Details are presented in Table 
4.16. 
Table 4.16 Variation of removed, biotransformed and wasted percentage of Ibuprofen at constant kb with respect to kd, 
SRT= 15 days, HRT=12 hr 
Rate Parameter %removed %biotransformed %wasted 
K
b=
 0
.1
94
3 Kd11=7.53E-4, Kd21=6.26E-5 99.23 98.79 0.44 
Kd12=3.24E-4, Kd22=1.96E-5 99.19 99.02 0.17 
Kd13=1.59E-5, Kd23=1.32E-6 99.07 99.01 0.06 
When the value of kd was held constant kb was increased the biodegradation rate increased (Figures 
4.15b, d), the effluent concentration was lower (Figures 4.13b, d), and there was an improved removal 
in the liquid phase. However the sorption rate decreased (Figure 4.16b and d) and the particulate 
concentration in the solid phase was lower, (Figure 4.14b, d). Table 4.17 presents details of these 
responses. 
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Table 4.17 Variation of removed, biotransformed and wasted percentage of Ibuprofen at constant kd with respect to 
kb, SRT= 15 days, HRT=12 hr 
Rate Parameter %removed %biotransformed %wasted 
K
d1
2=
3.
24
E-
4,
 
K
d2
2=
1.
96
E-
5 Kb1=0.2877 99.50 99.41 0.09 
Kb2=0.1943 99.19 99.02 0.17 
Kb3=0.0681 97.92 97.69 0.23 
From Figure 4.13, it can be seen that, with increasing kb value at kd constant, the reduction in Szh and 
Szi, was about 75.96% and 75.93% respectively and the reduction of Szh and Szi with increasing kd at 
kb constant was just 0.154% and 0.085% respectively. However, the reduction in Szh and Szi over the 
range of SRT=5-20 days, with constant kb and kd was 33.6% and 33.8% respectively. This result 
shows that the fate of Ibuprofen was more sensitive to the biodegradation rate and SRT than the 
sorption rate constant. Due to different biodegradation and sorption rates that were reported in the 
literature, the different removal efficiency can be expected in practice due to the sensitivity of the 
model to the biodegradation rate constant. 
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(c) (d) 
Figure 4.13. (a) Soluble Ibuprofen (neutral form) in effluent (Szh) with respect to kd in constant kb, (b) Soluble Ibuprofen (neutral form) in 
effluent (Szh) with respect to kb in constant kd, (c) Soluble Ibuprofen (ionized form) in effluent (Szi) with respect to kd in constant kb, and (d) 
Soluble Ibuprofen (ionized form) in effluent (Szi) with respect to kb in constant kd, Influent conc. of Szh= 24000 ng/l, Szi= 4.3673E6 ng/l, 
HRT=12hr 
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(c) (d) 
Figure 4.14. (a) Particulate Ibuprofen (neutral form) in effluent (Xzb) with respect to kd in constant kb, (b) Particulate Ibuprofen (neutral form) in 
effluent (Xzb) with respect to kb in constant kd, (c) Particulate Ibuprofen (ionized form) in effluent (Xzc) with respect to kd in constant kb, and (d) 
Particulate Ibuprofen (ionized form) in effluent (Xzc) with respect to kb in constant kd, Influent conc. of Xzc=Xzd=0, HRT=12hr 
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(c) (d) 
Figure 4.15. (a) Biodegradation rate for Ibuprofen (neutral form) with respect to kd in constant kb, (b) Biodegradation rate for Ibuprofen (neutral 
form) with respect to kb in constant kd, (c) Biodegradation rate for Ibuprofen (ionized form) with respect to kd in constant kb, and (d) 
Biodegradation rate for Ibuprofen (ionized form) with respect to kb in constant kd, HRT=12hr 
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(c) (d) 
Figure 4.16. (a) Net sorption rate for Ibuprofen (neutral form) with respect to kd in constant kb, (b) Net sorption rate for Ibuprofen (neutral form) 
with respect to kb in constant kd, (c) Net sorption rate for Ibuprofen (ionized form) with respect to kd in constant kb, and (d) Net sorption rate for 
Ibuprofen (ionized form) with respect to kb in constant kd, HRT=12hr 
Generally, at higher SRT, there was higher removal, biotransformation of Ibuprofen and a lower 
wasted percentage of this compound (Table 4.18). 
Table 4.18 Variation of removed, biotransformed and wasted percentage of Ibuprofe at constant kb and 
kd, kb=0.1943, kd1=3.24E-4, kd2=1.96E-5, versus SRT, HRT=12 
SRT (d) %removed %biotransformed %wasted 
5 98.82 98.65 0.17 
9 99.07 99.05 0.018 
13 99.16 99.15 0.011 
17 99.21 99.202 0.008 
20 99.22 99.213 0.007 
Important conclusions that can be obtained from SRT sensitivity analysis in this section are as 
follows:  
? Higher SRT provides a good operational condition for removal of Ibuprofen, since at higher 
SRT, there is higher removal efficiency and lower wasted of Ibuprofen. 
? At SRT higher than 13 days, the removal efficiency does not change significantly, so 
SRT=13 days can be reported as the optimal SRT for this case. 
? In the region of low SRT the decreasing rate of effluent concentration of SMX is higher that 
that higher SRT region. 
? Results of Table 4.16 and 4.17 show the removal efficiency is more sensitive to 
biodegradation rate than sorption rate. 
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4.3.2 Effect of hydraulic retention time 
The hydraulic retention time (HRT) of the aerobic reactor typically cannot be varied as an operational 
parameter.  However it represents the time in the reactor during which the biomass can contact and 
utilize the XOCs as a secondary substrate.  Hence, in this section, the effect of varying the aerobic 
reactor HRT was examined in each case study. 
4.2.2.1 Case study 1  
The effect of aeration hydraulic retention time on removal of SMX in Case study 1 was evaluated. 
For regulating HRT, the volume of aeration basin was changed and the range of HRT was between 5 
and 24 hours.  The concentrations of TSS and viable biomass in the aeration reactor decreased at 
higher HRT because of higher aeration volume (Figure 4.17). 
(a) (b) 
Figure 4.17. (a) Active heterotrophic biomass (xbh), (b) Total suspended solid (TSS) in aeration, SRT=16d 
In this analysis the influent concentrations of Szf and Szg were set at 210 and 467 ng/l respectively. 
The rate biodegradation of Szf was found to decrease with increasing HRT (Figure 4.21) due to 
reduction in viable biomass (xbh), (Figure 4.17a). However, the concentration of the soluble parent 
compound decreased, because the higher volume compensated for the lower biodegradation rate 
(Figure 4.18). The concentration of compound biotransformed via the parent compound (Szg) 
decreased by increasing HRT (Figure 4.19a), although the biodegradation rate of this compound 
decreased. In this case, the higher volume compensated for the effect of the lower biodegradation 
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rate, (Figure 4.19b). The concentration of particulate SMX (Xza) in the wastage flow decreased at the 
higher HRT, (Figure 4.20) because of reduction in the TSS concentration in the aeration basin (Figure 
4.17b), higher aeration volume and lower net sorption rate (Figure 4.22). 
Figures 4.18-4.22 presents the responses for different biodegradation and sorption rate coefficients.  
These plots are similar in format to the plots presented in section 4.3.1.1. For example, with kd 
constant and a higher kb value, there was a lower effluent concentration in the liquid phase (Figure 
4.18b) and a lower particulate compound concentration in the wastage flow (Figure 4.20b). At 
constant kb and higher kd values, there was a lower effluent concentration in liquid phase (Figure 
4.18a) and higher particulate compound concentration in the wastage flow (Figure 4.20a). Higher kd 
values provided lower biodegradation rates, (Figure 4.21a) and higher net sorption rates (Figure 
4.22a). On the other hand, higher kb values gave higher biodegradation rates (Figure 4.21b) and lower 
net sorption rates (Figure 4.22b). From these figures, it can be seen that, with increasing kb values at 
and kb constant, the reduction in Szf, was about 34% and the reduction of Szf with increasing kd at kb 
constant was just 1.47%.  However, the reduction in Szf over the range of HRT= from 5 to 24 days, 
with constant kb and kd was 1.2%. This result shows that the fate of SMX was more sensitive to the 
biodegradation rate and sorption rate constants than HRT. Due to different biodegradation rates that 
were reported in the literature, the different removal efficiency can be expected in practice due to the 
sensitivity of the model to the biodegradation rate constant.  
In Figure 4.18a and b, there was a sharp break in the curve around HRT= 8.5 days. That was due to 
the effects of two different phenomena, biodegradation of SMX and transformation of the conjugate 
to SMX, which are responsible for transformation of this compound. At HRT lower than 8.5, more 
conjugate compound is transformed to SMX, and for HRT higher than 8.5, there is lower amount of 
conjugate to be transformed. Therefore, the variations in concentration of SMX at HRT lower than 
8.5 is more significant than that at higher SRT. 
 
  
 85 
 
(a) (b) 
Figure 4.18. (a) Soluble SMX in effluent (Szf) with respect to kd in constant kb and (b) Soluble SMX in effluent (Szf) with 
respect to kb in constant kd, Influent concentration of Szf= 210 ng/l, SRT=16d 
(a) (b) 
Figure 4.19. (a) Szg and (b) Biodegradation rate for Szg, SRT=16d 
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(a) (b) 
Figure 4.20. (a) Particulate SMX in wastage flow (Xza) with respect to kd in constant kb and Particulate SMX in wastage 
flow (Xza) with respect to kb in constant kd, Influent conc. of Xza=0, SRT=16d 
(a) (b) 
Figure 4.21. (a) Biodegradation rate for SMX with respect to kd in constant kb and (b) Biodegradation rate for SMX with 
respect to kb in constant kd, SRT=16d 
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The following conclusions were arrived at from the HRT sensitivity analysis:  
? Higher HRT provides a reasonable operational condition for removal of SMX 
? At HRT higher than 14 hours, the removal efficiency does not change significantly; therefore, 
HRT=10-14 hr according to also wasted percentage can be reported as the optimal HRT for 
this case. 
? In the region of low HRT the decreasing rate of effluent concentration of SMX is higher than 
that of higher HRT region. 
  
(a) (b) 
Figure 4.22. (a) Net sorption rate for SMX with respect to kd in constant kb and (b) Net sorption rate for SMX with respect 
to kb in constant kd, SRT=16d 
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4.2.2.2 Case study 2 
The effect of HRT on removal of NPEO component was studied. For regulating HRT, the aeration 
volume was changed and the range of HRT was between 7 and 24 hours. Figure 4.23 depicts the 
effect of HRT on fCOD in the effluent, viable biomass, xbh in the aeration basin and also TSS in the 
aeration basin. Similar to case study 1, response of viable biomass (xbh) versus HRT (Figure 4.23b) 
was used for the interpretation of other responses that described the effect of HRT on removal of 
NPEO. From Figure 4.23a it can be seen that the concentration of soluble COD (fCOD) decreased 
slightly with increasing HRT. The concentrations of active heterotrophic biomass (xbh) in Figures 
4.23b and total suspended solid (TSS) in aeration in Figures 4.23c decreased with increasing HRT 
because of the increase in the volume of aeration basin. 
  
(a) (b) 
 
(c) 
Figure 4.23. (a) Filtered COD (soluble COD), (b) Active heterotrophic biomass (xbh), (c) Total suspended solid (TSS) in aeration, SRT=15d 
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Figures 4.24a, b and c depict the effect of HRT on the effluent concentrations of Sza, Szb and Szc, 
respectively. The concentration of NPEO in the bulk liquid decreased with increasing HRT (Figure 
4.24a) while the concentration of Szb decreased with increasing HRT (Figure 4.24b). The viable 
biomass is reduced with increasing HRT and this leads to a reduction in biodegradation and 
hydrolysis rates.  However the higher volume compensated for these phenomena and as a result, the 
concentration of Szb and Szc decreases with increasing HRT.  
Figures 4.24b and d also presented the responses for different biodegradation rate parameters kb, the 
upper and lower kb are the µ±σ, where µ is the mean of experimental date range on biodegradation 
rate parameter and σ is the standard deviation of experimental data reported in the literature. The 
intermediate (solid) line presents results with the calibrated value for kb. Since different kb values 
affect only the biodegradation and hydrolysis rates, the concentration of Szb changed with different 
kb. At higher kb, there was a lower concentration of Szb in effluent. As there was not a large range of 
biodegradation rates of Szb, the impact of different kb values for this species could not be discerned. 
From this figure, it can be seen that, with increasing kb value, the reduction in Szb, which was the 
biodegradable portion of NPEO and at constant HRT and SRT was about 60.8%. However, the 
reduction in Szb over the range of HRT=5-24 days, with constant kb was 70%. This result shows that 
the fate of NPEO was sensitive to both the biodegradation rate constant and HRT.  
Generally, at higher HRT, there was higher removal and at HRT higher than 15 hours, the removal 
efficiency did not change significantly so HRT=15 days can be reported as optimum HRT for this 
case. At low HRT, the response of effluent concentration of NPEO to changes in kb was higher than 
that of the higher region.  
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4.3.2.3 Case study 3 
In this section, the effects of Hydraulic Retention Time (HRT) on removal of an ionized compound 
(Ibuprofen) were investigated. For regulating HRT, the aeration volume was changed and the range of 
HRT was between 5 and 19 hours. The concentrations of TSS and viable biomass in the aeration 
reactor decreased at higher HRT and constant SRT because of the higher aeration volume (Figure 
4.25). 
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(c) (d) 
Figure 4.24 (a) CNPEO (Sza) (NPEO in the bulk liquid CNPEO), (b) SS,NPEO (Szb) (readily biodegradable substrate portion of NPEO), (c) 
SH,NPEO (Szc) (slowly biodegradable portion of NPEO) and (d) Biodegradation rate of NPEO with respect to different kb, Influent conc. of Sza= 
114mg/l, SRT=15d 
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Figure 4.25. (a) Active heterotrophic biomass (xbh), (b) Total suspended solid (TSS) in aeration , SRT=15d 
The biodegradation rates for Szh and Szi were predicted to decrease with an increase in HRT (Figure 
4.28) due to the reduction in viable biomass xbh (Figure 4.25a). However, the concentrations of the 
soluble compounds (Szh and Szi) decreased, because the higher volume compensated for the lower 
biodegradation rate (Figure 4.26). The concentration of particulate Ibuprofen (Xzb and Xzc) in the 
wastage flow, decreased at higher HRT (Figure 4.27), because of the reduction in TSS concentration 
in aeration basin (Figure 4.25b), the higher aeration volume and lower net sorption rate (Figure 4.29). 
Figures 4.26-4.29 present the effect of different biodegradation and sorption rates on ibuprofen fate 
over a range of HRTs. The plots have similar formats to those of the SRT plots in section 4.3.1.3.  For 
example, with constant kb, higher kd values result in lower effluent concentrations in the liquid phase 
(Figure 4.26a and c) and higher particulate compound concentrations in the wastage flow (Figure 
4.27a and c). With kd constant and higher kb values there were lower effluent concentrations in the 
liquid phase (Figure 4.26 b and d) and lower particulate compound concentrations in the wastage flow 
(Figure 4.27b and d). Higher kd values provide lower biodegradation rates (Figure 4.28a and c) and 
higher net sorption rates (Figure 4.29a and c). On the other hand, higher kb values gives higher 
biodegradation rate (Figure 4.28b and d) and lower net sorption rates (Figure 4.29b and d). From this 
figure, it can be seen that, with increasing kb values and kd constant, the reduction in Szh and Szi, 
were about 75.96% and 75.93% respectively and the reduction of Szh and Szi with increasing kd at kb 
constant was just 0.154% and 0.085% respectively. However, the reduction in Szh and Szi over the 
range of HRT=5-19 days, with constant kb and kd was 22.6% and 29% respectively. This result 
shows that the fate of ibuprofen was more sensitive to the biodegradation rate and HRT than the 
sorption rate constant. Due to different biodegradation and sorption rates that were reported in the 
literature, the different removal efficiency can be expected in practice due to the sensitivity of the 
model to the biodegradation rate constant.  
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(a) (b) 
(c) (d) 
Figure 4.26 (a) Soluble Ibuprofen (neutral form) in effluent (Szh) with respect to kd in constant kb, (b) Soluble Ibuprofen 
(neutral form) in effluent (Szh) with respect to kb in constant kd, (c) Soluble Ibuprofen (ionized form) in effluent (Szi) with 
respect to kd in constant kb, and (d) Soluble Ibuprofen (ionized form) in effluent (Szi) with respect to kb in constant kd, 
Influent conc. of Szh= 24000ng/l, Szi= 4.3673E6ng/l, SRT=15d 
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(a) (b) 
(c) (d) 
Figure 4.27 (a) Particulate Ibuprofen (neutral form) in effluent (Xzb) with respect to kd in constant kb, (b) Particulate 
Ibuprofen (neutral form) in effluent (Xzb) with respect to kb in constant kd, (c) Particulate Ibuprofen (ionized form) in 
effluent (Xzc) with respect to kd in constant kb, and (d) Particulate Ibuprofen (ionized form) in effluent (Xzc) with respect to 
kb in constant kd, Influent conc. of Xzb=Xzc=0, SRT=15d 
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(a) (b) 
(c) (d) 
Figure 4.28 (a) Biodegradation rate for Ibuprofen (neutral form) with respect to kd in constant kb, (b) Biodegradation rate 
for Ibuprofen (neutral form) with respect to kb in constant kd, (c) Biodegradation rate for Ibuprofen (ionized form) with 
respect to kd in constant kb, and (d) Biodegradation rate for Ibuprofen (ionized form) with respect to kb in constant kd, 
SRT=15d 
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(a) (b) 
(c) (d) 
Figure 4.29. (a) Net sorption rate for Ibuprofen (neutral form) with respect to kd in constant kb, (b) Net sorption rate for 
Ibuprofen (neutral form) with respect to kb in constant kd, (c) Net sorption rate for Ibuprofen (ionized form) with respect to 
kd in constant kb, and (d) Net sorption rate for Ibuprofen (ionized form) with respect to kb in constant kd , SRT=15d 
Important results that can be obtained from HRT sensitivity analysis in this section are as follows:  
? Higher HRT provides a good operational condition for removal of Ibuprofen. 
? At HRT higher than 10 hours, the removal efficiency does not change significantly, 
HRT=10hr is counted as optimum. 
? In the region of low HRT, the decreasing rate of particulate concentration of Ibuprofen is 
higher than that in the higher HRT region. 
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4.3.3 Effect of pH-case study 3 
In this section, the effect of pH on removal of ionized compound was examined. pH was examined 
over the range of pH values from 6-8. Figure 4.30 displays this effect on removal of Ibuprofen for 
both the neutral and ionized forms of this compound in the solid and liquid phases. The 
biodegradation and sorption rates were presented in Figure 4.31.  
At lower pH, there was a higher removal of the neutral form of ibuprofen (Figure 4.30a); and this is in 
good agreement with the literature that states in acidic condition, the ionized compounds behave like 
neutral compounds [41]. By increasing the pH, the concentration of the neutral form increased and the 
reduction in the biodegradation rate at higher pH supports this phenomenon (Figure 4.31a). On the 
other hand, with higher pH, there was better removal of the ionized form of ibuprofen (Szi) (Figure 
4.30a), but the trends in concentration were different in acidic and basic conditions as there was a 
sharp drop in concentration of Szi in basic conditions. This was due to the structure of biodegradation 
process rate that includes the dissociation constant pka, pH, etc (see case study 3 matrix model, 
Appendix F). The increase of biodegradation rate of Szi supports this phenomenon (Figure 4.31b) as 
the soluble concentration of Szi (4.30b) and biodegradation rate of Szi (4.31b) mirror each other. 
The concentration of compounds in the solid phase in the neutral form (Xzb) increased at higher pH 
values (Figure 4.30c), since the sorption rate increased at higher pH (Figure 4.31c). The concentration 
of the ionized form in the solid phase (Xzc) decreased at higher pH, but trends of reduction in acidic 
and basic condition were different (Figure 4.31d). The reduction of Xzc in basic conditions was 
sharper than that of acidic condition (Figure 4.30d). The reduction in sorption rate at higher pH 
supports that phenomenon (Figure 4.31d). 
The following observations were drawn from the pH sensitivity analysis in this section:  
? Acidic condition provides better condition for removal of neutral form. On the other hand, 
basic condition provides suitable condition for removal of ionized form. 
? Reduction of biodegradation rate for neutral form in acidic condition is sharper than that in 
basic condition (Figure 4.31a), and increasing rate in biodegradation rate of ionized form in 
basic condition is sharper that that in acidic condition (Figure 4.30b). 
? Reduction rate in net sorption rate of ionized form in basic condition is sharper than acidic 
condition (Figure 4.31d), and increasing rate in net sorption of neutral form in basic condition 
is sharper than that in acidic condition (Figure 4.31c).   
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(a) (b) 
(c) (d) 
Figure 4.30 (a) Szh, (b) Szi, (c) Xzb, (d) Xzc in effluent flow versus pH, Influent conc. of Szh=24000ng/l, Szi= 4.3673E6ng/l, 
Xzb=Xzc=0, HRT=12 hr, SRT=15 d 
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(a) (b) 
(c) (d) 
Figure 4.31 (a,b) Biodegradation and (c,d) Net sortion rate versus pH, HRT=12 hr, SRT=15 d 
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4.3.4 Chapter summary 
In this chapter, the calibration employed for each case study was described. Following the calibration 
process, simulation results for each case study were reported. The comparison of each submodel 
against corresponding literature date (different from that used for calibration) was discussed. 
Based on the sensitivity analysis reported in this section, the removal efficiency of XOCs was found 
to be  sensitive to SRT, HRT, pH, kb and kd, although the fate model was more sensitive to kb and kd 
than to operational conditions. In wastewater treatment plants, varying the operational parameters, 
SRT, HRT, and pH imposes some costs to the plant. It is a fundamental engineering trade-off in 
WWTP between cost and removal efficiency. Depending on the allowable cost at the WWTP, the 
operation engineer can tune SRT, HRT and pH to improve removal efficiency. Additionally, based on 
various results shown on the sensitivity of the simulation outputs to the calibration parameters kb and 
kd, one can conclude that the results are considerably sensitive. This implies that although the 
integrated model of this thesis provides a novel framework for removing XOCs, a good source for 
these parameters is required.  
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CHAPTER 5 
CONCLUSIONS AND RECOMMENDATIONS 
5.1 Summary 
A fate model was developed that can be used to better understand and optimize the removal of 
Xenobiotic Organic Compounds (XOCs) in combination with the removal of traditional pollutants in 
wastewater treatment plants. Through the modeling work, major mechanisms responsible for removal 
of XOCs in wastewater treatment were identified and integrated with an ASM1 model to create an 
uncalibrated model matrix. Activated sludge models (ASM) can differentiate between viable and non-
viable biomass, so it was expected that ASM-based integrated fate models would be able to provide 
more accurate predictions of XOC fate over a range of operating conditions. Hence the development 
of an integrated fate and ASM model was employed in this research to have an improved estimate of 
the viable biomass. 
Since specific groups of mechanisms were responsible for the removal of selected compounds, three 
different case studies were created for three different groups of compounds. Therefore, three different 
submodels were created and categorized within the fate model.  Case Study 1 was categorized to 
express the removal of antibiotics like Sulfamethoxazole (SMX). Its removal mechanisms are 
biodegradation, sorption, and parent compound formation, with co-metabolism and competitive 
inhibition effects being inserted into the structure of the model. Removal mechanisms for Case Study 
2, which is created for removing nonylphenol ethoxylates (NPEOs), are abiotic oxidative cleavage, 
hydrolysis, and biodegradation. The third case study includes removal of neutral and ionized XOCs 
through biodegradation and sorption. 
Each submodel was calibrated separately for both conventional and trace compounds using available 
experimental data sets. The optimal model parameters for these data sets were obtained through a 
calibration process.  The calibrated submodels were then integrated into the GPS-X modeling 
platform.  
Using the model developer tool of the GPS-X software, the corresponding matrix components for 
each submodel (case study) were created. Each case study was simulated by implementing the 
corresponding layout and plant operational parameters within the GPS-X software. The validation 
process assessed the reliability of the model under the reported conditions. In this study, different data 
sets were used for the validation of the submodels; these results were discussed separately. From the 
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case studies, it was determined that the crucial controllable operational parameter for the target XOCs 
is the solids retention time (SRT), which has been identified in the literature. Hydraulic retention time 
(HRT), which is fixed by the process unit design volume and influent flow rate, is an example of a 
parameter that is relatively non-controllable. pH is another factor that mainly influences the removal 
of ionized compounds. The importance of the three aforementioned factors in removing XOCs was 
investigated via a sensitivity analysis in the GPS-X software. Other parameters in the proposed 
model, such as biodegradation and sorption rate coefficients (kb, kd) have been reported in the 
literature to span a range of values. Although values for these parameters were computed through the 
calibration process, a sensitivity analysis was performed separately for each case study to study the 
robustness of the simulation results.  
The findings of this research can be summarized as follows: 
? The removal efficiency of the SMX was found to be negative, because the conjugate was 
converted to SMX during the biotransformation process; this phenomenon compensates for 
biodegradation of SMX. 
? The removal efficiency of XOCs was found to be sensitive to SRT, HRT, pH, kb and kd, 
although in most cases the fate model was more sensitive to kb and kd than to operational. 
? Increases in SRT can enhance removal of all compounds that were studied in this research. 
Those compounds include SMX and its conjugate, NPEO, Ibuprofen (ionized compound) and 
Bisphenol-A (neutral compound) 
? At SRT greater than 15 days, the removal efficiency in each case study does not change 
significantly, so 15 (days) can be reported as the optimal SRT. 
? Higher HRT provides a good operational condition for removal of the compounds studied in 
this research. At HRT higher than 10-14 hours, the removal efficiency does not change 
significantly; HRT from 10 to 14 hr can be counted as optimum. 
? Sensitivity analysis of three different cases showed that the fate model was more sensitive to 
biodegradation rate than to sorption rate. 
? The study of pH effect in this thesis showed that for the ionized compound fate model, acidic 
condition provides better condition for removal of the neutral form. On the other hand, 
alkaline condition provides suitable condition for removal of the ionized form. 
  
 102 
 
5.2 Recommendations 
Although the integrated model of this thesis provides a novel framework for XOC fate simulation, 
recommendations for further study on the fate of XOCs compounds include the following:  
? Various reliable sources of experimental data for both XOC and conventional compounds are 
important. The availability of this data for both conventional and trace compounds will lead 
to more robust and more accurate calibration and validation.  
? There is a lack of information on XOCs transformation products in the aquatic systems that 
can impact the observed fate of the parent compounds in wastewater treatment. These 
products account for a broad range of compounds, including human conjugates, such as 
glucoronide, acetyl, sulphate; and other pharmaceuticals biotransformed via the parent 
compound. More experimental work is required to measure accurately the outcome of those 
compounds in wastewater treatment. 
? Since a cometabolism mechanism is involved in the fate of most XOCs, the simultaneous 
measurement of primary substrate along with secondary substrate is required to better predict 
concentrations of trace organic compounds such as SMX and NPEO. 
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Model : 
PPCP I: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
GPS-X 
library: 
cniplib 
Stoichiometry matrix NPEO 
j Rate
s
xbh xba xu xs xi xnd ss snh snd sno si so snn salk xii Sza Szb 
 Unit
s:
gCOD gCOD gCOD gCOD gCOD gN gCOD gN gN gN gCOD gCOD gN Mole HCO3 gCOD g/m3 g/m3 
1 r1 1      -1/yh -ibhn    -(1-yh)/yh  -ibhn/14    
2 r2 1      -1/yh -ibhn  -(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))    
3 r3 1      -1/yh   -ibhn  -(1-yh)/yh  -ibhn/14    
4 r4 1      -1/yh   -ibhn-(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))    
5 r5 -1  fuh 1-fuh  ibhn-fuh.iuhn            
6 r6    -1   1           
7 r7      -1   1         
8 r8        1 -1     1/14    
9 r9        -ibhn-1/ya  1/ya  -(4.57-ya)/ya  (-ibhn/14)-1/(ya.7)    
10 r10  1 fua 1-fua  ibhn-fua.iuhn            
11 r11  -1              -(1-fINPEO) α 
12 r12                 1 
13 r13 1           -(1-yh)/yh     -1 
14 r14                  
15 r15                  
16 r16                  
17 r17                  
18 r18                  
19 r19                  
20 r20                  
21 r21                  
22 r22                  
23 r23                  
24 r24                  
25 r25                  
26 r26                  
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18 19 20 21 22 23 24 25 26 27 28    
NPEO SMX Ibuprofen (Ionized compound) 
BPA (Neutral 
compound) Compi Process rate equations: Units 
Szc Szd Szf Szg Xza Szh Xzb Szi Xzc Szj Xzd    
g/m
3 g/m
3 g/m3 g/m
3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3    
           aerobic growth of heterotrophs on soluble substrate with ammonia as N source muh.MssHET.MsoHET.MsnhGEN.salksatHET.xbh gCOD/m3/d 
           anoxic growth of heterotrophs on soluble substrate with ammonia as N source etag.muh.MssHET.inhibsoaxHET.MsnoHET.MsnhGEN.salksatHET.xbh gCOD/m3/d 
           aerobic growth of heterotrophs on soluble substrate with nitrate as N source muh.MssHET.MsoHET.inhibsnhHET.MsnoHET.salksatHET.xbh gCOD/m3/d 
           anoxic growth of heterotrophs soluble substrate with nitrate as N source etag.muh.MssHET.inhibsoaxHET.inhibsnhHET.MsnoHET.salksatHET.xb
h
gCOD/m3/d 
           decay of heterotrophs bh.xbh gCOD/m3/d 
           hydrolysis of entrapped organics kh. (subsatHET).(MsoHET + etah.inhibsoo2HET.MsnoHET).xbh gCOD/m3/d 
           hydrolysis of entrapped organic nitrogen r6.(xnd/(xs)) gCOD/m3/d 
           ammonification of soluble organic nitrogen ka.snd.xbh gN/m3/d 
           growth of autotrophs mua.MsnhGEN.MsnhNIT.MsoNIT.salksatAUT.xba gCOD/m3/d 
           decay of autotrophs ba.xba gCOD/m3/d 
1-α fINPEO          abiotic cleavage KOCL.Sza gCOD/m3/d 
-1           hydrolysis of Sza KhNPEO.(Szc/xbh/(KxNPEO+Szc/xbh)).xbh gCOD/m3/d 
           growth on Szb KbioNPEO.Szb.(Ks)/(Ks+ss).so/(Koh+so).xbh g/m3/d 
  -1         aerobic biotransformation of Szf K1BioOx.Szf.(Ks. ηbio)/(Ks. ηbio+ss).so/(Ko+so).xbh g/m3/d 
  1 -1        aerobic parent compound formation K1DecOx.Szg.(Ks. η1Dec)/(Ks. η1Dec+ss).so/(Ko+so).xbh g/m3/d 
  1  -1       aerobic desorption of Szf KDes.Szf. so/(Ko+so) g/m3/d 
  1  -1       anoxic desorption of Szf KDes.Szf . Ko/(Ko+so) g/m3/d 
  -1  1       aerobic sorption of Szf KDes.K1DOx.Szf.so/(Ko+so). Xss g/m3/d 
  -1         anoxic biotransformation of Szf K1BioAx.Szf.(Ks. ηbio)/(Ks. ηbio+ss).Ko/(Ko+so).xbh g/m3/d 
  1 -1        anoxic parent compound formation K1DecAx.Szg.(Ks. η1Dec)/(Ks. η1Dec+Ss).Ko/(Ko+so).xbh g/m3/d 
  -1  1       anoxic sorption of Szf KDes.K1DAx.Szf.Ko/(Ko+so). Xss g/m3/d 
     -1 1     sorption of neutral form of compound (HA) K1des.KD1.Szh. Xss g/m3/d 
     1 -1     Desorption of neutral form of compound (HA) K1des.Xzb g/m3/d 
     -1      Biodegradation of neutral form of compound (HA) Kbio1.(Szh+Szi).xbh.so/(Koh + so).(1/(10^(pH-pka)+1)) g/m3/d 
       -1 1   sorption of ionized form of compound (A-) K2des.KD2.Szi. Xss g/m3/d 
       1 -1   Desorption of ionized form of compound (A-) K2des.Xzc g/m3/d 
       -1    Biodegradation of ionized form of compound (A-) Kbio2.(Szh+Szi).xbh.so/(Koh + so).(1/(10^(pka-pH)+1)) g/m3/d 
         -1 1 sorption of neutral compound Kdes3.Kd3.Szj. Xss g/m3/d 
         1 -1 Desorption of neutral  compound Kdes3.Xzd g/m3/d 
         -1  Biodegradation of neutral  compound Kbio3.Szj.xbh.so/(koh + so) g/m3/d 
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Appendix A Cont’d: Internal variables of uncalibrated model (PPCP), ASM1 and Mantis Models 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Internal variables: Units Description 
Aerobic Growth of Heterotrophs at DO Saturation    
r1sat =muh.MssHET.MsnhGEN.xbh gCOD/m3/d aerobic growth of heterotrophs at DO saturation 
Aerobic Growth of Autotrophs at DO Saturation    
 r9sat =mua.MsnhGEN.MsnhNIT.xba gCOD/m3/d aerobic growth of autotrophs at DO saturation 
Actual Oxygen Uptake Rate (OUR)    
our=-rso gO2/m3/d actual oxygen uptake rate 
Maximal Oxygen Uptake Rate    
ourmax = -(coeffso(1).muh.MssHET.MsnhGEN.xbh+coeffso(3).muh.MssHET.inhibsnhHET.MsnoHET.xbh+coeffso(9).mua.MsnhGEN.MsnhNIT.xba) gO2/m3/d maximal oxygen uptake rate (at DO saturation) 
Actual Nitrogen Utilization Rate (NUR)    
nur =-(coeffsnh(9).r9) gN/m3/d actual nitrogen utilization rate 
Maximal Nitrogen Utilization Rate     
nurmax = -(coeffsnh(9).mua.MsnhGEN.MsnhNIT.xba) gN/m3/d maximal nitrogen utilization rate (at DO saturation) 
Denitrification Rate    
dnr = -(coeffsno(2).r2+coeffsno(4).r4) gN/m3/d denitrification rate 
Saturation and Inhibition Functions    
MsnhGEN = snh/(snh + knh) - ammonia (as nutrient) saturation function 
subsatHET = ((xs/(xbh))/((xs/(xbh)) + kx)) - slowly biodegradable substrate saturation function for hydrolysis 
MssHET = ss/(ss + ksh) - readily biodegradable substrate saturation function for heterotrophs 
MsoHET = so/(so + koh) - oxygen saturation function for heterotrophs 
MsnoHET = sno/(sno + kno) - nitrate saturation function for heterotrophs 
Inhibsoo2HET = koh/(so + koh) - oxygen inhibition function for heterotrophs - anaerobic conditions 
InhibsoaxHET = kad/(so + kad) - oxygen inhibition function for heterotrophs - anoxic conditions 
inhibsnhHET = knh/(snh+knh) - ammonia (as nutrient) inhibition function 
MsnhNIT = snh/(snh + kna) - ammonia saturation function for autotrophs 
MsoNIT = so/(so + koa) - oxygen saturation function for autotrophs 
salksatHET=salk/(kalk+salk) - alkalinity saturation function  for  heterotrophs 
salksatAUT = salk/(kalka+salk) - alkalinity saturation function  for autotrophs 
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Appendix B 
ASM1 Model 
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The International Association on Water Pollution Research and Control (IAWPRC) Task Group realized 
that due to the long solids retention times and low growth rates of the bacteria, the actual effluent 
substrate concentrations between different activated sludge treatment plants did not vary greatly. What 
significantly different were the levels of MLSS and electron acceptor (oxygen or nitrate). Thus the focus 
of the Activated Sludge Model No.1 (called asm1 in GPS-X) is the prediction of the solids and electron 
acceptor. 
The Task Group considered the trade-off between model accuracy and practicality. They identified the 
major biological processes occurring in the system and characterized these processes with the simplest 
rate expressions that could be used, resembling the real reactions. 
The use of switching functions was made by the Task Group since some reactions depended on the type 
of electron acceptor present. These functions were of the form: 
o
OH o
S
K S+  
(3.1)
OH
OH o
K
K S+  
(3.2)
In equation 3.1, at low concentration of dissolved oxygen (So), the parameter KOH dominated the 
expression and approaches a value of zero, but for equation 3.2, the amount of that approaches unity. At 
high values of So, the parameter KOH would be negligible and the expression approaches unity, and for 
the other equation, So is the dominant so the equation approaches zero. If the switching function was 
inverted, then the limits when So were high or low are reversed. A consequence of using switching 
functions of this form is that they are continuous functions unlike discontinuous on/off switches which are 
more difficult to simulate.  
In the development of activated sludge modelling, the manner in which the quantity of organic matter is 
measured (BOD, COD or TOC) is inconsistent. The Task Group decided to use COD since mass balances 
can be carried out and since it has links to the electron equivalents in the organic substrate, biomass and 
electron acceptor.  
The organic material is categorized according to a number of characteristics. First is the biodegradability 
of the material. The non-biodegradable organics pass through the system unchanged and can be further 
categorized according to their physical state (soluble or particulate), which is removed from the system by 
different pathways. The particulate material is generally removed with the waste activated sludge, while 
the soluble material leaves with the effluent. The biodegradable material is categorized as either readily or 
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slowly biodegradable. The Task Group treated the former as soluble material, while the latter was treated 
as particulate material (this is not strictly correct, but simplifies matters). The readily biodegradable 
organics may be utilized for cell maintenance or growth with a transfer of electrons to the acceptors. The 
particulate (slowly) biodegradable substrate is hydrolysed to readily biodegradable material, assuming no 
energy utilization and no corresponding use of electron acceptor. 
Two types of biomass are modelled: 1) heterotrophic; and 2) autotrophic. 
The heterotrophic biomass is generated by the growth on readily biodegradable substrate under aerobic or 
anoxic conditions and decays (including endogenous respiration, death, predation and lysis) under all 
conditions. 
The nitrogenous material is categorized according to its biodegradability and physical state. The non-
biodegradable material is modelled as a fraction of the non-biodegradable particulate COD, while the non 
biodegradable soluble material is ignored. The biodegradable nitrogenous material is divided into 
ammonia (free and ionized), soluble organic and particulate organic is converted to ammonia by the 
heterotrophic biomass. The conversion of ammonia to nitrate by the autotrophs is assumed to take place 
in one step 
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Model : 
ASM1 I: 1 2 3 4 5 6 7 8 9 10 11 12 13 
GPS-X 
library: 
cniplib 
Stoichiometry matrix 
j Rates SI SS XI XS XBH XBA XU SO SNO SNH SND XND SALK 
 Units: gCOD gCOD gCOD gCOD gCOD gCOD gCOD gCOD gN gN gN gN Mole HCO3 
1 r1  -1/yh   1   -(1-yh)/yh  -iXB   -iXB/14 
2 r2  -1/yh   1    -(1-yh)/(2.86.yh) -iXB   [-(1-yh)/(14.2.86yh)]- iXB/14 
3 r3      1  -(4.57-ya)/ya 1/ya -iXB-1/ya   (iXB/14)-(1/7ya) 
4 r4    1-fP -1  fP    iXB-fPiXP  
5 r5    1-fP  -1 fP     iXB-fPiXP  
6 r6          1 -1  1/14 
7 r7  1  -1          
8 r8           1 -1  
 
    
N0. Compi Process rate equations: Units 
1ρ  Aerobic growth of heterotrophs µmH. (SS/KS+ SS). (SO/KOH+ SO). XBH gCOD/m3/d 
2ρ  Anoxic growth of heterotrophs µmH. (SS/KS+ SS). (KOH/KOH+ SO). (SNO/KNO+ SNO).ηg. XBH gCOD/m3/d 
3ρ  Aerobic growth of autotrophs µmA. (SNH/KNH+ SNH). (SO/KOA+ SO). XBA gCOD/m3/d 
4ρ  Decay of heterotrophs BH. XBH gCOD/m3/d 
5ρ  Decay of autotrophs BA. XBA gCOD/m3/d 
6ρ  Ammonification Ka.SND. XBH gN/m3/d 
7ρ  Hydrolysis of organic compounds KH.(Xs/XBH)/(KX+ Xs/XBH).[( SO/KOH+ SO)+ ηh.(KOH/KOH+ SO). (SNO/KNO+ SNO)]. XBH gCOD/m3/d 
8ρ  Hydrolysis of organic N 7ρ .(XND/Xs) gCOD/m3/d 
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Appendix C 
 Mantis Model Matrix 
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Model : 
MANTIS I: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
GPS-X 
library: 
cniplib 
Stoichiometry matrix 
j Rate
s xbh xba xu xs xi xnd ss snh snd sno si so snn salk xii 
 Unit
s: gCOD gCOD gCOD gCOD gCOD gN gCOD gN gN gN gCOD gCOD gN Mole HCO3 gCOD 
1 r1 1      -1/yh -ibhn    -(1-yh)/yh  -ibhn/14  
2 r2 1      -1/yh -ibhn  -(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))  
3 r3 1      -1/yh   -ibhn  -(1-yh)/yh  -ibhn/14  
4 r4 1      -1/yh   -ibhn-(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))  
5 r5 -1  fuh 1-fuh  Ibhn-fuh.iuhn          
6 r6    -1   1         
7 r7      -1   1       
8 r8        1 -1     1/14  
9 r9        -ibhn-1/ya  1/ya  -(4.57-ya)/ya  (-ibhn/14)-1/(ya.7)  
10 r10  1 fua 1-fua  Ibhn-fua.iuhn          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Compi Process rate equations: Units 
   
   
aerobic growth of heterotrophs on soluble substrate with ammonia as N source muh.MssHET.MsoHET.MsnhGEN.salksatHET.xbh gCOD/m3/d 
anoxic growth of heterotrophs on soluble substrate with ammonia as N source etag.muh.MssHET.inhibsoaxHET.MsnoHET.MsnhGEN.salksatHET.xbh gCOD/m3/d 
aerobic growth of heterotrophs on soluble substrate with nitrate as N source muh.MssHET.MsoHET.inhibsnhHET.MsnoHET.salksatHET.xbh gCOD/m3/d 
anoxic growth of heterotrophs soluble substrate with nitrate as N source etag.muh.MssHET.inhibsoaxHET.inhibsnhHET.MsnoHET.salksatHET.xbh gCOD/m3/d 
decay of heterotrophs bh.xbh gCOD/m3/d 
hydrolysis of entrapped organics kh. (subsatHET).(MsoHET + etah.inhibsoo2HET.MsnoHET).xbh gCOD/m3/d 
hydrolysis of entrapped organic nitrogen r6.(xnd/(xs)) gCOD/m3/d 
ammonification of soluble organic nitrogen ka.snd.xbh gN/m3/d 
growth of autotrophs mua.MsnhGEN.MsnhNIT.MsoNIT.salksatAUT.xba gCOD/m3/d 
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Appendix D 
 Case Study 1 Matrix 
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Model : 
PPCP I: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
GPS-X 
library: 
cniplib 
Stoichiometry matrix NPEO 
j Rates xbh xba xu xs xi xnd ss snh snd sno si so snn salk xii Sza Szb 
 Units: gCOD gCOD gCOD gCOD gCOD gN gCOD gN gN gN gCOD gCOD gN Mole HCO3 gCOD g/m3 g/m3 
1 r1 1      -1/yh -ibhn    -(1-yh)/yh  -ibhn/14    
2 r2 1      -1/yh -ibhn  -(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))    
3 r3 1      -1/yh   -ibhn  -(1-yh)/yh  -ibhn/14    
4 r4 1      -1/yh   -ibhn-(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))    
5 r5 -1  fuh 1-fuh  ibhn-fuh.iuhn            
6 r6    -1   1           
7 r7      -1   1         
8 r8        1 -1     1/14    
9 r9        -ibhn-1/ya  1/ya  -(4.57-ya)/ya  (-ibhn/14)-1/(ya.7)    
10 r10  1 fua 1-fua  ibhn-fua.iuhn            
11 r11  -1              0 0 
12 r12                 0 
13 r13 1           -(1-yh)/yh     0 
14 r14                  
15 r15                  
16 r16                  
17 r17                  
18 r18                  
19 r19                  
20 r20                  
21 r21                  
22 r22                  
23 r23                  
24 r24                  
25 r25                  
26 r26                  
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18 19 20 21 22 23 24 25 26 27 28    
NPEO SMX and its metabolite 
Ibuprofen (Ionized 
compound) 
BPA (Neutral 
compound) Compi Process rate equations: Units 
Szc Szd Szf Szg Xza Szh Xzb Szi Xzc Szj Xzd    
g/m
3 g/m
3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3    
           aerobic growth of heterotrophs on soluble substrate with ammonia as N source muh.MssHET.MsoHET.MsnhGEN.salksatHET.xbh gCOD/m3/d 
           anoxic growth of heterotrophs on soluble substrate with ammonia as N source etag.muh.MssHET.inhibsoaxHET.MsnoHET.MsnhGEN.salksatHET.xbh gCOD/m3/d 
           aerobic growth of heterotrophs on soluble substrate with nitrate as N source muh.MssHET.MsoHET.inhibsnhHET.MsnoHET.salksatHET.xbh gCOD/m3/d 
           anoxic growth of heterotrophs soluble substrate with nitrate as N source etag.muh.MssHET.inhibsoaxHET.inhibsnhHET.MsnoHET.salksatHET.x
bh
gCOD/m3/d 
           decay of heterotrophs bh.xbh gCOD/m3/d 
           hydrolysis of entrapped organics kh. (subsatHET).(MsoHET + etah.inhibsoo2HET.MsnoHET).xbh gCOD/m3/d 
           hydrolysis of entrapped organic nitrogen r6.(xnd/(xs)) gCOD/m3/d 
           ammonification of soluble organic nitrogen ka.snd.xbh gN/m3/d 
           growth of autotrophs mua.MsnhGEN.MsnhNIT.MsoNIT.salksatAUT.xba gCOD/m3/d 
           decay of autotrophs ba.xba gCOD/m3/d 
0 0          abiotic oxidative cleavage KOCL.Sza gCOD/m3/d 
0           hydrolysis of Sza KhNPEO.(Szc/xbh/(KxNPEO+Szc/xbh)).xbh gCOD/m3/d 
           growth on Szb KbioNPEO.Szb.(Ks)/(Ks+ss).so/(Koh+so).xbh g/m3/d 
  -1         aerobic biotransformation of Szf K1BioOx.Szf.(Ks. ηbio)/(Ks. ηbio+ss).so/(Ko+so).xbh g/m3/d 
  1 -1        aerobic parent compound formation K1DecOx.Szg.(Ks. η1Dec)/(Ks. η1Dec+Ss).so/(Ko+so).xbh g/m3/d 
  1  -1       aerobic desorption of Szf KDes.Szf. so/(Ko+so) g/m3/d 
  1  -1       anoxic desorption of Szf KDes.Szf . Ko/(Ko+so) g/m3/d 
  -1  1       aerobic sorption of Szf KDes.K1DOx.Szf.so/(Ko+so). Xss g/m3/d 
  -1         anoxic biotransformation of Szf K1BioAx.Szf.(Ks. ηbio)/(Ks. ηbio+Ss).Ko/(Ko+so).xbh g/m3/d 
  1 -1        anoxic parent compound formation K1DecAx.Szg.(Ks. η1Dec)/(Ks. η1Dec+Ss).Ko/(Ko+so).xbh g/m3/d 
  -1  1       anoxic sorption of Szf KDes.K1DAx.Szf.Ko/(Ko+so). Xss g/m3/d 
     0 0     sorption of neutral form of compound (HA) K1des.KD1.Szh. Xss g/m3/d 
     0 0     Desorption of neutral form of compound (HA) K1des.Xzb g/m3/d 
     0      Biodegradation of neutral form of compound (HA) Kbio1.(Szh+Szi).xbh.so/(koh + so).(1/(10^(pH-pka)+1)) g/m3/d 
       0 0   sorption of ionized form of compound (A-) K2des.KD2.Szi. Xss g/m3/d 
       0 0   Desorption of ionized form of compound (A-) K2des.Xzc g/m3/d 
       0    Biodegradation of ionized form of compound (A-) Kbio2.(Szh+Szi).xbh.so/(koh + so).(1/(10^(pka-pH)+1)) g/m3/d 
         0 0 sorption of neutral compound Kdes3.Kd3.Szj. Xss g/m3/d 
         0 0 Desorption of neutral  compound Kdes3.Xzd g/m3/d 
         0  Biodegradation of neutral  compound Kbio3.Szj.xbh.so/(koh + so) g/m3/d 
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Appendix D Cont’d: Internal variables of Case Study 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Internal variables: Units Description 
Aerobic Growth of Heterotrophs at DO Saturation    
r1sat =muh.MssHET.MsnhGEN.xbh gCOD/m3/d aerobic growth of heterotrophs at DO saturation 
Aerobic Growth of Autotrophs at DO Saturation    
 r9sat =mua.MsnhGEN.MsnhNIT.xba gCOD/m3/d aerobic growth of autotrophs at DO saturation 
Actual Oxygen Uptake Rate (OUR)    
our=-rso gO2/m3/d actual oxygen uptake rate 
Maximal Oxygen Uptake Rate    
ourmax = -(coeffso(1).muh.MssHET.MsnhGEN.xbh+coeffso(3).muh.MssHET.inhibsnhHET.MsnoHET.xbh+coeffso(9).mua.MsnhGEN.MsnhNIT.xba) gO2/m3/d maximal oxygen uptake rate (at DO saturation) 
Actual Nitrogen Utilization Rate (NUR)    
nur =-(coeffsnh(9).r9) gN/m3/d actual nitrogen utilization rate 
Maximal Nitrogen Utilization Rate     
nurmax = -(coeffsnh(9).mua.MsnhGEN.MsnhNIT.xba) gN/m3/d maximal nitrogen utilization rate (at DO saturation) 
Denitrification Rate    
dnr = -(coeffsno(2).r2+coeffsno(4).r4) gN/m3/d denitrification rate 
Saturation and Inhibition Functions    
MsnhGEN = snh/(snh + knh) - ammonia (as nutrient) saturation function 
subsatHET = ((xs/(xbh))/((xs/(xbh)) + kx)) - slowly biodegradable substrate saturation function for hydrolysis 
MssHET = ss/(ss + ksh) - readily biodegradable substrate saturation function for heterotrophs 
MsoHET = so/(so + koh) - oxygen saturation function for heterotrophs 
MsnoHET = sno/(sno + kno) - nitrate saturation function for heterotrophs 
Inhibsoo2HET = koh/(so + koh) - oxygen inhibition function for heterotrophs - anaerobic conditions 
InhibsoaxHET = kad/(so + kad) - oxygen inhibition function for heterotrophs - anoxic conditions 
inhibsnhHET = knh/(snh+knh) - ammonia (as nutrient) inhibition function 
MsnhNIT = snh/(snh + kna) - ammonia saturation function for autotrophs 
MsoNIT = so/(so + koa) - oxygen saturation function for autotrophs 
salksatHET=salk/(kalk+salk) - alkalinity saturation function  for  heterotrophs 
salksatAUT = salk/(kalka+salk) - alkalinity saturation function  for autotrophs 
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Appendix D1: Case study 1_Considering aerobic parent compound transformation and aerobic biodegradation only for sensitivity analysis  
Model : 
PPCP I: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
GPS-X 
library: 
cniplib 
Stoichiometry matrix NPEO 
j Rates xbh xba xu xs xi xnd ss snh snd sno si so snn salk xii Sza Szb 
 Units: gCOD gCOD gCOD gCOD gCOD gN gCOD gN gN gN gCOD gCOD gN Mole HCO3 gCOD g/m3 g/m3 
1 r1 1      -1/yh -ibhn    -(1-yh)/yh  -ibhn/14    
2 r2 1      -1/yh -ibhn  -(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))    
3 r3 1      -1/yh   -ibhn  -(1-yh)/yh  -ibhn/14    
4 r4 1      -1/yh   -ibhn-(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))    
5 r5 -1  fuh 1-fuh  ibhn-fuh.iuhn            
6 r6    -1   1           
7 r7      -1   1         
8 r8        1 -1     1/14    
9 r9        -ibhn-1/ya  1/ya  -(4.57-ya)/ya  (-ibhn/14)-1/(ya.7)    
10 r10  1 fua 1-fua  ibhn-fua.iuhn            
11 r11  -1              0 0 
12 r12                 0 
13 r13 1           -(1-yh)/yh     0 
14 r14                  
15 r15                  
16 r16                  
17 r17                  
18 r18                  
19 r19                  
20 r20                  
21 r21                  
22 r22                  
23 r23                  
24 r24                  
25 r25                  
26 r26                  
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18 19 20 21 22 23 24 25 26 27 28    
NPEO SMX Ibuprofen (Ionized compound) 
BPA (Neutral 
compound) Compi Process rate equations: Units 
Szc Szd Szf Szg Xza Szh Xzb Szi Xzc Szj Xzd    
g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3
g/m
3 g/m
3 g/m3 g/m3    
           aerobic growth of heterotrophs on soluble substrate with ammonia as N source muh.MssHET.MsoHET.MsnhGEN.salksatHET.xbh gCOD/m3/d 
           anoxic growth of heterotrophs on soluble substrate with ammonia as N source etag.muh.MssHET.inhibsoaxHET.MsnoHET.MsnhGEN.salksatHET.xb
h
gCOD/m3/d 
           aerobic growth of heterotrophs on soluble substrate with nitrate as N source muh.MssHET.MsoHET.inhibsnhHET.MsnoHET.salksatHET.xbh gCOD/m3/d 
           anoxic growth of heterotrophs soluble substrate with nitrate as N source etag.muh.MssHET.inhibsoaxHET.inhibsnhHET.MsnoHET.salksatHET.
xbh
gCOD/m3/d 
           decay of heterotrophs bh.xbh gCOD/m3/d 
           hydrolysis of entrapped organics kh. (subsatHET).(MsoHET + etah.inhibsoo2HET.MsnoHET).xbh gCOD/m3/d 
           hydrolysis of entrapped organic nitrogen r6.(xnd/(xs)) gCOD/m3/d 
           ammonification of soluble organic nitrogen ka.snd.xbh gN/m3/d 
           growth of autotrophs mua.MsnhGEN.MsnhNIT.MsoNIT.salksatAUT.xba gCOD/m3/d 
           decay of autotrophs ba.xba gCOD/m3/d 
0 0          abiotic oxidative cleavage KOCL.Sza gCOD/m3/d 
0           hydrolysis of Sza KhNPEO.(Szc/xbh/(KxNPEO+Szc/xbh)).xbh gCOD/m3/d 
           growth on Szb KbioNPEO.Szb.(Ks)/(Ks+ss).so/(Koh+so).xbh g/m3/d 
  -1         aerobic biotransformation of Szf K1BioOx.Szf.(Ks. ηbio)/(Ks. ηbio+ss).so/(Ko+so).xbh g/m3/d 
  1 -1        aerobic parent compound formation K1DecOx.Szg.(Ks. η1Dec)/(Ks. η1Dec+Ss).so/(Ko+so).xbh g/m3/d 
  1  -1       aerobic desorption of Szf KDes.Szf. so/(Ko+so) g/m3/d 
  -1  1       aerobic sorption of Szf KDes.K1DOx.Szf.so/(Ko+so). Xss g/m3/d 
     0 0     sorption of neutral form of compound (HA) K1BioAx.Szf.(Ks. ηbio)/(Ks. ηbio+Ss).Ko/(Ko+so).xbh g/m3/d 
     0 0     Desorption of neutral form of compound (HA) K1DecAx.Szg.(Ks. η1Dec)/(Ks. η1Dec+Ss).Ko/(Ko+so).xbh g/m3/d 
     0      Biodegradation of neutral form of compound (HA) KDes.K1DAx.Szf.Ko/(Ko+so). Xss g/m3/d 
       0 0   sorption of ionized form of compound (A-) K1des.KD1.Szh. Xss g/m3/d 
       0 0   Desorption of ionized form of compound (A-) K1des.Xzb g/m3/d 
       0    Biodegradation of ionized form of compound (A-) Kbio1.(Szh+Szi).xbh.so/(koh + so).(1/(10^(pH-pka)+1)) g/m3/d 
         0 0 sorption of neutral compound K2des.KD2.Szi. Xss g/m3/d 
         0 0 Desorption of neutral  compound K2des.Xzc g/m3/d 
         0  Biodegradation of neutral  compound Kbio2.(Szh+Szi).xbh.so/(koh + so).(1/(10^(pka-pH)+1)) g/m3/d 
 135 
 
Appendix D1 Cont’d: Internal variables of Case Study 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Internal variables: Units Description 
Aerobic Growth of Heterotrophs at DO Saturation    
r1sat =muh.MssHET.MsnhGEN.xbh gCOD/m3/d aerobic growth of heterotrophs at DO saturation 
Aerobic Growth of Autotrophs at DO Saturation    
 r9sat =mua.MsnhGEN.MsnhNIT.xba gCOD/m3/d aerobic growth of autotrophs at DO saturation 
Actual Oxygen Uptake Rate (OUR)    
our=-rso gO2/m3/d actual oxygen uptake rate 
Maximal Oxygen Uptake Rate    
ourmax = -(coeffso(1).muh.MssHET.MsnhGEN.xbh+coeffso(3).muh.MssHET.inhibsnhHET.MsnoHET.xbh+coeffso(9).mua.MsnhGEN.MsnhNIT.xba) gO2/m3/d maximal oxygen uptake rate (at DO saturation) 
Actual Nitrogen Utilization Rate (NUR)    
nur =-(coeffsnh(9).r9) gN/m3/d actual nitrogen utilization rate 
Maximal Nitrogen Utilization Rate     
nurmax = -(coeffsnh(9).mua.MsnhGEN.MsnhNIT.xba) gN/m3/d maximal nitrogen utilization rate (at DO saturation) 
Denitrification Rate    
dnr = -(coeffsno(2).r2+coeffsno(4).r4) gN/m3/d denitrification rate 
Saturation and Inhibition Functions    
MsnhGEN = snh/(snh + knh) - ammonia (as nutrient) saturation function 
subsatHET = ((xs/(xbh))/((xs/(xbh)) + kx)) - slowly biodegradable substrate saturation function for hydrolysis 
MssHET = ss/(ss + ksh) - readily biodegradable substrate saturation function for heterotrophs 
MsoHET = so/(so + koh) - oxygen saturation function for heterotrophs 
MsnoHET = sno/(sno + kno) - nitrate saturation function for heterotrophs 
Inhibsoo2HET = koh/(so + koh) - oxygen inhibition function for heterotrophs - anaerobic conditions 
InhibsoaxHET = kad/(so + kad) - oxygen inhibition function for heterotrophs - anoxic conditions 
inhibsnhHET = knh/(snh+knh) - ammonia (as nutrient) inhibition function 
MsnhNIT = snh/(snh + kna) - ammonia saturation function for autotrophs 
MsoNIT = so/(so + koa) - oxygen saturation function for autotrophs 
salksatHET=salk/(kalk+salk) - alkalinity saturation function  for  heterotrophs 
salksatAUT = salk/(kalka+salk) - alkalinity saturation function  for autotrophs 
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Appendix E 
Case Study 2 Matrix 
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Model : 
PPCP I: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
GPS-X 
library: 
cniplib 
Stoichiometry matrix NPEO 
j Rates xbh xba xu xs xi xnd ss snh snd sno si so snn salk xii Sza Szb 
 Units: gCOD gCOD gCOD gCOD gCOD gN gCOD gN gN gN gCOD gCOD gN Mole HCO3 gCOD g/m3 g/m3 
1 r1 1      -1/yh -ibhn    -(1-yh)/yh  -ibhn/14    
2 r2 1      -1/yh -ibhn  -(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))    
3 r3 1      -1/yh   -ibhn  -(1-yh)/yh  -ibhn/14    
4 r4 1      -1/yh   -ibhn-(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))    
5 r5 -1  fuh 1-fuh  ibhn-fuh.iuhn            
6 r6    -1   1           
7 r7      -1   1         
8 r8        1 -1     1/14    
9 r9        -ibhn-1/ya  1/ya  -(4.57-ya)/ya  (-ibhn/14)-1/(ya.7)    
10 r10  1 fua 1-fua  ibhn-fua.iuhn            
11 r11  -1              -(1-fINPEO) α 
12 r12                 1 
13 r13 1           -(1-yh)/yh     -1 
14 r14                  
15 r15                  
16 r16                  
17 r17                  
18 r18                  
19 r19                  
20 r20                  
21 r21                  
22 r22                  
23 r23                  
24 r24                  
25 r25                  
26 r26                  
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18 19 20 21 22 23 24 25 26 27 28    
NPEO SMX Ibuprofen (Ionized compound) 
BPA 
(Neutral 
compound) 
Compi Process rate equations: Units 
Szc Szd Szf Szg Xza Szh Xzb Szi Xzc Szj Xzd    
g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3    
           aerobic growth of heterotrophs on soluble substrate with ammonia as N 
source
muh.MssHET.MsoHET.MsnhGEN.salksatHET.xbh gCOD/m3/d 
           anoxic growth of heterotrophs on soluble substrate with ammonia as N 
source
etag.muh.MssHET.inhibsoaxHET.MsnoHET.MsnhGEN.salksatHET.x
bh
gCOD/m3/d 
           aerobic growth of heterotrophs on soluble substrate with nitrate as N 
source
muh.MssHET.MsoHET.inhibsnhHET.MsnoHET.salksatHET.xbh gCOD/m3/d 
           anoxic growth of heterotrophs soluble substrate with nitrate as N source etag.muh.MssHET.inhibsoaxHET.inhibsnhHET.MsnoHET.salksatHET
xbh
gCOD/m3/d 
           decay of heterotrophs bh.xbh gCOD/m3/d 
           hydrolysis of entrapped organics kh. (subsatHET).(MsoHET + etah.inhibsoo2HET.MsnoHET).xbh gCOD/m3/d 
           hydrolysis of entrapped organic nitrogen r6.(xnd/(xs)) gCOD/m3/d 
           ammonification of soluble organic nitrogen ka.snd.xbh gN/m3/d 
           growth of autotrophs mua.MsnhGEN.MsnhNIT.MsoNIT.salksatAUT.xba gCOD/m3/d 
           decay of autotrophs ba.xba gCOD/m3/d 
1-α fINPEO          abiotic oxidative cleavage KOCL.Sza gCOD/m3/d 
-1           hydrolysis of Sza KhNPEO.(Szc/xbh/(KxNPEO+Szc/xbh)).xbh gCOD/m3/d 
           growth on Szb KbioNPEO.Szb.(Ks)/(Ks+ss).so/(Koh+so).xbh g/m3/d 
  0         aerobic biotransformation of Szf K1BioOx.Szf.(Ks. ηbio)/(Ks. ηbio+ss).so/(Ko+so).xbh g/m3/d 
  0 0        aerobic parent compound formation K1DecOx.Szg.(Ks. η1Dec)/(Ks. η1Dec+Ss).so/(Ko+so).xbh g/m3/d 
  0  0       aerobic desorption of Szf KDes.Szf. so/(Ko+so) g/m3/d 
  0  0       anoxic desorption of Szf KDes.Szf . Ko/(Ko+so) g/m3/d 
  0  0       aerobic sorption of Szf KDes.K1DOx.Szf.so/(Ko+so). Xss g/m3/d 
  0         anoxic biotransformation of Szf K1BioAx.Szf.(Ks. ηbio)/(Ks. ηbio+Ss).Ko/(Ko+so).xbh g/m3/d 
  0 0        anoxic parent compound formation K1DecAx.Szg.(Ks. η1Dec)/(Ks. η1Dec+Ss).Ko/(Ko+so).xbh g/m3/d 
  0  0       anoxic sorption of Szf KDes.K1DAx.Szf.Ko/(Ko+so). Xss g/m3/d 
     0 0     sorption of neutral form of compound (HA) K1des.KD1.Szh. Xss g/m3/d 
     0 0     Desorption of neutral form of compound (HA) K1des.Xzb g/m3/d 
     0      Biodegradation of neutral form of compound (HA) Kbio1.(Szh+Szi).xbh.so/(koh + so).(1/(10^(pH-pka)+1)) g/m3/d 
       0 0   sorption of ionized form of compound (A-) K2des.KD2.Szi. Xss g/m3/d 
       0 0   Desorption of ionized form of compound (A-) K2des.Xzc g/m3/d 
       0    Biodegradation of ionized form of compound (A-) Kbio2.(Szh+Szi).xbh.so/(koh + so).(1/(10^(pka-pH)+1)) g/m3/d 
         0 0 sorption of neutral compound Kdes3.Kd3.Szj. Xss g/m3/d 
         0 0 Desorption of neutral  compound Kdes3.Xzd g/m3/d 
         0  Biodegradation of neutral  compound Kbio3.Szj.xbh.so/(koh + so) g/m3/d 
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Appendix F 
Case Study 3 Matrix 
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Model : 
PPCP I: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
GPS-X 
library: 
cniplib 
Stoichiometry matrix NPEO 
j Rates xbh xba xu xs xi xnd ss snh snd sno si so snn salk xii Sza Szb 
 Units: gCOD gCOD gCOD gCOD gCOD gN gCO
D
gN gN gN gCOD gCOD gN Mole HCO3 gCOD g/m3 g/m3 
1 r1 1      -1/yh -ibhn    -(1-yh)/yh  -ibhn/14    
2 r2 1      -1/yh -ibhn  -(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))    
3 r3 1      -1/yh   -ibhn  -(1-yh)/yh  -ibhn/14    
4 r4 1      -1/yh   -ibhn-(1-yh)/(2.86.yh)   (1-yh(/(2.86.yh) (-ibhn/14)+((1-yh)/14.2.86.yh))    
5 r5 -1  fuh 1-fuh  ibhn-fuh.iuhn            
6 r6    -1   1           
7 r7      -1   1         
8 r8        1 -1     1/14    
9 r9        -ibhn-1/ya  1/ya  -(4.57-ya)/ya  (-ibhn/14)-1/(ya.7)    
10 r10  1 fua 1-fua  ibhn-fua.iuhn            
11 r11  -1              0 0 
12 r12                 0 
13 r13 1           -(1-yh)/yh     0 
14 r14                  
15 r15                  
16 r16                  
17 r17                  
18 r18                  
19 r19                  
20 r20                  
21 r21                  
22 r22                  
23 r23                  
24 r24                  
25 r25                  
26 r26                  
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18 19 20 21 22 23 24 25 26 27 28    
NPEO SMX Ibuprofen (Ionized compound) 
BPA (Neutral 
compound) Compi Process rate equations: Units 
Szc Szd Szf Szg Xza Szh Xzb Szi Xzc Szj Xzd    
g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3 g/m3    
           aerobic growth of heterotrophs on soluble substrate with ammonia as N 
source
muh.MssHET.MsoHET.MsnhGEN.salksatHET.xbh gCOD/m3/d 
           anoxic growth of heterotrophs on soluble substrate with ammonia as N 
source
etag.muh.MssHET.inhibsoaxHET.MsnoHET.MsnhGEN.salksatHET.xbh gCOD/m3/d 
           aerobic growth of heterotrophs on soluble substrate with nitrate as N source muh.MssHET.MsoHET.inhibsnhHET.MsnoHET.salksatHET.xbh gCOD/m3/d 
           anoxic growth of heterotrophs soluble substrate with nitrate as N source etag.muh.MssHET.inhibsoaxHET.inhibsnhHET.MsnoHET.salksatHET.xbh gCOD/m3/d 
           decay of heterotrophs bh.xbh gCOD/m3/d 
           hydrolysis of entrapped organics kh. (subsatHET).(MsoHET + etah.inhibsoo2HET.MsnoHET).xbh gCOD/m3/d 
           hydrolysis of entrapped organic nitrogen r6.(xnd/(xs)) gCOD/m3/d 
           ammonification of soluble organic nitrogen ka.snd.xbh gN/m3/d
           growth of autotrophs mua.MsnhGEN.MsnhNIT.MsoNIT.salksatAUT.xba gCOD/m3/d 
           decay of autotrophs ba.xba gCOD/m3/d 
0 0          abiotic oxidative cleavage KOCL.Sza gCOD/m3/d 
0           hydrolysis of Sza KhNPEO.(Szc/xbh/(KxNPEO+Szc/xbh)).xbh gCOD/m3/d 
           growth on Szb KbioNPEO.Szb.(Ks)/(Ks+ss).so/(Koh+so).xbh g/m3/d 
  0         aerobic biotransformation of Szf K1BioOx.Szf.(Ks. ηbio)/(Ks. ηbio+ss).so/(Ko+so).xbh g/m3/d 
  0 0        aerobic parent compound formation K1DecOx.Szg.(Ks. η1Dec)/(Ks. η1Dec+Ss).so/(Ko+so).xbh g/m3/d 
  0  0       aerobic desorption of Szf KDes.Szf. so/(Ko+so) g/m3/d 
  0  0       anoxic desorption of Szf KDes.Szf . Ko/(Ko+so) g/m3/d 
  0  0       aerobic sorption of Szf KDes.K1DOx.Szf.so/(Ko+so). Xss g/m3/d 
  0         anoxic biotransformation of Szf K1BioAx.Szf.(Ks. ηbio)/(Ks. ηbio+Ss).Ko/(Ko+so).xbh g/m3/d 
  0 0        anoxic parent compound formation K1DecAx.Szg.(Ks. η1Dec)/(Ks. η1Dec+Ss).Ko/(Ko+so).xbh g/m3/d 
  0  0       anoxic sorption of Szf KDes.K1DAx.Szf.Ko/(Ko+so). Xss g/m3/d 
     -1 1     sorption of neutral form of compound (HA) K1des.KD1.Szh. Xss g/m3/d 
     1 -1     Desorption of neutral form of compound (HA) K1des.Xzb g/m3/d 
     -1      Biodegradation of neutral form of compound (HA) Kbio1.(Szh+Szi).xbh.so/(koh + so).(1/(10^(pH-pka)+1)) g/m3/d 
       -1 1   sorption of ionized form of compound (A-) K2des.KD2.Szi. Xss g/m3/d 
       1 -1   Desorption of ionized form of compound (A-) K2des.Xzc g/m3/d 
       -1    Biodegradation of ionized form of compound (A-) Kbio2.(Szh+Szi).xbh.so/(koh + so).(1/(10^(pka-pH)+1)) g/m3/d 
         -1 1 sorption of neutral compound Kdes3.Kd3.Szj. Xss g/m3/d 
         1 -1 Desorption of neutral  compound Kdes3.Xzd g/m3/d 
         -1  Biodegradation of neutral  compound Kbio3.Szj.xbh.so/(koh + so) g/m3/d 
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Appendix G 
Different XOCs along with Major References Including 
Some Parameter Variables and Experimental data 
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Different XOCs along with major references including some parameter variables and experimental data, [40] 
Compound Remarks and Major References 
Antibiotics 
Ampicilin (AMP) Li and Zhang 2010 ( HK , data) 
Cefalexin (CLX) Li and Zhang 2010 ( HK , bioK , data) 
Sulfamethoxazole (SMX) 
Li and Zhang 2010 ( HK , bioK , data), Suarez et al. 2010 ( HK , dK ), Plosz et al. 
2009 ( bioK , dK , data), Suarez et al. 2008 ( HK , dK , bioK ) 
Sulfadiazine (SDZ) Li and Zhang 2010 ( HK , bioK , data) 
Norfloxacin (NOR) Li and Zhang 2010 ( HK , bioK , data), Siegrist et al. 2005 ( dK , bioK ) 
Ciprofloxacin (CIP) Li and Zhang 2010 ( HK , bioK , data), Plosz et al. 2009 ( bioK , dK , data) 
Ofloxacin (OFL) Li and Zhang 2010 ( HK , bioK , data) 
Tetracycline (TC) Li and Zhang 2010 ( HK , data), Plosz et al. 2009 ( bioK , dK , data) 
Roxithromycin (ROX) 
Li and Zhang 2010 ( HK , data), Suarez et al. 2010 ( HK , dK ), Joss et al. 2006 ( bioK
), Suarez et al. 2008 ( HK , dK , bioK ) 
Erythromycin (ERY) 
Li and Zhang 2010 ( HK , data), Suarez et al. 2010 ( HK , dK ), Suarez et al. 2008 (
HK , dK , bioK ) 
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Azithromycin Joss et al. 2006 ( bioK , dK ) 
Clarithromycin Joss et al. 2006 ( bioK , dK , data) 
(Anhydro-) erythromycin Joss et al. 2006 ( bioK , dK ) 
N4-acetyl-sulfamethoxazole Joss et al. 2006 ( bioK , data) 
Contrast agent 
Trimethoprim (TMP) 
Li and Zhang 2010 ( HK , data), Suarez et al. 2010 ( HK , dK ), Suarez et al. 2008 (
HK , dK ) 
Iopromide (IPM) Joss et al. 2006 ( bioK , dK , data), Suarez et al. 2008 ( HK , dK , bioK ) 
ATH Joss et al. 2006 ( bioK ) 
DAMI Joss et al. 2006 ( bioK ) 
Diatrizoate Joss et al. 2006 ( bioK , data) 
Iohexol Joss et al. 2006 ( bioK ) 
Iomeprol Joss et al. 2006 ( bioK ) 
Iopamidol Joss et al. 2006 ( bioK ) 
Iothalamic acid Joss et al. 2006 ( bioK ) 
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Ioxithalamic acid Joss et al. 2006 ( bioK ) 
Lipid regulator 
Bezafibrate (BZF) Joss et al. 2006 ( bioK , data), Clara et al. 2004 ( bioK , data) 
Clofibric acid Joss et al. 2006 ( bioK , dK ) 
Fenofibric acid Joss et al. 2006 ( bioK ) 
Gemfibrozil Joss et al. 2006 ( bioK , dK , data) 
Statin Pharmaceticals 
Atorvastatin Ottmar et al. 2010 ( dK , data) 
Simvastatin acid Ottmar et al. 2010 ( dK , data) 
Hormones 
17α-ethinylestradiol (EE2) 
Suarez et al. 2010 ( HK , dK ), Clara et al. 2004 ( bioK , data), Monteith et al. 2009 (
HK , dK , bioK ), Clouzot et al. 2010 ( bioK , dK , data), Racz et al. 2009 ( HK , dK ,
bioK , data), Gaulke et al. 2009 ( bioK ), Clark et al. 2009 ( bioK , data), Suarez et al. 
2008 ( HK , dK , bioK ) 
17β-estradiol (E2) 
Suarez et al. 2010 ( HK , dK ), Clara et al. 2004 ( bioK , data), Racz et al. 2009 ( HK ,
dK , bioK , data), Monteith et al. 2009 ( HK , dK , bioK ), Gaulke et al. 2009 ( bioK , 
data), Siegrist et al. 2005 ( dK , bioK ), Suarez et al. 2008 ( HK , dK , bioK ) 
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Estrone (E1) 
Clara et al. 2004 ( bioK , data), Racz et al. 2009 ( HK , dK , bioK , data), Monteith et al. 
2009 ( HK , dK , bioK ), Gaulke et al. 2009 ( bioK , data), Suarez et al. 2008 ( HK , dK ,
bioK ) 
Estriol (E3) Clara et al. 2004 ( bioK , data), Racz et al. 2009 ( HK , bioK , data) 
Anti-depressants 
Fluoxetine (FLX) Suarez et al. 2010 ( HK , dK ), Suarez et al. 2008 ( HK ) 
Citalopram (CTL) Suarez et al. 2008 ( HK ) 
Anti-inflammatores 
Ibuprofen (IBP) 
Suarez et al. 2010 ( HK , dK ), Joss et al. 2006 ( bioK , dK , data), Clara et al. 2004 (
bioK , data), Suarez et al. 2008 ( HK , dK , bioK ) 
Naproxen (NPX) 
Suarez et al. 2010 ( HK , dK ), Joss et al. 2006 ( bioK , dK ), Suarez et al. 2008 ( HK  ,
bioK ) 
Diclofenac (DCF) 
Suarez et al. 2010 ( HK , dK ), Joss et al. 2006 ( bioK , dK ), Clara et al. 2004 ( bioK , 
data), Suarez et al. 2008 ( HK , dK , bioK ) 
Fenoprofen Joss et al. 2006 ( bioK , dK ) 
Indomethacin Joss et al. 2006 ( bioK , dK ) 
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Paracetamol Joss et al. 2006 ( bioK , dK , data) 
Fragrances (Musks) 
Galaxolide (HHCB) Suarez et al. 2010 ( HK , dK ), Suarez et al. 2008 ( HK , dK , bioK ) 
Tonalide (AHTN) Suarez et al. 2010 ( HK , dK ), Suarez et al. 2008 ( HK , dK , bioK ) 
Celestolide (ADBI) Suarez et al. 2010 ( HK , dK ), Suarez et al. 2008 ( HK , dK ) 
Other XOCs 
Fluorene Barret et al. 2010 ( partK , DCMK , data) 
Phenanthrene Barret et al. 2010 ( partK , DCMK , data) 
Anthracene Barret et al. 2010 ( partK , DCMK , data) 
Fluoranthene Barret et al. 2010 ( partK , DCMK , data) 
Pyrene Barret et al. 2010 ( partK , DCMK , data) 
Benzo(a)anthracene Barret et al. 2010 ( partK , DCMK , data) 
Chrysene Barret et al. 2010 ( partK , DCMK , data) 
Benzo(b)fluoranthene Barret et al. 2010 ( partK , DCMK , data) 
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Benzo(k)fluoranthene Barret et al. 2010 ( partK , DCMK , data) 
Benzo(a)pyrene Barret et al. 2010 ( partK , DCMK , data) 
Dibenzo(a,h)anthracene Barret et al. 2010 ( partK , DCMK , data) 
Benzo(g,h,i)perylene Barret et al. 2010 ( partK , DCMK , data) 
Indeno(1,2,3,c,d)pyrene Barret et al. 2010 ( partK , DCMK , data) 
Bisphenol-A (BPA) 
Lindblom et al. 2009 ( HK , dK , bioK , data), Clara et al. 2004 ( bioK , data), Siegrist et 
al. 2005 ( dK , bioK ) 
Carbamazepine (CBZ) 
Suarez et al. 2010 ( HK , dK ), Clara et al. 2004 ( bioK , data), Suarez et al. 2008 ( HK ,
dK , bioK ) 
Diazepam (DZP) Suarez et al. 2010 ( HK , dK ), Suarez et al. 2008 ( HK , dK , bioK ) 
Piracetam Joss et al. 2006 ( bioK ) 
Nonylphenol ethoxylate (NPEO’s) Karahan et al. 2010( dK , bioK , data) 
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Appendix H 
Degradation Rate Constant Kbio Observed in Batch 
Experiments with Activated Sludge 
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Degradation rate constant bioK observed in batch experiments with activated sludge from nutrient 
removing wastewater treatment in municipal plants. The range indicates the 95% confidence interval 
obtained from two batch experiments (12 samples, taken over 48 hours).The sign ‘≤’ indicates that the 
lower limit was beyond experimental resolution. CAS: full-scale conventional activated sludge process, 
[17]. 
Group Compound 
bioK for CAS LgSS-1d-1 
Antibiotics Azithromycin ≤0.1 
 Clarothromycin ≤0.4 
 (Anhydro-)erythromicin ≤0.1 
 N4-Ac-sulfamethoxazole 5.9-6.7 
 Roxithromycin ≤0.2 
Antiphlogistics Diclofenac ≤0.1 
 Fenoprofen 10-14 
 Ibuprofen 21-35 
 Indomethacin ≤0.3 
 Naproxen 1.0-1.9 
 Paracetamol 58-80 
Contrast Media ATH 1.3-1.9 
 DAMI 1.9-4.9 
 Diatrizoate ≤0.1 
 Iohexol 1.8-2.4 
 Iomeprol 1.2-1.6 
 Iopmidol ≤0.36 
 Iopromide 1.6-2.5 
 Iothalamic acid ≤0.24 
 Ioxithalamic acid 0.2-0.7 
Lipid regulators Bezafibrate 2.1-3.0 
 Clofibric acid 0.3-0.8 
 Fenofibric acid 7.2-10.8 
 Gemfibrozil 6.4-9.6 
Nootropic Piracetam 2.5-4.3 
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Appendix I 
The Process Variables and The Compound Parameters for 
Case Study 1 
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Mantis model variables and parameters 
  
Initial value in act. 
sludge 
  
COMPONENTS     
Inorganic Suspended Solids   
xii 
inert inorganic 
suspended 
solids 
41 g / m3 
Organic Variables   
si 
soluble inert 
organic 
material 
35 g COD / m3 
ss 
readily 
biodegradable 
substrate 
152 g COD / m3 
xi 
particulate 
inert organic 
material 
58 g COD / m3 
xs 
slowly 
biodegradable 
substrate 
163 g COD / m3 
xbh 
active 
heterotrophic 
biomass 
0 g COD / m3 
xba 
active 
autotrophic 
biomass 
0 g COD / m3 
xu 
unbiodegrada
ble particulate 
matter from 
cell decay 
0 g COD / m3 
Dissolved Oxygen   
so dissolved oxygen g O2/ m
3 
Nitrogen compounds   
snh 
free and 
ionized 
ammonia 
23.45 g N / m3 
snd 
soluble 
biodegradable 
organic 
nitrogen 
3 g N / m3 
xnd 
particulate 
biodegradable 
organic 
nitrogen 
9.27 g N / m3 
sno 
nitrate and 
nitrite 
nitrogen 
0 g N / m3 
snn dissolved dinitrogen 0 g N / m
3 
Alkalinity   
salk alkalinity 7 mole / m
3 
COMPOSITE VARIABLES    
Organic Matter (COD, BOD, TSS)   
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scod filtered COD     187 gCOD/m3 
xcod particulate COD                221 gCOD/m
3 
cod total COD 408 gCOD/m3 
sbod 
filtered 
carbonaceous 
BOD5         
100.3 gO2/m3 
xbod 
particulate 
carbonaceous 
BOD5               
107.6 gO2/m3 
bod 
total 
carbonaceous 
BOD5                
207.9 gO2/m3 
sbodu 
filtered 
ultimate 
carbonaceous 
BOD 
152 gO2/m3 
xbodu 
particulate 
ultimate 
carbonaceous 
BOD               
163 gO2/m3 
bodu 
total ultimate 
carbonaceous 
BOD 
315 gO2/m3 
vss 
volatile 
suspended 
solids                 
122.8 g/m3 
x 
total 
suspended 
solids 
163.8 g/m3 
Inorganic Matter   
xiss 
inert inorganic 
suspended 
solids             
41 g/m3 
Nitrogen compounds   
stkn filtered TKN      26.5 gN/m3 
xtkn 
paticulate 
TKN  13.2 gN/m
3 
tkn total TKN 39.7 gN/m3 
tn 
total nitrogen     
 
                       
39.7 gN/m3 
SMX compounds 
Szf 
concentration 
of dissolved 
SMX parent 
compound 
 
 
 
0.00021 g / m3 
Szg 
concentration 
of substance, 
biotransforme
d via the SMX 
parent 
compound
0.000467 g / m3 
Xza 
concentration 
of SMX 
parent 
0 g / m3 
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compound in 
solid phase 
Stoichiometric and kinetic parameters at 20°C Unit 
Composite Variable 
Stoichiometry     
Organic Fractions   
icv XCOD/VSS   1.48 gCOD/gVSS 
fbod BOD5/BODultimate ratio 0.66 - 
Nutrient Fractions   
ibhn N content of active biomass 0.068 g N / g COD 
iuhn N content of endogenous/inert mass 0.068 g N / g COD 
Model Stoichiometry   
Active Heterotrophic 
Biomass   
yh heterotrophic yield 0.666 gCOD/gCOD 
fuh heterotrophic endogenous fraction 0.08 gCOD/gCOD 
Active Autotrophic 
Biomass    
ya autotrophic yield 0.24 g COD/ g N 
fua autotrophic endogenous fraction 0.080 gCOD/gCOD  
Kinetic   
muh heterotrophic maximum specific growth rate 3.2 1/d 
ksh readily biodegradable substrate half saturation coefficient  5.00 gCOD/m
3 
KDes 
desorption rate coefficient for 
SMX 0.1 1/d 
K1DOx 
SMX aerobic solid-liquid sorption 
coefficient 2.914E-4 m
3/gbiomass 
K1DecOx 
SMX aerobic biotransformation 
rate coefficient  3.312E-2 m
3/gbiomass/d 
 η1Dec 
SMX Correction factor for Ss 
inhibition on CLI formation 1.920  
K1BioOx 
SMX aerobic biotransformation 
rate for CLI 1.529E-3 m
3/gbiomass/d 
 ηbio 
correction factor for Ss inhibition 
on CLI biodegradation 2.886  
K1DAx 
SMX anoxic solid-liquid sorption 
coefficient 5.5E-4 m
3/gbiomass 
K1DecAx 
SMX anoxic biotransformation 
rate coefficient 3.823 E-2 m
3/gbiomass/d 
K1BioAx 
SMX anoxic biotransformation 
rate for CLI 1.529E-3 m
3/gbiomass/d 
Ks half-saturation coefficient for Ss 10 g/m3 
koh aerobic oxygen half saturation coefficient    0.2 gO2/m
3 
kad anoxic oxygen half saturation coefficient  0.2 gO2/m
3 
etag anoxic growth factor 0.50 - 
kno nitrate half saturation coefficient 0.100 gN/m
3 
knh ammonia (as nutrient) half saturation coefficient  0.05 gN/m
3 
bh heterotrophic decay rate 0.62 1/d 
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kalk alkalinity half saturation coefficient 0.10 mole / m
3 
mua autotrophic maximum specific growth rate  0.90 1/d 
kna ammonia (as substrate) half saturation coefficient 0.70 gN/m
3 
koa oxygen half saturation coefficient 0.25 gO2/m
3 
ba autotrophic decay rate 0.17 1/d 
kalka alkalinity half saturation coefficient for autotrophic growth 0.50 mole / m
3 
Hydrolysis   
kh maximum specific hydrolysis rate 3.00 1/d 
kx slowly biodegradable substrate half saturation coefficient 0.10 gCOD/gCOD 
etah anoxic hydrolysis factor 0.60 - 
Ammonification   
ka ammonification rate 0.080 m
3/g COD/d 
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Mantis model variables and 
parameters 
  
 
 
COMPONENTS      
Inorganic Suspended Solids   Initial value in act. sludge Units 
xii inert inorganic suspended solids 69.4 g / m
3 
Organic Variables    
si soluble inert organic material 25 g COD / m
3 
ss readily biodegradable substrate 100 g COD / m
3 
xi particulate inert organic material 65 g COD / m
3 
xs slowly biodegradable substrate 310 g COD / m
3 
xbh active heterotrophic biomass 0 g COD / m
3 
xba active autotrophic biomass 0 g COD / m
3 
xu unbiodegradable particulate matter from cell decay 
0 g COD / m3 
Dissolved Oxygen    
so dissolved oxygen 0 g O2/ m
3 
Nitrogen compounds    
snh free and ionized ammonia 10 g N / m
3 
snd soluble biodegradable organic nitrogen 1.11 g N / m
3 
xnd particulate biodegradable organic nitrogen 
24.5 g N / m3 
sno nitrate and nitrite nitrogen 0 g N / m
3 
snn dissolved dinitrogen 0 g N / m
3 
Alkalinity    
salk alkalinity 7 mole / m
3 
COMPOSITE VARIABLES   
 
Organic Matter (COD, BOD, TSS)    
scod filtered COD                                 125 gCOD/m3 
xcod particulate COD                 204.5 gCOD/m3 
cod total COD 500 gCOD/m3 
sbod filtered carbonaceous BOD5         66 gO2/m3 
xbod particulate carbonaceous BOD5                204.6 gO2/m3 
bod total carbonaceous BOD5                           270.6 gO2/m3 
sbodu filtered ultimate carbonaceous BOD 100 gO2/m3 
xbodu particulate ultimate carbonaceous BOD       310 gO2/m3 
bodu total ultimate carbonaceous BOD 410 gO2/m3 
vss volatile suspended solids                    208.3 g/m3 
x total suspended solids 277.8 g/m3 
Inorganic Matter    
xiss inert inorganic suspended solids             69.4 g/m3 
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Nitrogen compounds    
stkn filtered TKN                                 11.1 gN/m3 
xtkn paticulate TKN 28.9 gN/m3 
tkn total TKN 40 gN/m3 
tn total nitrogen                          40 gN/m3 
NPEO compounds  
Sza (CNPEO) NPEO  concentration in bulk liquid 114 g / m3 
Szb (SS,NPEO) readly biodegradable substrade of NPEO 0 g / m3 
Szc (SH,NPEO) 
slowly biodegradable portion of NPEO  
 
0 g / m3 
Szd (SI,NPEO) non biodegradable portion of NPEO 0 g / m3 
Stoichiometric and kinetic parameters  Unit
Composite Variable Stoichiometry   at 20°C 
Organic Fractions   
icv XCOD/VSS   1.48 gCOD/gVSS 
fbod BOD5/BODultimate ratio 0.66 - 
Nutrient Fractions   
ibhn N content of active biomass 0.068 g N / g COD 
iuhn N content of endogenous/inert mass 0.068 g N / g COD 
Model Stoichiometry   
Active Heterotrophic Biomass   
yh heterotrophic yield 0.666 
gCOD/gCOD 
fuh heterotrophic endogenous fraction 0.08 gCOD/gCOD 
Active Autotrophic Biomass   
ya autotrophic yield 0.24 g COD/ g N 
fua autotrophic endogenous fraction 0.080 gCOD/gCOD  
Kinetic   
muh heterotrophic maximum specific growth rate 3.2 1/d 
ksh readily biodegradable substrate half saturation coefficient  5.00 gCOD/m
3 
muhNPEO rate of heterotrophic growth on NPEO 4.3 1/d 
ksNPEO half saturation coefficient for NPEO 25.0 gCOD/m3 
kbioNPEO 
  0.2168±0.095 m
3/gbiomass/
d 
koh aerobic oxygen half saturation coefficient   0.2 gO2/m
3 
kad anoxic oxygen half saturation coefficient  0.2 gO2/m
3 
etag anoxic growth factor 0.50 - 
kno nitrate half saturation coefficient 0.100 gN/m
3 
knh ammonia (as nutrient) half saturation coefficient  0.05 gN/m
3 
bh heterotrophic decay rate 0.62 1/d 
kalk alkalinity half saturation coefficient 0.10 mole / m3 
mua autotrophic maximum specific growth rate  0.90 1/d 
kna ammonia (as substrate) half saturation coefficient 0.70 gN/m
3 
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koa oxygen half saturation coefficient 0.25 gO2/m
3 
ba autotrophic decay rate 0.17 1/d 
kalka alkalinity half saturation coefficient for autotrophic growth 0.50 mole / m
3 
Hydrolysis   
kh maximum specific hydrolysis rate 3.00 1/d 
Kx slowly biodegradable substrate half saturation coefficient 0.10 gCOD/gCOD 
KhNPEO hydrolysis rate coefficientof NPEO 1.3 1/d 
KxNPEO 
half saturation coefficient for the 
hydrolysis of NPEO 0.0200 gCOD/gCOD 
fINPEO non-biodegradable fraction of NPEO 0.2 gCOD/gCOD 
α 
readly biodegradable fraction of NPEO 
produced through adsorption/oxidative 
cleavage 
0.2 gCOD/gCOD 
KOCL 
first-order adsorption/oxidative cleavage 
coefficient 250.0 1/d 
fes fraction of metabolic products 0.2 gCOD/gCOD 
etah anoxic hydrolysis factor 0.60 - 
Ammonification   
ka ammonification rate 0.080 m3/g COD/d 
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Mantis model variables and parameters 
  
Initial value in act. 
sludge 
  
COMPONENTS     
Inorganic Suspended Solids   
xii inert inorganic suspended solids 59.7 g / m
3 
Organic Variables   
si soluble inert organic material 21.5 g COD / m
3 
ss 
readily 
biodegradable 
substrate 
86 g COD / m3 
xi particulate inert organic material 55.9 g COD / m
3 
xs 
slowly 
biodegradable 
substrate 
266.6 g COD / m3 
xbh 
active 
heterotrophic 
biomass 
0 g COD / m3 
xba 
active 
autotrophic 
biomass 
0 g COD / m3 
xu 
unbiodegradable 
particulate 
matter from cell 
decay 
0 g COD / m3 
Dissolved Oxygen   
so dissolved oxygen g O2/ m
3 
Nitrogen compounds   
snh free and ionized ammonia 10 g N / m
3 
snd 
soluble 
biodegradable 
organic nitrogen 
1.11 g N / m3 
xnd 
particulate 
biodegradable 
organic nitrogen 
25.1 g N / m3 
sno nitrate and nitrite nitrogen 0 g N / m
3 
snn dissolved dinitrogen 0 g N / m
3 
Alkalinity   
salk alkalinity 7 mole / m
3 
COMPOSITE VARIABLES    
Organic Matter (COD, BOD, TSS)   
scod filtered COD         107.5 gCOD/m3 
xcod particulate COD    322.5 gCOD/m3 
cod total COD 430 gCOD/m3 
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sbod 
filtered 
carbonaceous 
BOD5         
56.8 gO2/m3 
xbod 
particulate 
carbonaceous 
BOD5                
176 gO2/m3 
bod 
total 
carbonaceous 
BOD5                    
232.7 gO2/m3 
sbodu 
filtered ultimate 
carbonaceous 
BOD 
86 gO2/m3 
xbodu 
particulate 
ultimate 
carbonaceous 
BOD               
266.6 gO2/m3 
bodu 
total ultimate 
carbonaceous 
BOD 
352.6 gO2/m3 
vss volatile suspended solids   179.2 g/m
3 
x total suspended solids 239.9 g/m
3 
Inorganic Matter   
xiss inert inorganic suspended solids   59.7 g/m
3 
Nitrogen compounds   
stkn filtered TKN         11.1 gN/m3 
xtkn paticulate TKN  28.9 gN/m3 
tkn total TKN 40 gN/m3 
tn 
total nitrogen        
 
                       
40 gN/m3 
Neutral and ionized compounds 
Szh 
concentration of 
neutral dissolved 
Ibuprofen 
0.024 g / m3 
Szi 
concentration of 
ionized 
Ibuprofen 
4.3673 g / m3 
Xzb 
concentration of 
neutral 
particulate 
Ibuprofen 
0 g / m3 
Xzc 
concentration of 
ionized 
particulate 
Ibuprofen 
0 g / m3 
Szj 
concentration of 
neutral dissolved 
Bisphenol-A 
0.024 g / m3 
Xzd 
concentration of 
neutral 
particulate 
Bisphenol-A 
0 g / m3 
Stoichiometric and kinetic parameters at 20°C Unit 
Composite Variable Stoichiometry   
Organic Fractions   
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icv XCOD/VSS   1.8 gCOD/gVSS 
fbod BOD5/BODultimate ratio 0.66 - 
Nutrient Fractions   
ibhn N content of active biomass 0.068 g N / g COD 
iuhn N content of endogenous/inert mass 0.068 g N / g COD 
Model Stoichiometry   
Active Heterotrophic Biomass   
Yh  heterotrophic yield 0.666 gCOD/gCOD 
fuh heterotrophic endogenous fraction 0.08 gCOD/gCOD 
Active Autotrophic Biomass   
ya autotrophic yield 0.24 g COD/ g N 
fua autotrophic endogenous fraction 0.080 
gCOD/gCOD 
 
Kinetic   
muh heterotrophic maximum specific growth rate 3.2 1/d 
ksh 
readily biodegradable 
substrate half saturation 
coefficient  
5.00 gCOD/m3 
Kbio1, Kbio2 
Biodegradation 
coefficient for neutral 
and ionized form of 
compound  
0.1943 m3/gbiomass/d 
KD1 
sorption partition 
coefficient for neutral 
form 
3.23E-4 m3/gbiomass 
KD2 
sorption partition 
coefficient for ionized 
form 1.96E-5  
K1des 
desorption rate 
coefficient for neutral 
form 0.1 
1/d 
K2des 
desorption rate 
coefficient for ionized 
form 0.1 
1/d 
pH   
7  
pKa   
4.74  
Kbio3 
Biodegradation 
coefficient for 
Bisphenol A 0.0502 
m3/gbiomass/d 
K3des 
desorption rate 
coefficient for neutral 
compound (Bisphenol-
A) 
0.1 m3/d 
KD3 
neutral (Bisphenol A) 
partitioning coefficient 4.935E-4 m3/gbiomass 
Ks half-saturation coefficient for Ss 10 g/m
3 
koh aerobic oxygen half saturation coefficient    0.2 gO2/m
3 
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kad anoxic oxygen half saturation coefficient  0.2 gO2/m
3 
etag anoxic growth factor 0.50 - 
kno nitrate half saturation coefficient 0.100 gN/m
3 
knh 
ammonia (as nutrient) 
half saturation 
coefficient  
0.05 gN/m3 
bh heterotrophic decay rate 0.62 1/d 
kalk alkalinity half saturation coefficient 0.10 mole / m
3 
mua autotrophic maximum specific growth rate  0.90 1/d 
kna 
ammonia (as substrate) 
half saturation 
coefficient 
0.70 gN/m3 
koa oxygen half saturation coefficient 0.25 gO2/m
3 
ba autotrophic decay rate 0.17 1/d 
kalka 
alkalinity half saturation 
coefficient for 
autotrophic growth 
0.50 mole / m3 
Hydrolysis   
kh maximum specific hydrolysis rate 3.00 1/d 
kx 
slowly biodegradable 
substrate half saturation 
coefficient 
0.10 gCOD/gCOD 
etah anoxic hydrolysis factor 0.60 - 
Ammonification   
ka ammonification rate 0.080 m
3/g COD/d 
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Six libraries are available for GPS-X: 
‐ Carbon – Nitrogen (CNLIB) 
‐ Carbon – Nitrogen – Industrial Pollutant (CNIPLIB) 
‐ Carbon – Nitrogen – Phosphorus (CNIPLIB) 
‐ Carbon – Nitrogen – Phosphorous – Industrial Pollutant (CNPIPLIB)  
‐ Advanced – Carbon – Nitrogen (CN2LIB) 
‐ Advanced – Carbon – Nitrogen – Industrial Pollutant (CN2IPLIB) 
Table L1. Carbon – Nitrogen – Industrial Pollutant Library (CNIPLIB) 
 
No.  State Variable  GPS-X Symbols Units 
1  Soluble inert organics si gCOD/m3 
2  Readily biodegradable (soluble substrate) ss gCOD/m3 
3  Particulate inert organics  xi gCOD/m3 
4  Slowly biodegradable (Stored, particulate) substrate xs gCOD/m3 
5  Active heterotrophic biomass  xbh gCOD/m3 
6  Active autotrophic biomass  xba gCOD/m3 
7  Unbiodegradable particulate from cell decay xu gCOD/m3 
8  Cell internal storage product  xsto gCOD/m3 
9  Dissolved oxygen  so gO2/m3 
10  Nitrate and nitrite N  sno gN/m3 
11  Free and ionized ammonia  snh gN/m3 
12  Soluble biodegradable organic nitrogen (in ss) snd gN/m3 
13  Particulate biodegradable organic nitrogen (in xs) xnd gN/m3 
14  Dinitrogen  snn gN/m3 
15  Alkalinity  salk Mole/ m3 
16  Inert inorganic suspended solids  xii g/m3 
17  Soluble component “a”  Sza notset 
18  Soluble component “b”  Szb notset 
19  Soluble component “c”  Szc notset 
20  Soluble component “d”  Szd notset 
21  Soluble component “e”  Sze notset 
22  Soluble component “f”  Szf notset 
23  Soluble component “g”  Szg notset 
24  Soluble component “h”  Szh notset 
25  Soluble component “i”  Szi notset 
26  Soluble component “j”  Szj notset 
27  Soluble component “k”  Szk notset 
28  Soluble component “l”  Szl notset 
29  Soluble component “m”  Szm notset 
30  Soluble component “n”  Szn notset 
31  Soluble component “o”  Szo notset 
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32  Particulate component “a”  Xza notset 
33  Particulate component “b”  Xzb notset 
34  Particulate component “c”  Xzc notset 
35  Particulate component “d”  Xzd notset 
36  Particulate component “e”  Xze notset 
37  Particulate component “f”  Xzf notset 
38  Particulate component “g”  Xzg notset 
39  Particulate component “h”  Xzh notset 
40  Particulate component “i”  Xzi notset 
41  Particulate component “j”  Xzj notset 
42  Particulate component “k”  Xzk notset 
43  Particulate component “l”  Xzl notset 
44  Particulate component “m”  Xzm notset 
45  Particulate component “n”  Xzn notset 
46  Particulate component “o”  Xzo notset 
 
Table L2. Nomenclature for the Jacobsen et al. 1996 matrix model 
XA Active nonspecific biomass ML-3 
XI Inactive, organic particulate matter ML-3 
XS Degradable organic particulate matter ML-3 
X1 Active specific biomass for SOC degradation  ML-3 
XSI Sorbed form of specific compound ML-3 
SI Dissolved form of specific compound ML-3 
S Degradable dissolved primary substrate  ML-3 
SO2 Concentration of dissolved oxygen ML-3 
kLa Liquid-air transfer rate T-1 
mμ  Maximum specific biomass growth rate T-1 
, AS X
k   Half saturation constant for XA ML-3 
hydk   Specific hydrolysis rate T
-1 
xk   Half saturation for in monod equation ML
-3 
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AX
b   Specific biomass loss rate for XA T-1 
, ,S X I Sk Half saturation constant for biomass X1 degrading S  ML
-3 
, ,bio m SIk
 
Maximum specific S1 biodegradation rate constant MS1MX1 T-1 
1Xb   Specific biomass loss rate for X1 T
-1 
2,O satS   Saturation concentration of dissolved oxygen ML
-3 
2,O setS   Set point concentration of dissolved oxygen ML
-3 
Y  Biomass growth yield coefficient MX MS-1 
fi Fraction  
 
